
<html lang="en"     class="pb-page"  data-request-id="f1e63d07-059c-449c-b9e4-3310c8fa189f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.9b00847;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity" /></meta><meta name="dc.Creator" content="Lei  Zhang" /></meta><meta name="dc.Creator" content="Christopher R.  Butler" /></meta><meta name="dc.Creator" content="Kevin P.  Maresca" /></meta><meta name="dc.Creator" content="Akihiro  Takano" /></meta><meta name="dc.Creator" content="Sangram  Nag" /></meta><meta name="dc.Creator" content="Zhisheng  Jia" /></meta><meta name="dc.Creator" content="Ryosuke  Arakawa" /></meta><meta name="dc.Creator" content="Justin R.  Piro" /></meta><meta name="dc.Creator" content="Tarek  Samad" /></meta><meta name="dc.Creator" content="Deborah L.  Smith" /></meta><meta name="dc.Creator" content="Deane M.  Nason" /></meta><meta name="dc.Creator" content="Steven  O’Neil" /></meta><meta name="dc.Creator" content="Laura  McAllister" /></meta><meta name="dc.Creator" content="Klaas  Schildknegt" /></meta><meta name="dc.Creator" content="Patrick  Trapa" /></meta><meta name="dc.Creator" content="Timothy J.  McCarthy" /></meta><meta name="dc.Creator" content="Anabella  Villalobos" /></meta><meta name="dc.Creator" content="Christer  Halldin" /></meta><meta name="dc.Description" content="Monoacylglycerol lipase (MAGL), a serine hydrolase extensively expressed throughout the brain, serves as a key gatekeeper regulating the tone of endocannabinoid signaling. Preclinically, inhibition..." /></meta><meta name="Description" content="Monoacylglycerol lipase (MAGL), a serine hydrolase extensively expressed throughout the brain, serves as a key gatekeeper regulating the tone of endocannabinoid signaling. Preclinically, inhibition..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 4, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00847" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00847" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00847" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00847" /></link>
        
    
    

<title>Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00847" /></meta><meta property="og:title" content="Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0013.jpeg" /></meta><meta property="og:description" content="Monoacylglycerol lipase (MAGL), a serine hydrolase extensively expressed throughout the brain, serves as a key gatekeeper regulating the tone of endocannabinoid signaling. Preclinically, inhibition of MAGL is known to provide therapeutic benefits for a number of neurological disorders. The availability of a MAGL-specific positron emission tomography (PET) ligand would considerably facilitate the development and clinical characterization of MAGL inhibitors via noninvasive and quantitative PET imaging. Herein, we report the identification of the potent and selective irreversible MAGL inhibitor 7 (PF-06809247) as a suitable radioligand lead, which upon radiolabeling was found to exhibit a high level of MAGL specificity; this enabled cross-species measurement of MAGL brain expression (Bmax), assessment of in vivo binding in the rat, and nonhuman primate PET imaging." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00847"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00847">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00847&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00847&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00847&amp;href=/doi/10.1021/acs.jmedchem.9b00847" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8532-8543</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00778" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00911" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Lei Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#561a333f780c3e373831651626303f2c33247835393b"><span class="__cf_email__" data-cfemail="c985aca0e793a1a8a7aefa89b9afa0b3acbbe7aaa6a4">[email protected]</span></a>. Phone: +1 617 395 0640.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Zhang">Lei Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8118-1402" title="Orcid link">http://orcid.org/0000-0001-8118-1402</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher R. Butler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher R. Butler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.++Butler">Christopher R. Butler</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9387-5011" title="Orcid link">http://orcid.org/0000-0002-9387-5011</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin P. Maresca</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin P. Maresca</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Clinical & Translational Imaging, Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+P.++Maresca">Kevin P. Maresca</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Akihiro Takano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akihiro Takano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akihiro++Takano">Akihiro Takano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sangram Nag</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sangram Nag</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sangram++Nag">Sangram Nag</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhisheng Jia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhisheng Jia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhisheng++Jia">Zhisheng Jia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ryosuke Arakawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ryosuke Arakawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ryosuke++Arakawa">Ryosuke Arakawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Justin R. Piro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Justin R. Piro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Justin+R.++Piro">Justin R. Piro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tarek Samad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tarek Samad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tarek++Samad">Tarek Samad</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deborah L. Smith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deborah L. Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deborah+L.++Smith">Deborah L. Smith</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deane M. Nason</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deane M. Nason</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deane+M.++Nason">Deane M. Nason</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Steven O’Neil</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steven O’Neil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steven++O%E2%80%99Neil">Steven O’Neil</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura McAllister</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura McAllister</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++McAllister">Laura McAllister</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7406-2843" title="Orcid link">http://orcid.org/0000-0001-7406-2843</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Klaas Schildknegt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Klaas Schildknegt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical Sciences, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Klaas++Schildknegt">Klaas Schildknegt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patrick Trapa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Trapa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Trapa">Patrick Trapa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Timothy J. McCarthy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timothy J. McCarthy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Clinical & Translational Imaging, Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+J.++McCarthy">Timothy J. McCarthy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anabella Villalobos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anabella Villalobos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anabella++Villalobos">Anabella Villalobos</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Christer Halldin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christer Halldin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christer++Halldin">Christer Halldin</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00847&amp;href=/doi/10.1021%2Facs.jmedchem.9b00847" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8532–8543</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 4, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 May 2019</li><li><span class="item_label"><b>Published</b> online</span>4 September 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 September 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00847" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00847</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8532%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLei%2BZhang%252C%2BChristopher%2BR.%2BButler%252C%2BKevin%2BP.%2BMaresca%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D18%26contentID%3Dacs.jmedchem.9b00847%26title%3DIdentification%2Band%2BDevelopment%2Bof%2Ban%2BIrreversible%2BMonoacylglycerol%2BLipase%2B%2528MAGL%2529%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BRadioligand%2Bwith%2BHigh%2BSpecificity%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8543%26publicationDate%3DSeptember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00847"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1677</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00847" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. Butler&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;P. Maresca&quot;},{&quot;first_name&quot;:&quot;Akihiro&quot;,&quot;last_name&quot;:&quot;Takano&quot;},{&quot;first_name&quot;:&quot;Sangram&quot;,&quot;last_name&quot;:&quot;Nag&quot;},{&quot;first_name&quot;:&quot;Zhisheng&quot;,&quot;last_name&quot;:&quot;Jia&quot;},{&quot;first_name&quot;:&quot;Ryosuke&quot;,&quot;last_name&quot;:&quot;Arakawa&quot;},{&quot;first_name&quot;:&quot;Justin&quot;,&quot;last_name&quot;:&quot;R. Piro&quot;},{&quot;first_name&quot;:&quot;Tarek&quot;,&quot;last_name&quot;:&quot;Samad&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;L. Smith&quot;},{&quot;first_name&quot;:&quot;Deane&quot;,&quot;last_name&quot;:&quot;M. Nason&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;O’Neil&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;McAllister&quot;},{&quot;first_name&quot;:&quot;Klaas&quot;,&quot;last_name&quot;:&quot;Schildknegt&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Trapa&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;J. McCarthy&quot;},{&quot;first_name&quot;:&quot;Anabella&quot;,&quot;last_name&quot;:&quot;Villalobos&quot;},{&quot;first_name&quot;:&quot;Christer&quot;,&quot;last_name&quot;:&quot;Halldin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8532-8543&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00847&quot;},&quot;abstract&quot;:&quot;Monoacylglycerol lipase (MAGL), a serine hydrolase extensively expressed throughout the brain, serves as a key gatekeeper regulating the tone of endocannabinoid signaling. Preclinically, inhibition of MAGL is known to provide therapeutic benefits for a number of neurological disorders. The availability of a MAGL-specific positron emission tomography (PET) ligand would considerably facilitate the development and clinical characterization of MAGL inhibitors via noninvasive and quantitative PET imaging. Herein, we report the identification of the potent and selective irreversible MAGL inhibitor 7 (PF-06809247) as a suitable radioligand lead, which upon radiolabeling was found to exhibit a high level of MAGL specificity; this enabled cross-species measurement of MAGL brain expression (Bmax), assessment of in vivo binding in the rat, and nonhuman primate PET imaging.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00847&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00847" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00847&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00847" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00847&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00847" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00847&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00847&amp;href=/doi/10.1021/acs.jmedchem.9b00847" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00847" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00847" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00847%26sid%3Dliteratum%253Aachs%26pmid%3D31483137%26genre%3Darticle%26aulast%3DZhang%26date%3D2019%26atitle%3DIdentification%2Band%2BDevelopment%2Bof%2Ban%2BIrreversible%2BMonoacylglycerol%2BLipase%2B%2528MAGL%2529%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BRadioligand%2Bwith%2BHigh%2BSpecificity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D18%26spage%3D8532%26epage%3D8543%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/jmcmar.2019.62.issue-18/20190926/jmcmar.2019.62.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Monoacylglycerol lipase (MAGL), a serine hydrolase extensively expressed throughout the brain, serves as a key gatekeeper regulating the tone of endocannabinoid signaling. Preclinically, inhibition of MAGL is known to provide therapeutic benefits for a number of neurological disorders. The availability of a MAGL-specific positron emission tomography (PET) ligand would considerably facilitate the development and clinical characterization of MAGL inhibitors via noninvasive and quantitative PET imaging. Herein, we report the identification of the potent and selective irreversible MAGL inhibitor <b>7</b> (PF-06809247) as a suitable radioligand lead, which upon radiolabeling was found to exhibit a high level of MAGL specificity; this enabled cross-species measurement of MAGL brain expression (<i>B</i><sub>max</sub>), assessment of in vivo binding in the rat, and nonhuman primate PET imaging.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Monoacylglycerol lipase (MAGL) is a serine hydrolase target of growing interest due to its bifunctional nature of signaling, both through the endocannabinoid pathway via 2-arachidonoylglycerol (2-AG) as well its influence on arachidonic acid (AA) production in the brain.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> MAGL catalyzes the hydrolysis of 2-AG to liberate AA; approximately, 50% of AA produced in the brain derives from 2-AG. Peripherally, however, phospholipid hydrolysis by cytosolic phospholipase A2 acts as the predominant source of AA. The arachidonate pathway has a significant role in the inflammatory response, as AA is not only an inflammatory signal itself but moreover also can be converted downstream to pro-inflammatory eicosanoids. Thus, the dual impact of MAGL on brain inflammation occurs through the simultaneous modulation of both the endocannabinoid and arachidonate systems:<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> inhibition of MAGL decreases pro-inflammatory eicosanoids and cytokines in the brain while also increasing 2-AG signaling at CB1/2 receptors.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Mouse models of Alzheimer’s disease that invoke disruption of MAGL activity, either through genetic alteration or pharmacological inhibition, exhibit decreased neuroinflammation biomarkers, including cytokines and gliosis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Currently, steroids are the primary intervention for pronounced brain inflammation but are limited in their duration and frequency of dosing due to a lack of precision in their mode of action. As such, there is a strong interest in the development of potent, selective MAGL inhibitors for the treatment of acute and chronic diseases associated with neuroinflammation;<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> this will simultaneously require the identification of quantifiable and translational biomarkers to facilitate clinical development of such inhibitors. Specifically, we are interested in developing a positron emission tomography (PET) radioligand<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> with high target specificity to enable preclinical and clinical characterizations of MAGL inhibitors.</div><div class="NLM_p last">PET is a well-established, noninvasive imaging method that has proven to be particularly valuable for central nervous system (CNS) drug discovery, as it provides quantitative biomarker information, such as target expression and target occupancy measurements, that is otherwise unattainable in the clinical setting.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Our group has previously disclosed a set of physicochemical and in vitro absorption, distribution, metabolism, and excretion (ADME) parameters to guide the rational design of novel CNS PET tracers.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The application of these CNS PET ligand design parameters has facilitated our research team’s discovery of several first-in-class PET ligands, targeting PDE2,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> PDE4B,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and recently BACE1.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Specifically, we focus our PET ligand discovery effort within the favorable physicochemical property space defined by CNS PET multiparameter optimization score (MPO) >3. This optimization increases the likelihood of the desired alignment between passive permeability [Ralph–Russ canine kidney (RRCK) <i>P</i><sub>app</sub> AB > 5 × 10<sup>–6</sup> cm/s]/low efflux (MDR1 BA/AB ≤ 2.5) and fraction unbound in the brain [(Fu_b) > 0.05], for the brain permeability and low risk of nonspecific binding (NSB), respectively. Herein, we describe the discovery, guided by the aforementioned CNS PET ligand design parameters, of the highly specific MAGL PET radioligand lead PF-06809247 (<b>7</b>). This PET ligand enabled the measurement of cross-species MAGL expression, a rat in vivo binding study and, subsequently, a key nonhuman primate (NHP) PET imaging study, which demonstrated rapid brain uptake and high MAGL specificity for <b>7</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our PET ligand discovery effort started with a property survey on the available literature and Pfizer in-house MAGL inhibitor chemotypes, with a primary goal of defining an optimal starting point for PET-specific specific absorption rate (SAR). As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, previously disclosed MAGL PET radioligands bear two different types of leaving groups: a hexafluoroisopropanol (HFIP) moiety, such as [<sup>11</sup>C]KML29 (<b>1</b>)<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> and [<sup>11</sup>C]SAR127303 (<b>3</b>),<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> or a 1,2,4-triazole moiety, as found in [<sup>11</sup>C]JJKK-0048 (<b>2</b>)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and [<sup>11</sup>C]TZPU (<b>4</b>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Ligands incorporating the polar 1,2,4-triazole clearly demonstrate better properties for PET considerations, including low Clog <i>D</i>, favorable CNS PET MPO, and high cFu_b (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). The high reactivity of this moiety, however, leads to unfavorable selectivity versus other serine hydrolases,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and this hampers their usage as PET ligands. Unlike 1,2,4-triazole, HFIP exhibits sufficient reactivity toward Ser122 at the MAGL active site while retaining sufficient stability to minimize off-target serine hydrolase inhibitions, resulting in a desirable level of MAGL potency and selectivity. Unfortunately, the highly lipophilic nature of the HFIP moiety results in suboptimal CNS PET MPO scores (2.00 for compound <b>1</b> and 2.45 for compound <b>3</b>) and exceptionally low fractions unbound in the brain (0.002–0.003 for these two ligands), suggesting a high risk of nonspecific binding (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). In contrast, a new irreversible MAGL inhibitor <b>5</b> bearing a fine-tuned trifluoromethyl glycol leaving group, recently disclosed by our team,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> exhibits a well-balanced profile that not only retains the potency and selectivity of HFIP but also lowers lipophilicity; this translates to both favorable physicochemical properties (CNS PET MPO = 3.81) and a much improved in silico-calculated fraction unbound in the brain (cFu_b = 0.02). Although compound <b>5</b> did not fully satisfy our PET design criteria, it served as an encouraging starting point relative to the other irreversible chemotypes. In an effort to mitigate PET-specific shortcomings, a design strategy was employed that included the following: (1) further reduction in lipophilicity while maintaining desirable MAGL potency/selectivity and (2) introduction of a suitable functional group amenable to late-stage [<sup>3</sup>H]- or [<sup>11</sup>C]-radiolabeling, to enable saturation binding and PET imaging studies (e.g., a methoxy group).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structures of representative literature MAGL inhibitor chemotypes; (B) analysis of CNS PET parameters and serine hydrolase selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the SAR previously reported around <b>5</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> our chemistry effort focused on the R<sup>1</sup> vector due to its toleration of structural variations (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Significant prioritization was applied to potential analogs of interest by using in silico-calculated PET-specific properties. This provided a minimalistic approach that advanced only the top targets to synthesis, through application of the following criteria: (1) improved PET parameters compared to compound <b>5</b>, particularly Clog <i>D</i> and cFu_b; (2) the presence of structural moieties amenable to facile [<sup>3</sup>H]- and [<sup>11</sup>C]-labeling; and (3) the ready availability of coupling reagents plus high synthetic doability. From this exercise, analogs <b>6</b> and <b>7</b> clearly emerged as the top targets, each bearing a methoxy pyridyl moiety suitable for radiolabeling. The calculated PET properties of <b>6</b> and <b>7</b> are given in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, showing decreased lipophilicity (Clog <i>D</i> < 3), favorable predicted passive permeability (cRRCK), low efflux (cMDR1 BA/AB), and improved cFu_b. Compounds <b>6</b> and <b>7</b> were synthesized and evaluated in our primary human MAGL pharmacology assay. Encouragingly, both compounds retained suitable MAGL potency, with an approximately 4-fold drop from the reference compound <b>5</b>. Although the pharmacology profiles of these two compounds were indistinguishable, compound <b>7</b> (PF-06809247) was selected for further advancement, primarily based on structural considerations: this constitutional isomer is free of the potential competition between O- and N-methylation that could complicate radiolabeling of <b>6</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. PET-Specific SAR Around Compound <b>5</b><a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">CNS PET MPO represents the summation of scores of six commonly used individual physicochemical properties, using the transformed functions described in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">In silico-calculated passive permeability as a rate in 1 × 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">In silico-calculated MDR1 efflux ratio.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">In silico-calculated free fractions in the brain.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">IC<sub>50</sub> values measured from human recombinant MAGL enzyme inhibition assay (30 min pre-incubation). Values represent the geometric mean of at least three experiments (for the detailed assay condition, please see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>).</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last"><i>K</i><sub>inact</sub>/<i>K</i><sub>i</sub> ratio in human recombinant MAGL enzyme inhibition assay (for the detailed assay condition, please see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>).</p></div></div><div></div></div><div class="NLM_p">Additional pharmacology and selectivity data, as well as the in vitro pharmacokinetic (PK) profile of <b>7</b>, are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The results reveal minimal cross-species potency differences between human, rat, and mouse MAGL and a high level of selectivity versus fatty acid amide hydrolase (FAAH) (>1000-fold). The experimentally derived in vitro PK parameters align with the in silico-predicted values and reside in favorable PET property space, with good passive permeability (RRCK <i>P</i><sub>app</sub> AB = 13), low efflux (MDR1 BA/AB = 1.3), and improved unbound fractions in the brain (rat Fu_b = 0.041) and plasma (NHP Fu_p = 0.059 and human Fu_p = 0.044). To ascertain the selectivity of <b>7</b> beyond FAAH, it was screened against a panel of serine hydrolases, as summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. At a concentration of 10 μM, <b>7</b> demonstrated modest inhibition of carboxyesterase enzyme CES1 (76%) and α/β hydrolase domain 6 enzyme ABHD6 (67%), with minimal or no inhibition observed for the remainder of the panel, in line with the selectivity expected for this leaving group.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Furthermore, compound <b>7</b> exhibited an exquisite selectivity profile in the CEREP panel (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> showing no significant activities at the test concentration of 10 μM, except for the CB1 receptor (EC<sub>50</sub> = 1.5 μM). Further follow-up with an internal CB1 functional agonism assay revealed no appreciable CB1 agonism activity (EC<sub>50</sub> > 10 μM, see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_001.pdf" class="ext-link">Supporting Information</a>). Prompted by its favorable potency, in vitro PK, and good selectivity profile, compound <b>7</b> was advanced to [<sup>3</sup>H]- and [<sup>11</sup>C]-labeling to further assess its potential as a MAGL radioligand lead in both in vitro and in vivo settings.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Serine hydrolase selectivity profile of compound <b>7</b> (10 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potency, Selectivity, and in Vitro PK Profile of PET Radioligand Lead <b>7</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values measured from human recombinant MAGL enzyme inhibition assay (30 min pre-incubation). Values represent the geometric mean of at least three experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values measured from rat MAGL enzyme inhibition assay (30 min pre-incubation). Values represent the geometric mean of at least three experiments (for the detailed assay condition, please see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values measured from mouse MAGL enzyme inhibition assay (30 min pre-incubation). Values represent the geometric mean of at least three experiments (for the detailed assay condition, please see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>).</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">IC<sub>50</sub> values measured from FAAH enzyme inhibition assay (30 min pre-incubation). Values represent the geometric mean of at least three experiments (for the detailed assay condition, please see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>).</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Passive permeability measured as a rate in 1 × 10<sup>–6</sup> cm/s using the RRCK cell line with low transporter activity isolated from Madin–Darby canine kidney (MDCK) cells.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Ratio from <i>P</i><sub>app</sub> AB and <i>P</i><sub>app</sub> BA of the test compound (1 μM) across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t2fn7"><sup><sup>g</sup></sup><p class="last">Fraction unbound in the rat brain homogenate.</p></div><div class="footnote" id="t2fn8"><sup><sup>h</sup></sup><p class="last">Fraction unbound in the nonhuman primate plasma.</p></div><div class="footnote" id="t2fn9"><sup><sup>i</sup></sup><p class="last">Fraction unbound in the human plasma.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">The synthesis of compounds <b>6</b> and <b>7</b> was achieved using the general strategy outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Beginning with <i>tert</i>-butyl (1<i>R</i>,5<i>S</i>,6r)-6-(1<i>H</i>-pyrazol-3-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>8</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the pyrazole was regioselectively arylated with the requisite methoxypyridine moiety via either a Chan–Lam coupling with a 3-pyridyl boronic acid or a palladium-mediated coupling with a 2-chloropyridine, to afford compounds <b>9</b> and <b>10</b>, respectively. Removal of the <i>tert</i>-butyloxycarbonyl protecting group resulted in the corresponding secondary amines <b>11</b> and <b>12</b>, which were coupled with a mixed carbonate possessing a monoprotected glycol moiety to provide carbamates <b>13</b> and <b>14</b>. Removal of the <i>p</i>-methoxybenzyl (PMB) protecting group was achieved with trifluoroacetyl (TFA), affording the desired targets (<b>6</b> and <b>7</b>) in good yields. The synthesis of <b>7</b> was later modified to enable a late-stage introduction of a radiolabeled methyl group. The alternate synthesis proceeded, as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. In this case, intermediate <b>8</b> was arylated with 5-bromo-2-fluoropyridine via an nucleophilic aromatic substitution reaction. The resulting bromopyridine <b>15</b> was converted to a pinacol boronate and, subsequently, oxidized to hydroxypyridine intermediate <b>17</b>. Deprotection and carbamate formation, as described above, afforded key intermediate <b>20</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup>Reagents and conditions: (a) for compound <b>9</b>, (6-methoxypyridin-3-yl)boronic acid, Cu(OAc)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/pyridine, 40 °C; for compound <b>10</b>, 2-chloro-5-methoxypyridine, Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 120 °C; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt); (c) 1,1′-[carbonylbis(oxy)]dipyrrolidine-2,5-dione or bis(pentafluorophenyl) carbonate, <b>19</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN or tetrahydrofuran (THF), rt; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup>Reagents and conditions: (a) 5-bromo-2-fluoropyridine, Cs<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF), 150 °C, 86%; (b) bis(pinacolato)diboron, Pd(dppf)Cl<sub>2</sub>, KOAc, toluene, 110 °C, 97%; (c) NaOH, H<sub>2</sub>O<sub>2</sub>, THF/H<sub>2</sub>O, quantitative; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (e) bis(pentafluorophenyl)carbonate, <b>19</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN, 50% over two steps.</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>20</b> served as an attractive intermediate for the introduction of both [<sup>3</sup>H] and [<sup>11</sup>C] radiolabels, via methylation of the phenol moiety. To demonstrate the feasibility of this process, compound <b>20</b> was treated with methyl iodide and potassium carbonate in DMF. Methylation of the phenolic group proceeded cleanly, affording compound <b>14</b> in 96% yield (see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). This procedure was later translated into [<sup>3</sup>H]- and [<sup>11</sup>C]-radiolabeling, as illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Methylation of compound <b>20</b> with tritiated methyl iodide (CT<sub>3</sub>I) in DMF, followed by PMB deprotection at room temperature, yielded [<sup>3</sup>H]<b>7</b> in high radiochemical purity (99.2%) and specific activity (77.43 Ci/mmol). The C-11 radiolabeling was accomplished by employing a slightly modified procedure: methylation with [<sup>11</sup>C]methyl triflate, followed by a rapid PMB deprotection using trifluoroacetic acid at 100 °C to afford [<sup>11</sup>C]<b>7</b> in 25% yield. The radiochemical purity was >98% (<i>n</i> = 2), and the molar activity at the time of injection averaged 1640 GBq/μmol. The resultant [<sup>11</sup>C]<b>7</b> was formulated in sterile saline containing <10% (v/v) ethanol and demonstrated stability sufficient for subsequent in vivo studies.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup>Reagents and conditions: (a) CT<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, radiochemical purity 99.2%, specific activity 77.43 Ci/mmol; (c) [<sup>11</sup>C]CH<sub>3</sub>OTf, Cs<sub>2</sub>CO<sub>3</sub>, DMF, followed by TFA, 100 °C, 5 min, radiochemical purity >98%, radiochemical yield 25%, molar activity >1000 GBq/μmol.</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> MAGL Cross-Species Brain Expression (<i>B</i><sub>max</sub>) Determinations</h3><div class="NLM_p"><i>B</i><sub>max</sub> is a critical parameter for PET ligand discovery, as it helps to determine the potential of PET application for a given target, with higher expression corresponding to higher PET feasibility. It also defines the required potency range for novel PET ligand development: most successful PET ligands exhibit a <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> ratio >10.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> With [<sup>3</sup>H]<b>7</b> in hand, we performed a preliminary MAGL specificity assessment in rat brain homogenates, to determine whether there was sufficient specific binding (SB) to allow MAGL <i>B</i><sub>max</sub> measurement. Two rat brain regions were used in this study: frontal cortex and hippocampus. The total binding (TB) was measured using samples pretreated with the vehicle [50 mM Tris/10% dimethyl sulfoxide (DMSO)], while the nonspecific binding (NSB) was assessed using samples pretreated with the selective MAGL inhibitor CPD-4645<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (10 μM). As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, high levels of SB for [<sup>3</sup>H]<b>7</b> were observed for both brain regions: 93% for the rat frontal cortex and 89% for the rat hippocampus. Encouraged by this result, we next conducted a comprehensive saturation binding study of [<sup>3</sup>H]<b>7</b> using rat frontal cortex, rat hippocampus, and NHP frontal cortex brain tissues. Significant levels of MAGL expression were observed across all three brain tissues (>1500 fmol/mg protein), with no significant cross-species differences observed (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The NHP frontal cortex <i>B</i><sub>max</sub> was measured to be 1661 fmol/mg protein, which translates into approximately 83–166 nM based on the assumption of 50<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>–100 mg<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> protein/g wet tissue. The high level of brain MAGL expression suggested good PET imaging feasibility, and that the MAGL potency of <b>7</b> was likely sufficient based on high SB achieved.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Specific binding assessment of [<sup>3</sup>H]<b>7</b> in rat brain homogenates; (B) saturation binding of [<sup>3</sup>H]<b>7</b> in rat and NHP brain tissues for cross-species <i>B</i><sub>max</sub> comparison. TB: total binding; NSB: nonspecific binding; %SB: percentage of specific binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Binding in Rats</h3><div class="NLM_p">With high specific binding demonstrated in the tissue, we next conducted a rat in vivo binding study, to examine whether high MAGL-specific binding could be achieved in vivo. In this experiment, Sprague-Dawley rats were administrated [<sup>3</sup>H]<b>7</b> [50 μCi/kg, intravenous (iv) injection] after 25 min pretreatment with either vehicle or escalating doses of CPD-4645 (0.1–10 mg/kg, sc). Total binding was defined by the vehicle arm, and nonspecific binding was assessed using the group pretreated with CPD-4645 (10 mg/kg). We were gratified to find that the specific binding observed in vitro indeed translated in vivo, with [<sup>3</sup>H]<b>7</b> showing high specific binding in all three brain regions examined (frontal cortex, hippocampus, and cerebellum) as well as in the kidney, a representative peripheral tissue (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Importantly, the binding of [<sup>3</sup>H]<b>7</b> in the three brain regions was shown to be attenuated by CPD-4645 in a dose-dependent manner, providing a robust proof-of-concept for target occupancy measurement in an in vivo setting using <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo target occupancy study of [<sup>3</sup>H]<b>7</b> in Sprague-Dawley rats: (A) specific binding in three representative brain regions and the kidney; (B) dose–response inhibition of [<sup>3</sup>H]<b>7</b> binding by CPD-4645 (0.1, 0.32, 1, 3.2, and 10 mg/kg sc, 25 min, <i>n</i> = 4 per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> NHP PET Imaging</h3><div class="NLM_p">With high MAGL-specific binding clearly demonstrated in both brain tissue saturation binding and in vivo rodent binding studies, compound <b>7</b> was radiolabeled with C-11 and advanced to NHP PET imaging for further assessment. Brain PET images were dynamically acquired for 123 min under baseline condition and pretreatment condition (on the same day), after intravenous administration of [<sup>11</sup>C]<b>7</b> to a cynomolgus monkey. PET measurements were conducted using high-resolution research tomography (HRRT) (Siemens Molecular Imaging). The injected radioactivities (<i>n</i> = 2) of [<sup>11</sup>C]<b>7</b> were 162 and 155 MBq, with molar activities at the time of injection of 1599 and 1680 GBq/μmol, and injected masses of 0.042 and 0.038 μg, respectively, under baseline and pretreatment conditions. The radiochemical purity was higher than 98%. The summed whole-brain PET images were co-registered to the magnetic resonance imaging (MRI) image, as shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. The baseline scan demonstrated rapid, high brain uptake with a wide distribution pattern, as expected for the MAGL target. The time–activity curves (TACs) of the whole brain are shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. The baseline TAC indicated that [<sup>11</sup>C]<b>7</b> reached the peak concentration, ∼3.5 standardized uptake value (SUV) and 3% injected dose (ID), approximately 40 min post-injection and remained relatively plateaued throughout the 2 h time course, consistent with the irreversible nature of the radioligand. After 1 h pretreatment with a blocking compound A<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> at a dose of 1.27 mg/kg, the whole-brain uptake of [<sup>11</sup>C]<b>7</b> decreased clearly to a value of <0.5%ID after approximately 100 min. A robust level of blocking (approximately, 90% based on the average SUV over the 123 min time course) was seen in the NHP images of the pretreatment arm, demonstrating the high in vivo specificity of [<sup>11</sup>C]<b>7</b> in the monkey brain. It is noted that during the course of our work, several MAGL PET radioligands based on reversible chemotypes were recently reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The NHP brain uptake of [<sup>11</sup>C]<b>7</b>, which exceeds a maximum SUV of 3, compares favorably to [<sup>11</sup>C]MA-PB-1,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the best of the published MAGL PET tracers to date, and the in vivo blocking by [<sup>11</sup>C]<b>7</b> is on par with the complete inhibition of the signal reported recently reported for [<sup>18</sup>F]T-401.<a onclick="showRef(event, 'cit22a'); return false;" href="javascript:void(0);" class="ref cit22a">(22a)</a></div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MRI (A) and PET images of [<sup>11</sup>C]<b>7</b> in NHP summed from 0 to 123 min under (B) baseline and (C) blocking (pretreatment with compound A, 1.27 mg/kg, iv) conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Whole-brain time–activity curves for [<sup>11</sup>C]<b>7</b> under baseline and pretreatment conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Prioritization of existing chemical matter through the utilization of the CNS PET radioligand selection criteria enabled a rapid, focused effort to optimize these parameters, along with MAGL potency, and allowed us to identify <b>7</b> as a promising radioligand PET lead. Compound <b>7</b> exhibits high MAGL potency, good passive permeability, low measures of in vitro efflux, and reasonable unbound fraction in the brain. Additionally, <b>7</b> offers radiolabeling flexibility for its utilization in preclinical and clinical studies, as it is amenable to either [<sup>3</sup>H]- or [<sup>11</sup>C]-labeling. Saturation binding of [<sup>3</sup>H]<b>7</b> in rat and NHP brain homogenates showed extensive MAGL expression in the brain and minimal <i>B</i><sub>max</sub> differences across species. In rats, the specific binding of [<sup>3</sup>H]<b>7</b> across multiple brain regions (>90%) was blocked in a dose-responsive manner by a selective MAGL inhibitor. Further evaluation, in an in vivo NHP PET study, revealed a high brain uptake of [<sup>11</sup>C]<b>7</b> at the baseline and clear blocking effects after pretreatment with a MAGL inhibitor, demonstrating high specific binding of <b>7</b> to MAGL sites within the brain. Together, these data support [<sup>11</sup>C]<b>7</b> as a promising radioligand for clinical MAGL PET imaging. Additional studies, including NHP target occupancy, binding kinetics, and radiation dosimetry in NHPs, will be provided in future publications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Biology</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Saturation Binding</h4><div class="NLM_p last">Saturation studies with [<sup>3</sup>H]<b>7</b> were conducted in 96-well microtiter plates in a total volume of 200 μL containing 0.5–70 nM [<sup>3</sup>H]<b>7</b> (77.4 Ci/mmol; 1 mCi/mL). Total binding was defined with 50 mM Tris/10% DMSO. Nonspecific binding was defined with 10 μM CPD-4645. The binding assay was initiated by the addition of 300 μg of brain homogenates in binding buffer [50 mM Tris, 1 mM ethylenediaminetetraacetic acid (EDTA), 10 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), and 1% gelatin; pH 7], followed by incubation at room temperature for 120 min. The reaction was terminated by rapid vacuum filtration (Brandel Harvester) through presoaked (0.3% polyethyleneimine) Whatman GF/B filter sheets using the Brandel ML 96-well harvester, followed by washing with 50 mM Tris. Filters were transferred to scintillation vials containing Ultima Gold MV scintillation cocktail and allowed to sit overnight. Filter-bound radioactivity was measured using the PerkinElmer TriCarb liquid scintillation counter.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo Target Occupancy</h3><div class="NLM_p last">Sprague-Dawley rats were given a single subcutaneous dose (2 mL/kg) of the vehicle (5% DMSO; 5% Cremophor; 90% saline) or CPD-4645 (0.1–10 mg/kg) 25 min prior to an intravenous administration of [<sup>3</sup>H]<b>7</b> (50 μCi/kg). Animals were sacrificed by rapid decapitation 5 min following the iv treatment, and the cerebellum, frontal cortex, and hippocampus were immediately dissected and homogenized (100 mg/mL) in the assay buffer (50 mM Tris, 1 mM EDTA, 10 mM CHAPS, and 1% gelatin; pH 7) with a polytron for 10 s. The 5 min time point post-iv treatment was chosen as it provided maximum radiotracer binding in a time-course study (5, 15, 30, and 60 min post-iv treatment). Brain homogenates (400 μL) were filtered through presoaked (0.3% polyethyleneimine) Whatman GF/B filter circles, followed by 2 × 5 mL of 50 mM Tris. Filters were transferred to scintillation vials containing Ultima Gold MV scintillation cocktail and allowed to sit overnight. Filter-bound radioactivity was measured using the PerkinElmer TriCarb liquid scintillation counter. Total binding was defined by the vehicle, and nonspecific binding was determined by 10 mg/kg of CPD-4645.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Methods</h4><div class="NLM_p">All solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> or MgSO<sub>4</sub>. Concentration in vacuo refers to rotary evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSep Rf 4–120 g silica columns or Biotage disposable columns on a CombiFlash Companion or Biotage Horizon automatic purification system. Purification by mass-triggered high-performance liquid chromatography (HPLC) was carried out using Waters XTerra PrepMS C18 columns, 5 μm, 30 mm × 100 mm. Compounds were presalted as TFA salts and diluted with 1 mL of DMSO. Samples were purified by mass-triggered collection using a mobile phase of acetonitrile and 0.1% TFA in the water, with a gradient of 100% aqueous (aq) to 100% acetonitrile over 10 min at a flow rate of 20 mL/min. Liquid chromatography–mass spectrometry (LC–MS) analyses were performed on a Waters Acquity ultra-performance liquid chromatography (UPLC)–MS system with a Waters Aquity HSS T3, 1.7 μm C18 column (50 mm × 2.1 mm). UPLC conditions: mobile phase A = 0.1% formic acid in water (v/v), mobile phase B = 0.1% formic acid in acetonitrile; flow rate = 1.25 mL/min; compounds were eluted with a gradient of 5–95% B/A for 1.1 min. All tested compounds were found to be >95% pure by this method.</div><div id="sec4_3_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> (2<i>R</i>)-1,1,1-Trifluoro-3-hydroxypropan-2-yl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(6-Methoxypyridin-3-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>6</b>)</h5><div class="NLM_p last">A solution of <b>13</b> (40 mg, 0.075 mmol) in TFA (2 mL) and dichloromethane (2 mL) was stirred at 25 °C for 20 min. The reaction mixture was poured into sat. aq NaHCO<sub>3</sub> (10 mL), and the layers were separated. The aqueous layer was extracted with EtOAc (3 × 10 mL), and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude residue was purified twice by preparative thin-layer chromatography (TLC) (1:1 petroleum ether/EtOAc); the product was further purified by reversed-phase (RP) preparative HPLC [column: Agela Durashell C18, 21.2 mm, 5 μm; gradient: from 33% MeCN (0.225% formic acid) in water (0.225% formic acid) to 53% MeCN (0.225% formic acid) in water (0.225% formic acid); gradient time: 11 min; flow rate: 35 mL/min] to provide <b>6</b> (7.6 mg, 25%) as a light yellow gum. By <sup>1</sup>H NMR analysis, this was judged to be a mixture of rotamers. LC–MS <i>m</i>/<i>z</i> 413.0 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39 (d, <i>J =</i> 2.7 Hz, 1H), 7.90–7.85 (m, 1H), 7.71 (d, <i>J =</i> 2.3 Hz, 1H), 6.83 (d, <i>J =</i> 8.9 Hz, 1H), [6.20 (d, <i>J =</i> 2.3 Hz) and 6.19 (d, <i>J =</i> 2.3 Hz), total 1H], 5.31–5.21 (m, 1H), 4.04–3.98 (m, 1H), 3.97 (s, 3H), 3.92–3.81 (m, 3H), 3.66–3.58 (m, 2H), 2.07–2.00 (m, 2H), 1.90–1.84 (m, 1H).</div></div><div id="sec4_3_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> (2<i>R</i>)-1,1,1-Trifluoro-3-hydroxypropan-2-yl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(5-Methoxypyridin-2-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>7</b>)</h5><div class="NLM_p last">Trifluoroacetic acid (25 mL) was slowly added to a 0 °C solution of <b>14</b> (1.98 g, 3.72 mmol) in dichloromethane (100 mL). The reaction mixture was stirred at room temperature for 45 min, whereupon it was concentrated in vacuo and partitioned between dichloromethane and saturated NaHCO<sub>3</sub>. The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification of the crude residue by flash chromatography on silica gel (gradient: 10–60% ethyl acetate in heptane) afforded 1.31 g (85%) of <b>7</b> as a white solid. By <sup>1</sup>H NMR analysis, this was judged to be a mixture of rotamers. LC–MS <i>m</i>/<i>z</i> 413.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.32 (d, <i>J =</i> 2.5 Hz, 1H), 8.07 (d, <i>J =</i> 2.9 Hz, 1H), 7.80–7.76 (m, 1H), 7.51 (dd, <i>J =</i> 9.0, 3.0 Hz, 1H), [6.26 (d, <i>J =</i> 2.6 Hz) and 6.25 (d, <i>J =</i> 2.8 Hz), total 1H], 5.34–5.24 (m, 1H), 3.94–3.74 (m, 4H), 3.90 (s, 3H), 3.70–3.57 (m, 2H), 2.11–2.02 (m, 2H), [1.86 (dd, <i>J =</i> 3.6, 3.5 Hz) and 1.79 (dd, <i>J =</i> 3.5, 3.4 Hz), total 1H]. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 154.07, 153.70, 153.67, 153.66, 145.39, 145.38, 134.27, 127.32, 127.31, 123.85, 112.64, 104.74, 104.71, 72.63 (q, <i>J</i> = 30.6 Hz), 72.55 (q, <i>J</i> = 30.6 Hz), 60.36 (m), 55.98, 49.34, 49.29, 48.74, 48.66, 25.94, 25.14, 21.29, 21.26, CF<sub>3</sub> carbon not observed.</div></div><div id="sec4_3_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(6-Methoxypyridin-3-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>9</b>)</h5><div class="NLM_p last">To a solution of <i>tert</i>-butyl (1<i>R</i>,5<i>S</i>,6r)-6-(1<i>H</i>-pyrazol-3-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>8</b>) (80 mg, 0.32 mmol) in dichloromethane (10 mL) were added (6-methoxypyridin-3-yl)boronic acid (74 mg, 0.48 mmol), copper(II) acetate (87 mg, 0.48 mmol), pyridine (76 mg, 0.96 mmol), and 4 Å molecular sieves (0.1 g). After the reaction mixture had been stirred for 18 h at 30 °C, an additional aliquot of (6-methoxypyridin-3-yl)boronic acid (40 mg, 0.26 mmol) was added and the reaction mixture was heated at 40 °C for an additional 18 h. The reaction mixture was cooled and washed with aqueous ammonium hydroxide solution (10 mL). This aqueous layer was extracted with dichloromethane (2 × 100 mL), and the combined organic layers were washed with the saturated aqueous sodium chloride solution (20 mL), dried over sodium sulfate, filtered, and concentrated in vacuo. Purification by preparative TLC (3:1 petroleum ether/ethyl acetate) provided 75 mg (66%) of <b>9</b> as a clear oil. LC–MS <i>m</i>/<i>z</i> 357.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 2.4 Hz, 1H), 7.86 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 7.67 (d, <i>J</i> = 2.4 Hz, 1H), 6.79 (d, <i>J</i> = 9.0 Hz, 1H), 6.14 (d, <i>J</i> = 2.8 Hz, 1H), 3.94 (s, 3H), 3.77 (d, <i>J</i> = 10.8 Hz, 1H), 3.69 (d, <i>J</i> = 11.2 Hz, 1H), 3.44 (m, 2H), 1.91 (br s, 2H), 1.82 (t, <i>J</i> = 3.2 Hz, 1H), 1.44 (s, 9H).</div></div><div id="sec4_3_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> <i>tert</i>-Butyl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(5-Methoxypyridin-2-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>10</b>)</h5><div class="NLM_p last">Cesium carbonate (392 mg, 1.2 mmol), Xantphos (70 mg, 0.12 mmol), and tris(dibenzylideneacetone)dipalladium(0) (110 mg, 0.120 mmol) were added to a solution of <b>8</b> (100 mg, 0.40 mmol) and 2-chloro-5-methoxypyridine (86 mg, 0.60 mmol) in 1,4-dioxane (20 mL) at room temperature. The mixture was heated to 120 °C and stirred at that temperature for 18 h, whereupon it was cooled and concentrated at reduced pressure. The crude residue obtained was purified by preparative TLC (3:1 petroleum ether/EtOAc) to afford 40 mg (28%) of <b>10</b> as a yellow oil. LC–MS <i>m</i>/<i>z</i> 357.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.29 (m, 1H), 8.02 (m, 1H), 7.79 (d, <i>J =</i> 9.0 Hz, 1H), 7.29 (d, <i>J =</i> 9.0 Hz, 1H), 6.09 (m, 1H), 3.85 (s, 3H), 3.80–3.67 (m, 2H), 3.48–3.39 (m, 2H), 1.91 (m, 2H), 1.82 (m, 1H), 1.44 (s, 9H).</div></div><div id="sec4_3_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (2<i>R</i>)-1,1,1-Trifluoro-3-[(4-methoxybenzyl)oxy]propan-2-yl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(6-Methoxypyridin-3-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>13</b>)</h5><div class="NLM_p last">Trifluoroacetic acid (5 mL) was added to a solution of <b>9</b> (70 mg, 0.2 mmol) in dichloromethane (5 mL). The reaction mixture was stirred at room temperature for 2 h and then concentrated at reduced pressure to afford crude (1<i>R</i>,5<i>S</i>,6r)-6-[1-(6-methoxypyridin-3-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane (<b>11</b>), trifluoroacetate salt. The crude product was used without further purification. To a solution of (2<i>R</i>)-1,1,1-trifluoro-3-[(4-methoxybenzyl)oxy]propan-2-ol (<b>19</b>) (65 mg, 0.26 mmol) in acetonitrile (2 mL) were added triethylamine (79 mg, 0.78 mmol) and 1,1′-[carbonylbis(oxy)]dipyrrolidine-2,5-dione (67 mg, 0.26 mmol). The reaction mixture was stirred for 18 h at 25 °C and was then treated with a solution of crude <b>11</b>, trifluoroacetate salt (∼0.2 mmol), and triethylamine (83 mg, 0.82 mmol) in acetonitrile (5 mL). The reaction mixture was stirred at 25 °C for 3 days. The reaction mixture was concentrated in vacuo and purified by preparative TLC (2:1 petroleum ether/ethyl acetate) to afford 40 mg (37% over two steps) of <b>13</b> as a yellow oil. By <sup>1</sup>H NMR analysis, this was judged to be a mixture of rotamers. LC–MS <i>m</i>/<i>z</i> 533.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.37 (s, 1H), 7.87 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 7.69 (d, <i>J</i> = 2.2 Hz, 1H), 7.24 (m, 2H), 6.88 (m, 2H), 6.80 (d, <i>J</i> = 8.8 Hz, 1H), 6.18 (d, <i>J</i> = 2.2 Hz, 0.5 H), 6.15 (d, <i>J</i> = 2.2 Hz, 0.5 H), 5.45 (m, 1H), 4.54 (d, <i>J</i> = 12.0 Hz, 1H), 4.46 (d, <i>J</i> = 12.0 Hz, 1H), 3.95 (s, 3H), 3.84–3.56 (m, 6H), 3.80 (s, 0.5 × 3H), 3.79 (s, 0.5 × 3H), 2.00 (br s, 2H), 1.83 (m, 1H).</div></div><div id="sec4_3_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (2<i>R</i>)-1,1,1-Trifluoro-3-[(4-methoxybenzyl)oxy]propan-2-yl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(5-Methoxypyridin-2-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>14</b>)</h5><div class="NLM_p">Method A: Trifluoroacetic acid (5 mL) was added to a solution of <b>10</b> (40 mg, 0.11 mmol) in dichloromethane (5 mL). The reaction mixture was stirred at room temperature for 2 h and then concentrated at reduced pressure to afford crude (1<i>R</i>,5<i>S</i>,6r)-6-[1-(5-methoxypyridin-2-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane (<b>12</b>), trifluoroacetate salt. The crude product was used without further purification. To a solution of <b>19</b> (55 mg, 0.22 mmol) in THF (2 mL) were added triethylamine (67 mg, 0.66 mmol) and bis(pentafluorophenyl) carbonate (87 mg, 0.22 mmol). The reaction mixture was stirred for 6 h at 25 °C and was then treated with a solution of crude <b>12</b>, trifluoroacetate salt (∼0.11 mmol), and triethylamine (49 mg, 0.49 mmol) in THF (2 mL). The reaction mixture was stirred at 25 °C for 8 h, whereupon it was concentrated in vacuo and purified by preparative TLC (3:1 petroleum ether/ethyl acetate) to afford 30 mg (35% over two steps) of <b>14</b> as a yellow oil.</div><div class="NLM_p last">Method B: To a 0 °C solution of <b>20</b> (2.0 g, 3.9 mmol) in acetonitrile (40 mL) were added potassium carbonate (1.6 g, 11.6 mmol) and iodomethane (260 μL, 4.3 mmol), and the reaction mixture was stirred at 60 °C for 3.5 h. The reaction was cooled and again treated with iodomethane (120 μL, 2 mmol). The reaction mixture was stirred for an additional 2 h at 60 °C, cooled to room temperature, and filtered through celite. Concentration in vacuo and purification by silica gel chromatography (gradient: 5–30% ethyl acetate in heptane) afforded <b>14</b> as a viscous, clear oil (1.98 g, 96%). By <sup>1</sup>H NMR analysis, this was judged to be a mixture of rotamers. LC–MS <i>m</i>/<i>z</i> 533.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (d, <i>J =</i> 2.4 Hz, 1H), 8.05 (d, <i>J =</i> 2.8 Hz, 1H), 7.82 (d, <i>J =</i> 8.9 Hz, 1H), 7.32 (dd, <i>J =</i> 9.0, 2.9 Hz, 1H), 7.30–7.23 (m, 2H), 6.94–6.86 (m, 2H), [6.14 (d, <i>J =</i> 2.3 Hz) and 6.13 (d, <i>J =</i> 2.4 Hz), total 1H], 5.54–5.43 (m, 1H), [4.57 (d, half of AB quartet, <i>J =</i> 11.7 Hz) and 4.56 (d, half of AB quartet, <i>J =</i> 11.7 Hz), total 1H], 4.48 (d, half of AB quartet, <i>J =</i> 11.7 Hz, 1H), 3.92–3.65 (m, 4H), 3.87 (s, 3H), [3.81 (s) and 3.78 (s), total 3H], 3.64–3.53 (m, 2H), 2.06–1.97 (m, 2H), 1.89–1.82 (m, 1H).</div></div><div id="sec4_3_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> <i>tert</i>-Butyl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(5-Bromopyridin-2-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>15</b>)</h5><div class="NLM_p last">A mixture of <i>tert</i>-butyl (1<i>R</i>,5<i>S</i>,6r)-6-(1<i>H</i>-pyrazol-3-yl)-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>8</b>) (15.0 g, 60.2 mmol), 5-bromo-2-fluoropyridine (12.6 g, 71.0 mmol), and cesium carbonate (58.8 g, 180 mmol) in DMF (300 mL) was stirred at 150 °C for 1 h. The reaction mixture was cooled and poured into water (1.2 L). The resulting mixture was extracted with EtOAc (3 × 400 mL), and the combined extracts were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude solid obtained was triturated with heptane (500 mL); the remaining solids were collected by filtration and dried to afford 21.06 g (86%) of <b>15</b> as a white solid. LC–MS <i>m</i>/<i>z</i> 405.4, 407.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.41 (dd, <i>J =</i> 2.4, 0.6 Hz, 1H), 8.37 (d, <i>J =</i> 2.6 Hz, 1H), 7.87 (dd, half of ABX pattern, <i>J =</i> 8.7, 2.3 Hz, 1H), 7.80 (dd, half of ABX pattern, <i>J =</i> 8.7, 0.7 Hz, 1H), 6.16 (d, <i>J =</i> 2.6 Hz, 1H), 3.80 (d, <i>J =</i> 11.0 Hz, 1H), 3.72 (d, <i>J =</i> 11.0 Hz, 1H), 3.52–3.42 (m, 2H), 1.99–1.91 (m, 2H), 1.85 (dd, <i>J =</i> 3.5, 3.4 Hz, 1H), 1.47 (s, 9H).</div></div><div id="sec4_3_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> <i>tert</i>-Butyl (1<i>R</i>,5<i>S</i>,6r)-6-{1-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]-1<i>H</i>-pyrazol-3-yl}-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>16</b>)</h5><div class="NLM_p last">To a suspension of <b>15</b> (10.00 g, 24.7 mmol) in toluene (200 mL) were added 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-1,3,2-dioxaborolane (9.6 g, 37.0 mmol), [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (1.81 g, 2.47 mmol), and potassium acetate (7.26 g, 74.0 mmol), and the mixture was degassed with nitrogen for 5 min. The reaction mixture was stirred overnight at 110 °C, then filtered through celite and concentrated in vacuo to afford 17.2 g of a dark oil. The crude residue was purified by chromatography on silica gel (gradient: 0–40% ethyl acetate in heptane) to afford 10.86 g (97%) of <b>16</b> as a tan solid. LC–MS <i>m</i>/<i>z</i> 453.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73–8.69 (m, 1H), 8.48 (d, <i>J =</i> 2.5 Hz, 1H), 8.14 (dd, <i>J =</i> 8.2, 1.8 Hz, 1H), 7.86 (br d, <i>J =</i> 8.2 Hz, 1H), 6.16 (d, <i>J =</i> 2.5 Hz, 1H), 3.81 (d, <i>J =</i> 11 Hz, 1H), 3.73 (d, <i>J =</i> 11 Hz, 1H), 3.53–3.42 (m, 2H), 2.01–1.93 (m, 2H), 1.87 (dd, <i>J =</i> 3.3, 3.3 Hz, 1H), 1.47 (s, 9H), 1.37 (s, 12H).</div></div><div id="sec4_3_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> <i>tert</i>-Butyl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(5-Hydroxypyridin-2-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>17</b>)</h5><div class="NLM_p last">To a 0 °C mixture of <b>16</b> (10.86 g, 24.0 mmol) in tetrahydrofuran and water (1:1 mixture, 800 mL) was added aqueous sodium hydroxide solution (6 M; 11 mL, 66 mmol), followed by hydrogen peroxide (30% solution in water; 8.17 g, 72 mmol). The reaction mixture was warmed to 25 °C and stirred at room temperature overnight. The reaction was quenched with aqueous sodium thiosulfate solution, acidified to pH 6 with aqueous hydrochloric acid, and extracted with dichloromethane (3 × 300 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated under reduced pressure, and purified via chromatography on silica gel (gradient: 10–100% ethyl acetate in heptane) to provide 8.6 g (100%) of <b>17</b> as a white solid. LC–MS <i>m</i>/<i>z</i> 343.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (d, <i>J =</i> 2.4 Hz, 1H), 8.00 (d, <i>J =</i> 2.7 Hz, 1H), 7.73 (d, <i>J =</i> 8.8 Hz, 1H), 7.29 (dd, <i>J =</i> 8.8, 2.7 Hz, 1H), 6.11 (d, <i>J =</i> 2.7 Hz, 1H), 3.78 (d, <i>J =</i> 10.9 Hz, 1H), 3.71 (d, <i>J =</i> 10.9 Hz, 1H), 3.52–3.44 (m, 2H), 1.93 (m, 2H), 1.84 (t, <i>J =</i> 3.5 Hz, 1H), 1.47 (s, 9H).</div></div><div id="sec4_3_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (2<i>R</i>)-1,1,1-Trifluoro-3-[(4-methoxybenzyl)oxy]propan-2-yl (1<i>R</i>,5<i>S</i>,6r)-6-[1-(5-Hydroxypyridin-2-yl)-1<i>H</i>-pyrazol-3-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate (<b>20</b>)</h5><div class="NLM_p last">A solution of <b>17</b> (8.22 g, 24.0 mmol) in dichloromethane (200 mL) was cooled in an ice bath and then treated with trifluoroacetic acid (35 mL). The reaction mixture was stirred for 45 min at 25 °C, whereupon it was concentrated in vacuo. Toluene (100 mL) was added, and the mixture was concentrated in vacuo again to afford the trifluoroacetate salt of 6-{3-[(1<i>R</i>,5<i>S</i>,6r)-3-azabicyclo[3.1.0]hexan-6-yl]-1<i>H</i>-pyrazol-1-yl}pyridin-3-ol (<b>18</b>) as a thick yellow oil. LC–MS <i>m</i>/<i>z</i> 243.2 [M + H]<sup>+</sup>. Bis(pentafluorophenyl)carbonate (12.3 g, 31.2 mmol) was added to a 0 °C solution of <b>19</b> (7.81 g, 31.2 mmol) in acetonitrile (250 mL). Triethylamine (16.8 mL, 120 mmol) was added in a drop-wise manner, and the reaction was warmed to 25 °C and stirred for 1.5 h. The resulting solution of pentafluorophenyl (2<i>R</i>)-1,1,1-trifluoro-3-[(4-methoxybenzyl)oxy]propan-2-yl carbonate was then added to a solution of triethylamine (16.75 mL, 120 mmol) and the trifluoroacetate salt of <b>18</b> (∼24 mmol) in acetonitrile (250 mL) at 0 °C. The reaction mixture was warmed to room temperature and stirred overnight, whereupon it was concentrated in vacuo. The crude residue was dissolved in EtOAc and washed with 1 N HCl (100 mL), saturated NaHCO<sub>3</sub> (100 mL), and brine (100 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford 27.5 g of an amber oil, which was purified via chromatography on silica gel (gradient: 0–40% ethyl acetate in heptane) to provide 6.0 g (50% over two steps) of <b>20</b> as a white solid. By <sup>1</sup>H NMR analysis, this was judged to be a mixture of rotamers. LC–MS <i>m</i>/<i>z</i> 519.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (d, <i>J</i> = 2.4 Hz, 1H), 7.89 (d, <i>J</i> = 2.7 Hz, 1H), 7.74 (d, <i>J</i> = 8.8 Hz, 1H), 7.28–7.24 (m, 3H), 6.92–6.87 (m, 2H), 6.35 (br s, 1H), 6.15 (d, <i>J</i> = 2.4 Hz, 0.5H), 6.12 (d, <i>J</i> = 2.4 Hz, 0.5H), 5.51–5.43 (m, 1H), 4.57 (d, <i>J</i> = 11.7 Hz, 0.5H), 4.56 (d, <i>J</i> = 11.7 Hz, 0.5H), 4.48 (d, <i>J</i> = 11.7 Hz, 1H), 3.89–3.53 (m, 6H), 3.82 (s, 0.5 × 3H), 3.78 (s, 0.5 × 3H), 2.01 (m, 2H), 1.87–1.82 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 159.39, 153.81, 153.34, 153.30, 150.77, 145.18, 135.16, 129.37, 129.27, 127.39, 125.72, 113.91, 113.86, 113.06, 104.84, 104.82, 72.92, 69.75 (q, <i>J</i> = 31.3 Hz), 66.06, 55.28, 55.26, 49.25, 49.23, 48.62, 48.56, 25.94, 25.90, 25.20, 21.20, 21.16, CF<sub>3</sub> carbon not observed.</div></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Radiochemistry</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Synthesis of [<sup>3</sup>H]<b>7</b></h4><div class="NLM_p last">Compound <b>20</b> (3.22 mg, 6.21 μmol) and potassium carbonate (1.40 mg, 9.30 μmol) were mixed with anhydrous DMF (0.4 mL) and stirred for 20 min. To this, was added 50 mCi of tritiated methyl iodide (CT<sub>3</sub>I). The CT<sub>3</sub>I vial was rinsed with 0.1 mL of DMF and added to the reaction mixture. The reaction was sealed and stirred overnight at room temperature. The reaction was then diluted with ethanol, filtered, and evaporated to dryness under vacuum. This gave 48.7 mCi of the crude product with a radiochemical purity of 62.9% by HPLC (Gemini C18 column, 65:35:0.1 acetonitrile/water/TFA). The crude product was dissolved in DMSO (0.97 mL) and purified by HPLC (Gemini C18 semi-Prep column, 10 mm × 250 mm; eluted with 65:35:0.1 acetonitrile/water/TFA at 5.0 mL/min; 0.125 mL injections). The reaction product fractions were combined, diluted with water (three volumes), and passed through a Sep-Pak (Waters C18). The reaction product was eluted with 100% ethanol, which was then concentrated in vacuo to give 28.7 mCi of the protected product (PMB ether of [<sup>3</sup>H]<b>7</b>). This material was dissolved in dichloromethane (0.5 mL) and treated with trifluoroacetic acid (0.25 mL). The reaction mixture was stirred for 2 h at room temperature, whereupon the solvent was evaporated, and the residue was dissolved in ethanol (25.5 mL). Analysis by HPLC (Gemini C18, gradient from 90:10:0.1 to 5:95:0.1 water/acetonitrile/TFA over 15 min; retention time = 12.1 min) showed a radiochemical purity of 99.2%. Total yield was 27.8 mCi at a specific activity of 77.43 Ci/mmol.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Synthesis of [<sup>11</sup>C]<b>7</b></h4><div class="NLM_p last">[<sup>11</sup>C]Methane ([<sup>11</sup>C]CH<sub>4</sub>) was produced in-target via the <sup>14</sup>N(p,α)<sup>11</sup>C reaction on nitrogen mixed with 10% of hydrogen, with 16.4 MeV protons using a GEMS PET trace cyclotron (GE, Uppsala, Sweden). Typically, the target gas was irradiated for 15–20 min with a beam current of 35 μA. <sup>11</sup>C-Labeled methyl iodide, [<sup>11</sup>C]CH<sub>3</sub>I, was produced following the previously published method.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In short, the produced [<sup>11</sup>C]CH<sub>4</sub> was released from the target and collected in a Porapak Q trap cooled in liquid nitrogen. After collection, the [<sup>11</sup>C]CH<sub>4</sub> was released from the trap by heating with the pressurized air, and, subsequently, [<sup>11</sup>C]CH<sub>4</sub> was mixed with vapors from iodine crystals at 60 °C followed by a radical reaction at 720 °C. The formed [<sup>11</sup>C]CH<sub>3</sub>I was collected in a Porapak Q trap at room temperature, and the unreacted [<sup>11</sup>C]CH<sub>4</sub> was recirculated for 3 min. [<sup>11</sup>C]CH<sub>3</sub>I was released from the Porapak Q trap by heating the trap using a custom-made oven at 180 °C. [<sup>11</sup>C]Methyl triflate ([<sup>11</sup>C]CH<sub>3</sub>OTf) was produced by the inline transfer of [<sup>11</sup>C]CH<sub>3</sub>I through a glass column packed with silver triflate at 165 °C. [<sup>11</sup>C]CH<sub>3</sub>OTf was transferred into a solution of <b>20</b> (0.5–1 mg) and Cs<sub>2</sub>CO<sub>3</sub> in DMF by a helium stream. Deprotection was performed by adding TFA with heating at 100 °C for 5 min. The crude reaction mixture was diluted with sterile water (500 μL) before purification via HPLC to obtain the desired radiolabeled product. The HPLC system consisted of a semipreparative reversed-phase (RP) ACE column (C18, 10 mm × 250 mm, 5 μm particle size) and a Merck Hitachi UV detector (λ = 254 nm) (VWR, International, Stockholm, Sweden) in series with a GM-tube (Carroll-Ramsey, Berkeley, CA) used for radioactivity detection. Acetonitrile/TFA was used as the mobile phase. The radioactive fraction corresponding to pure [<sup>11</sup>C]<b>7</b> was collected from the HPLC, and the solvents from the HPLC mobile phase were removed by solid-phase extraction purification. Subsequently, [<sup>11</sup>C]<b>7</b> was eluted with ethanol and formulated in sterile saline containing less than 10% (v/v) ethanol. The product yield was ∼1000 MBq of [<sup>11</sup>C]<b>7</b>. Radiochemical purity (>98%) was analyzed by HPLC (XBridge C18 column, 150 mm × 4.6 mm; eluted with acetonitrile/TFA aqueous solution (0.1%); flow rate: 2 mL/min). [<sup>11</sup>C]<b>7</b> was stable in the formulated solution up to 90 min after the end of synthesis. The total synthesis time including purification was 40 min.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> NHP PET Imaging</h3><div class="NLM_p">The study was approved by the Animal Ethics Committee of the Swedish Animal Welfare Agency and was performed according to “Guidelines for planning, conducting, and documenting experimental research” (Dnr 4820/06-600) of Karolinska Institutet. One cynomolgus monkey (male, body weight 7400 g) was used. The NHP was housed in the Astrid Fagraeus Laboratory (AFL) of the Swedish Institute for Infectious Disease Control, Solna, Sweden. Anesthesia was induced by intramuscular injection of ketamine hydrochloride (approximately 10 mg/kg) at AFL and maintained by the administration of a mixture of isoflurane (1.5–2.0%), oxygen, and the medical air with endotracheal intubation in the KI PET center. The head was immobilized with a fixation device. Body temperature was maintained by a Bair Hugger model 505 (Arizant Healthcare, MN) and monitored by an esophageal thermometer. Electrocardiogram, heart rate, blood pressure, respiratory rate, and oxygen saturation were continuously monitored throughout the experiments. Fluid balance was maintained by a continuous infusion of saline. NHP was scanned twice, one baseline scan and one pretreatment scan on the same day. At pretreatment scan, compound A was administrated intravenously with bolus infusion (15 s, volume; 0.5 mL/kg) of 1.27 mg/kg approximately 1 h before PET scanning. Compound A was formulated by dissolving in phosphate-buffered saline. The pH of the final dose was approximately 7.5.</div><div class="NLM_p last">PET measurements were conducted using high-resolution research tomography (HRRT) (Siemens Molecular Imaging). A transmission scan of 6 min using a single <sup>137</sup>Cs source was performed before the [<sup>11</sup>C]<b>7</b> injection. List-mode data were acquired continuously for 123 min immediately after iv injection of the radioligand. List-mode data were reconstructed with a series of 34 frames (20 s × 9, 1 min × 3, 3 min × 5, and 6 min × 17) using the ordinary Poisson-three-dimensional-ordered subset expectation maximization (OP-3D-OSEM) algorithm, with 10 iterations and 16 subsets including modeling of the point spread function (PSF). The corresponding in-plane resolution with OP-3D-OSEM PSF was 1.5 mm full width at half-maximum in the center of the field of view and 2.4 mm at 10 cm off-center directions. The summed PET images of the whole scanning were co-registered to the MRI image of the individual NHP. By applying the co-registration parameters to the dynamic PET data, the time–activity curves of the whole brain were generated for each PET measurement.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00847" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00847" class="ext-link">10.1021/acs.jmedchem.9b00847</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra for compound <b>7</b> and its phenol precursor <b>20</b>, with peak assignments; selectivity profile of compound <b>7</b> in CEREP and serine hydrolase selectivity panels; the serine hydrolase selectivity profile of the parent compound of prodrug compound A used as the blocking compound in the NHP PET imaging experiment; inhibition data of standard MAGL inhibitors JZL184, KML29 and FAAH inhibitor URB597; in-house CB1 functional agonism assay protocol and dose–response curve of compound <b>7</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_001.pdf">jm9b00847_si_001.pdf (587.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_002.csv">jm9b00847_si_002.csv (0.57 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00847" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Zhang</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal Chemistry, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8118-1402" title="Orcid link">http://orcid.org/0000-0001-8118-1402</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2a664f430470424b444d196a5a4c43504f5804494547"><span class="__cf_email__" data-cfemail="1c5079753246747d727b2f5c6c7a7566796e327f7371">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. Butler</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal Chemistry, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9387-5011" title="Orcid link">http://orcid.org/0000-0002-9387-5011</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin P. Maresca</span> - <span class="hlFld-Affiliation affiliation">Clinical & Translational
Imaging,
Early Clinical Development, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akihiro Takano</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sangram Nag</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhisheng Jia</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryosuke Arakawa</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justin R. Piro</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tarek Samad</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah L. Smith</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deane M. Nason</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal
Chemistry, , and , Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven O’Neil</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal
Chemistry, , and , Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura McAllister</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal Chemistry, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7406-2843" title="Orcid link">http://orcid.org/0000-0001-7406-2843</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaas Schildknegt</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Sciences, , and , Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Trapa</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Pharmacokinetics,
Dynamics and Metabolism, , and , Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy J. McCarthy</span> - <span class="hlFld-Affiliation affiliation">Clinical & Translational
Imaging,
Early Clinical Development, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anabella Villalobos</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal Chemistry, , and , Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christer Halldin</span> - <span class="hlFld-Affiliation affiliation">Department
of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2412-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the Pfizer safety pharmacology group for providing the serine hydrolase selectivity data, the Pfizer ADME technology group for generating the in vitro PK data and developing the in silico RRCK, MDR1 BA/AB, and brain fractions unbound models, and Isosciences for conducting the trituration of compound <b>7</b>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">arachidonic acid</p></td></tr><tr><td class="NLM_term">2-AG</td><td class="NLM_def"><p class="first last">2-arachidonoylglycerol</p></td></tr><tr><td class="NLM_term">B<sub>max</sub></td><td class="NLM_def"><p class="first last">maximal brain expression</p></td></tr><tr><td class="NLM_term">CB</td><td class="NLM_def"><p class="first last">cannabinoid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CES1</td><td class="NLM_def"><p class="first last">carboxyesterase enzyme 1</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">Fu_b</td><td class="NLM_def"><p class="first last">fraction unbound in the brain</p></td></tr><tr><td class="NLM_term">HFIP</td><td class="NLM_def"><p class="first last">hexafluoroisopropanol</p></td></tr><tr><td class="NLM_term">HRRT</td><td class="NLM_def"><p class="first last">high-resolution research tomography</p></td></tr><tr><td class="NLM_term">MAGL</td><td class="NLM_def"><p class="first last">monoacylglycerol lipase</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">NHP</td><td class="NLM_def"><p class="first last">nonhuman primate</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">PSF</td><td class="NLM_def"><p class="first last">point spread function</p></td></tr><tr><td class="NLM_term">RRCK</td><td class="NLM_def"><p class="first last">Ralph–Russ canine kidney</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standardized uptake value</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">total binding</p></td></tr><tr><td class="NLM_term">NSB</td><td class="NLM_def"><p class="first last">nonspecific binding</p></td></tr><tr><td class="NLM_term">SB</td><td class="NLM_def"><p class="first last">specific binding</p></td></tr><tr><td class="NLM_term">TAC</td><td class="NLM_def"><p class="first last">time–activity curve</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabner, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schicho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taschler, U.</span></span> <span> </span><span class="NLM_article-title">Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.pharmthera.2017.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=28213089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2017&pages=35-46&author=G.+F.+Grabnerauthor=R.+Zimmermannauthor=R.+Schichoauthor=U.+Taschler&title=Monoglyceride+lipase+as+a+drug+target%3A+At+the+crossroads+of+arachidonic+acid+metabolism+and+endocannabinoid+signaling&doi=10.1016%2Fj.pharmthera.2017.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling</span></div><div class="casAuthors">Grabner, Gernot F.; Zimmermann, Robert; Schicho, Rudolf; Taschler, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Monoglyerides (MGs) are short-lived, intermediary lipids deriving from the degrdn. of phospho- and neutral lipids, and monoglyceride lipase (MGL), also designated as monoacylglycerol lipase (MAGL), is the major enzyme catalyzing the hydrolysis of MGs into glycerol and fatty acids.  This distinct function enables MGL to regulate a no. of physiol. and pathophysiol. processes since both MGs and fatty acids can act as signaling lipids or precursors thereof.  The most prominent MG species acting as signaling lipid is 2-arachidonoyl glycerol (2-AG) which is the most abundant endogenous agonist of cannabinoid receptors in the body.  Importantly, recent observations demonstrate that 2-AG represents a quant. important source for arachidonic acid, the precursor of prostaglandins and other inflammatory mediators.  Accordingly, MGL-mediated 2-AG degrdn. affects lipid signaling by cannabinoid receptor-dependent and independent mechanisms.  Recent genetic and pharmacol. studies gave important insights into MGL's role in (patho-)physiol. processes, and the enzyme is now considered as a promising drug target for a no. of disorders including cancer, neurodegenerative and inflammatory diseases.  This review summarizes the basics of MG (2-AG) metab. and provides an overview on the therapeutic potential of MGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGvyCs_XBdLVg90H21EOLACvtfcHk0lgKYzCglsFnlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kmt7k%253D&md5=af9f9beaa78954ad700885508e739900</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DGrabner%26aufirst%3DG.%2BF.%26aulast%3DZimmermann%26aufirst%3DR.%26aulast%3DSchicho%26aufirst%3DR.%26aulast%3DTaschler%26aufirst%3DU.%26atitle%3DMonoglyceride%2520lipase%2520as%2520a%2520drug%2520target%253A%2520At%2520the%2520crossroads%2520of%2520arachidonic%2520acid%2520metabolism%2520and%2520endocannabinoid%2520signaling%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D175%26spage%3D35%26epage%3D46%26doi%3D10.1016%2Fj.pharmthera.2017.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blankman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcondes, M. C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1126/science.1209200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1126%2Fscience.1209200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=22021672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=809-813&author=D.+K.+Nomuraauthor=B.+E.+Morrisonauthor=J.+L.+Blankmanauthor=J.+Z.+Longauthor=S.+G.+Kinseyauthor=M.+C.+G.+Marcondesauthor=A.+M.+Wardauthor=Y.+K.+Hahnauthor=A.+H.+Lichtmanauthor=B.+Contiauthor=B.+F.+Cravatt&title=Endocannabinoid+hydrolysis+generates+brain+prostaglandins+that+promote+neuroinflammation&doi=10.1126%2Fscience.1209200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span></div><div class="casAuthors">Nomura, Daniel K.; Morrison, Bradley E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Kinsey, Steven G.; Marcondes, Maria Cecilia G.; Ward, Anna M.; Hahn, Yun Kyung; Lichtman, Aron H.; Conti, Bruno; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6057</span>),
    <span class="NLM_cas:pages">809-813</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Phospholipase A2(PLA2) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins.  Here, we show that a distinct pathway exists in brain, where monoacyl-glycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins.  MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model.  These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA2.  These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRRB-JEf2GrVg90H21EOLACvtfcHk0lgKYzCglsFnlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ&md5=17967f2d83876f57e4bc901df2e7dc68</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1209200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1209200%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DMorrison%26aufirst%3DB.%2BE.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DMarcondes%26aufirst%3DM.%2BC.%2BG.%26aulast%3DWard%26aufirst%3DA.%2BM.%26aulast%3DHahn%26aufirst%3DY.%2BK.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DConti%26aufirst%3DB.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEndocannabinoid%2520hydrolysis%2520generates%2520brain%2520prostaglandins%2520that%2520promote%2520neuroinflammation%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D809%26epage%3D813%26doi%3D10.1126%2Fscience.1209200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Btesh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strassle, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piesla, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uveges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouranova, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, T. A.</span></span> <span> </span><span class="NLM_article-title">Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">996</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1124/mol.110.068304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1124%2Fmol.110.068304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=20855465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=996-1003&author=P.+K.+Chandaauthor=Y.+Gaoauthor=L.+Markauthor=J.+Bteshauthor=B.+W.+Strassleauthor=P.+Luauthor=M.+J.+Pieslaauthor=M.-Y.+Zhangauthor=B.+Binghamauthor=A.+Uvegesauthor=D.+Kowalauthor=D.+Garbeauthor=E.+V.+Kouranovaauthor=R.+H.+Ringauthor=B.+Batesauthor=M.+N.+Pangalosauthor=J.+D.+Kennedyauthor=G.+T.+Whitesideauthor=T.+A.+Samad&title=Monoacylglycerol+lipase+activity+is+a+critical+modulator+of+the+tone+and+integrity+of+the+endocannabinoid+system&doi=10.1124%2Fmol.110.068304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system</span></div><div class="casAuthors">Chanda, Pranab K.; Gao, Ying; Mark, Lilly; Btesh, Joan; Strassle, Brian W.; Lu, Peimin; Piesla, Michael J.; Zhang, Mei-Yi; Bingham, Brendan; Uveges, Albert; Kowal, Dianne; Garbe, David; Kouranova, Evguenia V.; Ring, Robert H.; Bates, Brian; Pangalos, Menelas N.; Kennedy, Jeffrey D.; Whiteside, Garth T.; Samad, Tarek A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">996-1003</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Endocannabinoids are lipid mols. that serve as natural ligands for the cannabinoid receptors CB1 and CB2.  They modulate a diverse set of physiol. processes such as pain, cognition, appetite, and emotional states, and their levels and functions are tightly regulated by enzymic biosynthesis and degrdn.  2-Arachidonoylglycerol (2-AG) is the most abundant endocannabinoid in the brain and is believed to be hydrolyzed primarily by the serine hydrolase monoacylglycerol lipase (MAGL).  Although 2-AG binds and activates cannabinoid receptors in vitro, when administered in vivo, it induces only transient cannabimimetic effects as a result of its rapid catabolism.  Here we show using a mouse model with a targeted disruption of the MAGL gene that MAGL is the major modulator of 2-AG hydrolysis in vivo.  Mice lacking MAGL exhibit dramatically reduced 2-AG hydrolase activity and highly elevated 2-AG levels in the nervous system.  A lack of MAGL activity and subsequent long-term elevation of 2-AG levels lead to desensitization of brain CB1 receptors with a significant redn. of cannabimimetic effects of CB1 agonists.  Also consistent with CB1 desensitization, MAGL-deficient mice do not show alterations in neuropathic and inflammatory pain sensitivity.  These findings provide the first genetic in vivo evidence that MAGL is the major regulator of 2-AG levels and signaling and reveal a pivotal role for 2-AG in modulating CB1 receptor sensitization and endocannabinoid tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXec6NludiW7Vg90H21EOLACvtfcHk0li3u2Oca8zqIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7jF&md5=f6c38107c51f0c6d0f76241043ff988d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.068304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.068304%26sid%3Dliteratum%253Aachs%26aulast%3DChanda%26aufirst%3DP.%2BK.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DMark%26aufirst%3DL.%26aulast%3DBtesh%26aufirst%3DJ.%26aulast%3DStrassle%26aufirst%3DB.%2BW.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DPiesla%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DM.-Y.%26aulast%3DBingham%26aufirst%3DB.%26aulast%3DUveges%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DGarbe%26aufirst%3DD.%26aulast%3DKouranova%26aufirst%3DE.%2BV.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DBates%26aufirst%3DB.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DKennedy%26aufirst%3DJ.%2BD.%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26atitle%3DMonoacylglycerol%2520lipase%2520activity%2520is%2520a%2520critical%2520modulator%2520of%2520the%2520tone%2520and%2520integrity%2520of%2520the%2520endocannabinoid%2520system%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D996%26epage%3D1003%26doi%3D10.1124%2Fmol.110.068304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, T. A.</span></span> <span> </span><span class="NLM_article-title">A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer’s disease</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2012.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.celrep.2012.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=22813736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=617-623&author=J.+R.+Piroauthor=D.+I.+Benjaminauthor=J.+M.+Duerrauthor=Y.+Piauthor=C.+Gonzalesauthor=K.+M.+Woodauthor=J.+W.+Schwartzauthor=D.+K.+Nomuraauthor=T.+A.+Samad&title=A+dysregulated+endocannabinoid-eicosanoid+network+supports+pathogenesis+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.celrep.2012.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Piro, Justin R.; Benjamin, Daniel I.; Duerr, James M.; Pi, YeQing; Gonzales, Cathleen; Wood, Kathleen M.; Schwartz, Joel W.; Nomura, Daniel K.; Samad, Tarek A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">617-623</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although inflammation in the brain is meant as a defense mechanism against neurotoxic stimuli, increasing evidence suggests that uncontrolled, chronic, and persistent inflammation contributes to neurodegeneration.  Most neurodegenerative diseases have now been assocd. with chronic inflammation, including Alzheimer's disease (AD).  Whether anti-inflammatory approaches can be used to treat AD, however, is a major unanswered question.  We recently demonstrated that monoacylglycerol lipase (MAGL) hydrolyzes endocannabinoids to generate the primary arachidonic acid pool for neuroinflammatory prostaglandins.  In this study, we show that genetic inactivation of MAGL attenuates neuroinflammation and lowers amyloid β levels and plaques in an AD mouse model.  We also find that pharmacol. blockade of MAGL recapitulates the cytokine-lowering effects through reduced prostaglandin prodn., rather than enhanced endocannabinoid signaling.  Our findings thus reveal a role of MAGL in modulating neuroinflammation and amyloidosis in AD etiol. and put forth MAGL inhibitors as a potential next-generation strategy for combating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhEmpHXwNVC7Vg90H21EOLACvtfcHk0li3u2Oca8zqIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrsrvM&md5=a84bec802e0b547d6e06052f39d1db0f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DPiro%26aufirst%3DJ.%2BR.%26aulast%3DBenjamin%26aufirst%3DD.%2BI.%26aulast%3DDuerr%26aufirst%3DJ.%2BM.%26aulast%3DPi%26aufirst%3DY.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BW.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26atitle%3DA%2520dysregulated%2520endocannabinoid-eicosanoid%2520network%2520supports%2520pathogenesis%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D1%26spage%3D617%26epage%3D623%26doi%3D10.1016%2Fj.celrep.2012.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span> <span> </span><span class="NLM_article-title">Monoacylglycerol lipase – a target for drug development?</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">1568</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01950.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1111%2Fj.1476-5381.2012.01950.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=22428756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=1568-1585&author=C.+J.+Fowler&title=Monoacylglycerol+lipase+%E2%80%93+a+target+for+drug+development%3F&doi=10.1111%2Fj.1476-5381.2012.01950.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacylglycerol lipase - a target for drug development?</span></div><div class="casAuthors">Fowler, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1568-1585</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid (eCB) system is involved in processes as diverse as control of appetite, perception of pain and the limitation of cancer cell growth and invasion.  The enzymes responsible for eCB breakdown are attractive pharmacol. targets, and fatty acid amide hydrolase inhibitors, which potentiate the levels of the eCB anandamide, are now undergoing pharmaceutical development.  "Drugable" selective inhibitors of monoacylglycerol lipase, a key enzyme regulating the levels of the other main eCB, 2-arachidonoylglycerol, were however not identified until very recently.  Their availability has resulted in a large expansion of our knowledge concerning the pharmacol. consequences of monoacylglycerol lipase inhibition and hence the role(s) played by the enzyme in the body.  In this review, the pharmacol. of monoacylglycerol lipase will be discussed, together with an anal. of the therapeutic potential of monoacylglycerol lipase inhibitors as analgesics and anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2hj7DUJaO97Vg90H21EOLACvtfcHk0lgMBrHlaF4JdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOku7rM&md5=b06b843ca0023abbe4e8cb6be83bcd52</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01950.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01950.x%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DMonoacylglycerol%2520lipase%2520%25E2%2580%2593%2520a%2520target%2520for%2520drug%2520development%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D1568%26epage%3D1585%26doi%3D10.1111%2Fj.1476-5381.2012.01950.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mulvihill, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of monoacylglycerol lipase inhibitors</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2012.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.lfs.2012.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=23142242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKqsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2013&pages=492-497&author=M.+M.+Mulvihillauthor=D.+K.+Nomura&title=Therapeutic+potential+of+monoacylglycerol+lipase+inhibitors&doi=10.1016%2Fj.lfs.2012.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of monoacylglycerol lipase inhibitors</span></div><div class="casAuthors">Mulvihill, Melinda M.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">492-497</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Marijuana and aspirin have been used for millennia to treat a wide range of maladies including pain and inflammation.  Both cannabinoids, like marijuana, that exert anti-inflammatory action through stimulating cannabinoid receptors, and cyclooxygenase (COX) inhibitors, like aspirin, that suppress pro-inflammatory eicosanoid prodn. have shown beneficial outcomes in mouse models of neurodegenerative diseases and cancer.  Both cannabinoids and COX inhibitors, however, have untoward effects that discourage their chronic usage, including cognitive deficits and gastrointestinal toxicity, resp.  Recent studies have uncovered that the serine hydrolase monoacylglycerol lipase (MAGL) links the endocannabinoid and eicosanoid systems together through hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG) to provide the major arachidonic acid (AA) precursor pools for pro-inflammatory eicosanoid synthesis in specific tissues.  Studies in recent years have shown that MAGL inhibitors elicit anti-nociceptive, anxiolytic, and anti-emetic responses and attenuate pptd. withdrawal symptoms in addiction paradigms through enhancing endocannabinoid signaling.  MAGL inhibitors have also been shown to exert anti-inflammatory action in the brain and protect against neurodegeneration through lowering eicosanoid prodn.  In cancer, MAGL inhibitors have been shown to have anti-cancer properties not only through modulating the endocannabinoid-eicosanoid network, but also by controlling fatty acid release for the synthesis of protumorigenic signaling lipids.  Thus, MAGL serves as a crit. node in simultaneously coordinating multiple lipid signaling pathways in both physiol. and disease contexts.  This review will discuss the diverse (patho)physiol. roles of MAGL and the therapeutic potential of MAGL inhibitors in treating a vast array of complex human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojyVx1YSerrVg90H21EOLACvtfcHk0lgMBrHlaF4JdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKqsL7O&md5=cb44625201730a7849701df80fadb708</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2012.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2012.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DM.%2BM.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DTherapeutic%2520potential%2520of%2520monoacylglycerol%2520lipase%2520inhibitors%26jtitle%3DLife%2520Sci.%26date%3D2013%26volume%3D92%26spage%3D492%26epage%3D497%26doi%3D10.1016%2Fj.lfs.2012.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span> For a recent review
on MAGL PET ligand development, please see:<span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phenix, C. P.</span></span> <span> </span><span class="NLM_article-title">Molecular imaging of hydrolytic enzymes using PET and SPECT</span>. <i>Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>, <span class="NLM_elocation-id">1536012117717852</span> <span class="refDoi"> DOI: 10.1177/1536012117717852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1177%2F1536012117717852" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&author=B.+P.+Rempelauthor=E.+W.+Priceauthor=C.+P.+Phenix&title=Molecular+imaging+of+hydrolytic+enzymes+using+PET+and+SPECT&doi=10.1177%2F1536012117717852"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1177%2F1536012117717852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1536012117717852%26sid%3Dliteratum%253Aachs%26aulast%3DRempel%26aufirst%3DB.%2BP.%26aulast%3DPrice%26aufirst%3DE.%2BW.%26aulast%3DPhenix%26aufirst%3DC.%2BP.%26atitle%3DMolecular%2520imaging%2520of%2520hydrolytic%2520enzymes%2520using%2520PET%2520and%2520SPECT%26jtitle%3DMol.%2520Imaging%26date%3D2017%26volume%3D16%26doi%3D10.1177%2F1536012117717852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. J.</span></span> <span> </span><span class="NLM_article-title">Positron emission tomography and single-photon emission computed tomography in central nervous system drug development</span>. <i>NeuroRx</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1602/neurorx.2.2.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1602%2Fneurorx.2.2.226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=15897947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntVeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=226-236&author=D.+J.+Brooks&title=Positron+emission+tomography+and+single-photon+emission+computed+tomography+in+central+nervous+system+drug+development&doi=10.1602%2Fneurorx.2.2.226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography and single-photon emission computed tomography in central nervous system drug development</span></div><div class="casAuthors">Brooks David J</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-36</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">In this review, the value of functional imaging [positron emission tomography (PET)/single-photon emission computed tomography (SPECT)] in drug development is considered.  Radionuclide imaging can help establish the diagnosis of neurodegenerative disorders where this is in doubt and provides a potential biomarker for following drug effects on disease progression.  PET and SPECT can help understand mechanisms of disease and determine the functional effects of therapeutic approaches on neurotransmission and metabolism.  Synthesizing radiotracer analogs of novel drugs can provide proof of principle that these agents reach their enzyme or receptor targets and delineate their regional brain distribution.  If such radiotracers do not prove to have ideal properties for imaging, the concept of microdosing potentially allows multiple other drug analogs to be tested with less stringent regulatory requirements than for novel medicinals.  Finally, PET tracers can provide receptor and enzyme active site dose occupancy profiles, thereby guiding dosage selection for phase 1 and phase 2 trials.  The eventual hope is that radiotracer imaging will provide a surrogate marker for drug efficacy, although this has yet to be realized, and progress the concept of personalized medicine where receptor/enzyme binding profiles help predict therapeutic outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8zmuJRBq_D-3MPKNEWB5RfW6udTcc2ebHBIPdqcN5jrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntVeisQ%253D%253D&md5=fe2cc9f1d9f2418894a104de364126c6</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.2.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.2.226%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DPositron%2520emission%2520tomography%2520and%2520single-photon%2520emission%2520computed%2520tomography%2520in%2520central%2520nervous%2520system%2520drug%2520development%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D226%26epage%3D236%26doi%3D10.1602%2Fneurorx.2.2.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauscher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gründer, G.</span></span> <span> </span><span class="NLM_article-title">The role of imaging in proof of concept for CNS drug discovery and development</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1038/npp.2008.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1038%2Fnpp.2008.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=18843264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=187-203&author=D.+F.+Wongauthor=J.+Tauscherauthor=G.+Gr%C3%BCnder&title=The+role+of+imaging+in+proof+of+concept+for+CNS+drug+discovery+and+development&doi=10.1038%2Fnpp.2008.166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development</span></div><div class="casAuthors">Wong, Dean F.; Tauscher, Johannes; Grunder, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-203</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuroimaging, particularly that of neuroreceptor radioisotope and functional magnetic resonance imaging (fMRI), has played a fundamental role in neuropharmacol. and neurophysiol.  Because of the unique and pioneering role, esp. of the radiolabeling of central nervous system (CNS) drugs for receptor and neurotransmitter system imaging, there is an increasingly major role to aid in CNS drug development.  One component is providing evidence for proof of concept of the target for which candidate drugs are being tested for receptor occupancy mechanism of action and ultimately rational drug dosing.  There is also a role for other areas of neuroimaging, including fMRI and magnetic resonance spectroscopy in other magnetic resonance-based techniques that, together with radioisotope imaging, represent CNS mol. imaging.  ' The role of these approaches and a review of the recent advances in such neuroimaging for proof-of-concept studies is the subject for this paper.  Moreover, hypothetical examples and possible algorithms for early discovery/phase I development using neuroimaging provide specific working approaches.  In summary, this article reviews the vital biomarker approach of neuroimaging in proof of concept studies.  Neuropsychopharmacol. (2009) 34, 187-203; doi:10.1038/npp.2008.166; published online 8 Oct. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8I0KCciAqxbVg90H21EOLACvtfcHk0lgpaTJV59H0Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN&md5=c5c7b9b30303e57ceabf287e7eec35b6</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2008.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2008.166%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520imaging%2520in%2520proof%2520of%2520concept%2520for%2520CNS%2520drug%2520discovery%2520and%2520development%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D187%26epage%3D203%26doi%3D10.1038%2Fnpp.2008.166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Imaging Techniques for Central Nervous System (CNS) Drug Discovery</span>. In  <i>Blood–Brain Barrier in Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span>, <span class="NLM_string-name">Kerns, E. H.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New Jersey</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">384</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1002%2F9781118788523.ch17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=365-384&author=L.+Zhang&author=A.+Villalobosauthor=D.+Li&author=E.+H.+Kerns&title=Blood%E2%80%93Brain+Barrier+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1002%2F9781118788523.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118788523.ch17%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DImaging%2520Techniques%2520for%2520Central%2520Nervous%2520System%2520%2528CNS%2529%2520Drug%2520Discovery%26btitle%3DBlood%25E2%2580%2593Brain%2520Barrier%2520in%2520Drug%2520Discovery%26aulast%3DLi%26aufirst%3DD.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2015%26spage%3D365%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span> <span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4568</span>– <span class="NLM_lpage">4579</span>, <span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lgpaTJV59H0Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuszpit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciabola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of a novel phosphodiesterase (PDE) 4B-preferring radioligand for positron emission tomography (PET) imaging</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8538</span>– <span class="NLM_lpage">8551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOmu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8538-8551&author=L.+Zhangauthor=L.+Chenauthor=E.+M.+Beckauthor=T.+A.+Chappieauthor=R.+V.+Coelhoauthor=S.+D.+Doranauthor=K.-H.+Fanauthor=C.+J.+Helalauthor=J.+M.+Humphreyauthor=Z.+Hughesauthor=K.+Kuszpitauthor=E.+A.+Lachapelleauthor=J.+T.+Lazzaroauthor=C.+Leeauthor=R.+J.+Matherauthor=N.+C.+Patelauthor=M.+B.+Skaddanauthor=S.+Sciabolaauthor=P.+R.+Verhoestauthor=J.+M.+Youngauthor=K.+Zasadnyauthor=A.+Villalobos&title=The+discovery+of+a+novel+phosphodiesterase+%28PDE%29+4B-preferring+radioligand+for+positron+emission+tomography+%28PET%29+imaging&doi=10.1021%2Facs.jmedchem.7b01050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging</span></div><div class="casAuthors">Zhang, Lei; Chen, Laigao; Beck, Elizabeth M.; Chappie, Thomas A.; Coelho, Richard V.; Doran, Shawn D.; Fan, Kuo-Hsien; Humphrey, John M.; Hughes, Zoe; Kuszpit, Kyle; Lachapelle, Erik A.; Lazzaro, John T.; Mather, Robert J.; Patel, Nandini C.; Skaddan, Marc B.; Sciabola, Simone; Verhoest, Patrick R.; Young, Joseph M.; Zasadny, Kenneth; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8538-8551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort in identifying phosphodiesterase (PDE) 4B-preferring inhibitors for the treatment of central nervous system (CNS) disorders, we sought to identify a positron emission tomog. (PET) ligand to enable target occupancy measurement in vivo.  Through a systematic and cost-effective PET discovery process, involving expression level (Bmax) and biodistribution detn., a PET-specific structure-activity relationship (SAR) effort, and specific binding assessment using a LC-MS/MS "cold tracer" method, we have identified 8 (PF-06445974) as a promising PET lead.  Compd. 8 has exquisite potency at PDE4B, good selectivity over PDE4D, excellent brain permeability, and a high level of specific binding in the "cold tracer" study.  In subsequent non-human primate (NHP) PET imaging studies, [18F]8 showed rapid brain uptake and high target specificity, indicating that [18F]8 is a promising PDE4B-preferring radioligand for clin. PET imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAKXd3Cu5nRLVg90H21EOLACvtfcHk0ljRVazLcAwp2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOmu7fI&md5=cecad407201ce6c59ac5a3257e921d07</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01050%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DCoelho%26aufirst%3DR.%2BV.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DFan%26aufirst%3DK.-H.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DZ.%26aulast%3DKuszpit%26aufirst%3DK.%26aulast%3DLachapelle%26aufirst%3DE.%2BA.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520a%2520novel%2520phosphodiesterase%2520%2528PDE%2529%25204B-preferring%2520radioligand%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8538%26epage%3D8551%26doi%3D10.1021%2Facs.jmedchem.7b01050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schildknegt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel positron emission tomography (PET) ligand for imaging β-site amyloid precursor protein cleaving enzyme 1 (BACE-1) in brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3296</span>– <span class="NLM_lpage">3308</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01769</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01769" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlyqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3296-3308&author=L.+Zhangauthor=L.+Chenauthor=J.+K.+Dutraauthor=E.+M.+Beckauthor=S.+Nagauthor=A.+Takanoauthor=N.+Aminiauthor=R.+Arakawaauthor=M.+A.+Brodneyauthor=L.+M.+Buzonauthor=S.+D.+Doranauthor=L.+F.+Lanyonauthor=T.+J.+McCarthyauthor=K.+R.+Balesauthor=C.+E.+Nolanauthor=B.+T.+O%E2%80%99Neillauthor=K.+Schildknegtauthor=C.+Halldinauthor=A.+Villalobos&title=Identification+of+a+novel+positron+emission+tomography+%28PET%29+ligand+for+imaging+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE-1%29+in+brain&doi=10.1021%2Facs.jmedchem.7b01769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain</span></div><div class="casAuthors">Zhang, Lei; Chen, Laigao; Dutra, Jason K.; Beck, Elizabeth M.; Nag, Sangram; Takano, Akihiro; Amini, Nahid; Arakawa, Ryosuke; Brodney, Michael A.; Buzon, Leanne M.; Doran, Shawn D.; Lanyon, Lorraine F.; McCarthy, Timothy J.; Bales, Kelly R.; Nolan, Charles E.; O'Neill, Brian T.; Schildknegt, Klaas; Halldin, Christer; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3296-3308</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by accumulation of β-amyloid (Aβ) plaques and neurofibrillary tau tangles in the brain. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) plays a key role in the generation of Aβ fragments via extracellular cleavage of the amyloid precursor protein (APP).  We became interested in developing a BACE1 PET ligand to facilitate clin. assessment of BACE1 inhibitors and explore its potential in the profiling and selection of patients for AD trials.  Using a set of PET ligand design parameters, compd. 3 (PF-06684511) was rapidly identified as a lead with favorable in vitro attributes and structural handles for PET radiolabeling.  Further evaluation in an LC-MS/MS "cold tracer" study in rodents revealed high specific binding to BACE1 in brain.  Upon radiolabeling, [18F]3 demonstrated favorable brain uptake and high in vivo specificity in nonhuman primate (NHP), suggesting its potential for imaging BACE1 in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG1yVp-f2aurVg90H21EOLACvtfcHk0ljRVazLcAwp2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyqu78%253D&md5=97501718b6e3db68047b7dae264a48bd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01769%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DNag%26aufirst%3DS.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DArakawa%26aufirst%3DR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DLanyon%26aufirst%3DL.%2BF.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DSchildknegt%26aufirst%3DK.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520a%2520novel%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligand%2520for%2520imaging%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE-1%2529%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3296%26epage%3D3308%26doi%3D10.1021%2Facs.jmedchem.7b01769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niphakis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cognetta, A. B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buczynski, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.chembiol.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=22542104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=579-588&author=J.+W.+Changauthor=M.+J.+Niphakisauthor=K.+M.+Lumauthor=A.+B.+Cognettaauthor=C.+Wangauthor=M.+L.+Matthewsauthor=S.+Niessenauthor=M.+W.+Buczynskiauthor=L.+H.+Parsonsauthor=B.+F.+Cravatt&title=Highly+selective+inhibitors+of+monoacylglycerol+lipase+bearing+a+reactive+group+that+is+bioisosteric+with+endocannabinoid+substrates&doi=10.1016%2Fj.chembiol.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span></div><div class="casAuthors">Chang, Jae Won; Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B.; Wang, Chu; Matthews, Megan L.; Niessen, Sherry; Buczynski, Matthew W.; Parsons, Loren H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), resp.  The recent discovery of O-aryl carbamates such as JZL184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo.  Nonetheless, JZL184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biol. studies.  Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH.  These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWEmTTUlQHCLVg90H21EOLACvtfcHk0lg7IiajcduhYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D&md5=d318d890c4c799d1579daab2e2c201f4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMatthews%26aufirst%3DM.%2BL.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DHighly%2520selective%2520inhibitors%2520of%2520monoacylglycerol%2520lipase%2520bearing%2520a%2520reactive%2520group%2520that%2520is%2520bioisosteric%2520with%2520endocannabinoid%2520substrates%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D579%26epage%3D588%26doi%3D10.1016%2Fj.chembiol.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotstein, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasdev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of sulfonamido-based [<sup>11</sup>C-<i>carbonyl</i>]-carbamates and ureas for imaging monoacylglycerol lipase</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1145</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.7150/thno.15257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.7150%2Fthno.15257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=27279908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Cis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1145-1159&author=L.+Wangauthor=W.+Moriauthor=R.+Chengauthor=J.+Yuiauthor=A.+Hatoriauthor=L.+Maauthor=Y.+Zhangauthor=B.+H.+Rotsteinauthor=M.+Fujinagaauthor=Y.+Shimodaauthor=T.+Yamasakiauthor=L.+Xieauthor=Y.+Nagaiauthor=T.+Minamimotoauthor=M.+Higuchiauthor=N.+Vasdevauthor=M.-R.+Zhangauthor=S.+H.+Liang&title=Synthesis+and+preclinical+evaluation+of+sulfonamido-based+%5B11C-carbonyl%5D-carbamates+and+ureas+for+imaging+monoacylglycerol+lipase&doi=10.7150%2Fthno.15257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preclinical evaluation of sulfonamidobased [11C-carbonyl]-carbamates and ureas for imaging monoacylglycerol lipase</span></div><div class="casAuthors">Wang, Lu; Mori, Wakana; Cheng, Ran; Yui, Joji; Hatori, Akiko; Ma, Longle; Zhang, Yiding; Rotstein, Benjamin H.; Fujinaga, Masayuki; Shimoda, Yoko; Yamasaki, Tomoteru; Xie, Lin; Nagai, Yuji; Minamimoto, Takafumi; Higuchi, Makoto; Vasdev, Neil; Zhang, Ming-Rong; Liang, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1145-1159</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a 33 kDa member of the serine hydrolase superfamily that preferentially degrades 2-arachidonoylglycerol (2-AG) to arachidonic acid in the endocannabinoid system.  Inhibition of MAGL is not only of interest for probing the cannabinoid pathway but also as a therapeutic and diagnostic target for neuroinflammation.  Limited attempts have been made to image MAGL in vivo and a suitable PET ligand for this target has yet to be identified and is urgently sought to guide small mol. drug development in this pathway.  Herein we synthesized and evaluated the physiochem. properties of an array of eleven sulfonamido-based carbamates and ureas with a series of terminal aryl moieties, linkers and leaving groups.  The most potent compds. were a novel MAGL inhibitor, N-((1-(1H-1,2,4-triazole-1-carbonyl)piperidin-4-yl) methyl)-4-chlorobenzenesulfonamide (TZPU; IC50 = 35.9 nM), and the known inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(((4-chlorophenyl)sulfonamido) methyl)piperidine-1- carboxylate (SAR127303; IC50 = 39.3 nM), which were also shown to be selective for MAGL over fatty acid amide hydrolase (FAAH), and cannabinoid receptors (CB1 & CB2).  Both of these compds. were radiolabeled with carbon-11 via [11C]COCl2, followed by comprehensive ex vivo biodistribution and in vivo PET imaging studies in normal rats to det. their brain permeability, specificity, clearance and metab.  Whereas TZPU did not show adequate specificity to warrant further evaluation, [11C]SAR127303 was advanced for preliminary PET neuroimaging studies in nonhuman primate.  The tracer showed good brain permeability (ca. 1 SUV) and heterogeneous regional brain distribution which is consistent with the distribution of MAGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5MOdhV6XvFbVg90H21EOLACvtfcHk0lg7IiajcduhYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Cis78%253D&md5=eb8493b2b83af17721a22d03151b7ba2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.7150%2Fthno.15257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.15257%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DRotstein%26aufirst%3DB.%2BH.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DShimoda%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DMinamimoto%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520sulfonamido-based%2520%255B11C-carbonyl%255D-carbamates%2520and%2520ureas%2520for%2520imaging%2520monoacylglycerol%2520lipase%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26spage%3D1145%26epage%3D1159%26doi%3D10.7150%2Fthno.15257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Griebel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeské, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Françon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Even, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Grancha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolstykh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houtmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallée, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augé, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergis, O. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avenet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikol, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escoubet, J.</span></span> <span> </span><span class="NLM_article-title">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">7642</span> <span class="refDoi"> DOI: 10.1038/srep07642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1038%2Fsrep07642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=25560837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&author=G.+Griebelauthor=P.+Pichatauthor=S.+Beesk%C3%A9author=T.+Leroyauthor=N.+Redonauthor=A.+Jacquetauthor=D.+Fran%C3%A7onauthor=L.+Bertauthor=L.+Evenauthor=M.+Lopez-Granchaauthor=T.+Tolstykhauthor=F.+Sunauthor=Q.+Yuauthor=S.+Brittainauthor=H.+Arltauthor=T.+Heauthor=B.+Zhangauthor=D.+Wiederschainauthor=T.+Bertrandauthor=J.+Houtmannauthor=A.+Rakauthor=F.+Vall%C3%A9eauthor=N.+Michotauthor=F.+Aug%C3%A9author=V.+Menetauthor=O.+E.+Bergisauthor=P.+Georgeauthor=P.+Avenetauthor=V.+Mikolauthor=M.+Didierauthor=J.+Escoubet&title=Selective+blockade+of+the+hydrolysis+of+the+endocannabinoid+2-arachidonoylglycerol+impairs+learning+and+memory+performance+while+producing+antinociceptive+activity+in+rodents&doi=10.1038%2Fsrep07642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span></div><div class="casAuthors">Griebel, Guy; Pichat, Philippe; Beeske, Sandra; Leroy, Thibaud; Redon, Nicolas; Jacquet, Agnes; Francon, Dominique; Bert, Lionel; Even, Luc; Lopez-Grancha, Mati; Tolstykh, Tatiana; Sun, Fangxian; Yu, Qunyan; Brittain, Scott; Arlt, Heike; He, Timothy; Zhang, Bailin; Wiederschain, Dmitri; Bertrand, Thomas; Houtmann, Jacques; Rak, Alexey; Vallee, Francois; Michot, Nadine; Auge, Franck; Menet, Veronique; Bergis, Olivier E.; George, Pascal; Avenet, Patrick; Mikol, Vincent; Didier, Michel; Escoubet, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7642</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) represents a primary degrdn. enzyme of the endogenous cannabinoid (eCB), 2-arachidonoyglycerol (2-AG).  This study reports a potent covalent MAGL inhibitor, SAR127303.  The compd. behaves as a selective and competitive inhibitor of mouse and human MAGL, which potently elevates hippocampal levels of 2-AG in mice.  In vivo, SAR127303 produces antinociceptive effects in assays of inflammatory and visceral pain.  In addn., the drug alters learning performance in several assays related to episodic, working and spatial memory.  Moreover, long term potentiation (LTP) of CA1 synaptic transmission and acetylcholine release in the hippocampus, two hallmarks of memory function, are both decreased by SAR127303.  Although inactive in acute seizure tests, repeated administration of SAR127303 delays the acquisition and decreases kindled seizures in mice, indicating that the drug slows down epileptogenesis, a finding deserving further investigation to evaluate the potential of MAGL inhibitors as antiepileptics.  However, the observation that 2-AG hydrolysis blockade alters learning and memory performance, suggests that such drugs may have limited value as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiPpgk18M26bVg90H21EOLACvtfcHk0lgLjtkhYiYbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL&md5=4160ed016b730ea80abb5c093e66a284</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2Fsrep07642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07642%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DPichat%26aufirst%3DP.%26aulast%3DBeesk%25C3%25A9%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DT.%26aulast%3DRedon%26aufirst%3DN.%26aulast%3DJacquet%26aufirst%3DA.%26aulast%3DFran%25C3%25A7on%26aufirst%3DD.%26aulast%3DBert%26aufirst%3DL.%26aulast%3DEven%26aufirst%3DL.%26aulast%3DLopez-Grancha%26aufirst%3DM.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DBrittain%26aufirst%3DS.%26aulast%3DArlt%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DAug%25C3%25A9%26aufirst%3DF.%26aulast%3DMenet%26aufirst%3DV.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DDidier%26aufirst%3DM.%26aulast%3DEscoubet%26aufirst%3DJ.%26atitle%3DSelective%2520blockade%2520of%2520the%2520hydrolysis%2520of%2520the%2520endocannabinoid%25202-arachidonoylglycerol%2520impairs%2520learning%2520and%2520memory%2520performance%2520while%2520producing%2520antinociceptive%2520activity%2520in%2520rodents%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26doi%3D10.1038%2Fsrep07642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Placzek, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Bittner, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span> <span> </span><span class="NLM_article-title">A novel radiotracer for imaging monoacylglycerol lipase in the brain using positron emission tomography</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.5b00293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=484-489&author=C.+Wangauthor=M.+S.+Placzekauthor=G.+C.+Van+de+Bittnerauthor=F.+A.+Schroederauthor=J.+M.+Hooker&title=A+novel+radiotracer+for+imaging+monoacylglycerol+lipase+in+the+brain+using+positron+emission+tomography&doi=10.1021%2Facschemneuro.5b00293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography</span></div><div class="casAuthors">Wang, Changning; Placzek, Michael S.; Van de Bittner, Genevieve C.; Schroeder, Frederick A.; Hooker, Jacob M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">484-489</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a serine hydrolase that hydrolyzes monoacylglycerols to glycerol and fatty acid and plays an important role in neuroinflammation.  MAGL inhibitors are a class of mols. with therapeutic potential for human diseases of the central nervous system (CNS), in areas such as pain and inflammation, immunol. disorders, and neurol. and psychiatric conditions.  Development of a noninvasive imaging probe would elucidate the distribution and functional roles of MAGL in the brain and accelerate medical research and drug discovery in this domain.  Herein, we describe the synthesis and pilot rodent imaging of a novel MAGL imaging agent, [11C]SAR127303.  Our imaging results demonstrate the high specificity, good selectivity, and appropriate kinetics and distribution of [11C]SAR127303, validating its utility for imaging MAGL in the brain.  Our findings support the translational potential for human CNS MAGL imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKwFMlYYqhfbVg90H21EOLACvtfcHk0lgLjtkhYiYbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7nP&md5=0cc854816045539b5ccb7b5d7819372b</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00293%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DPlaczek%26aufirst%3DM.%2BS.%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%2BC.%26aulast%3DSchroeder%26aufirst%3DF.%2BA.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26atitle%3DA%2520novel%2520radiotracer%2520for%2520imaging%2520monoacylglycerol%2520lipase%2520in%2520the%2520brain%2520using%2520positron%2520emission%2520tomography%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D484%26epage%3D489%26doi%3D10.1021%2Facschemneuro.5b00293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasdev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and ex vivo evaluation of [<sup>11</sup>C-<i>carbonyl</i>]carbamate- and urea-based monoacylglycerol lipase inhibitors</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.nucmedbio.2014.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=24969632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFentb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=688-694&author=J.+W.+Hicksauthor=J.+Parkesauthor=J.+Tongauthor=S.+Houleauthor=N.+Vasdevauthor=A.+A.+Wilson&title=Radiosynthesis+and+ex+vivo+evaluation+of+%5B11C-carbonyl%5Dcarbamate-+and+urea-based+monoacylglycerol+lipase+inhibitors&doi=10.1016%2Fj.nucmedbio.2014.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and ex vivo evaluation of [11C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors</span></div><div class="casAuthors">Hicks, Justin W.; Parkes, Jun; Tong, Junchao; Houle, Sylvain; Vasdev, Neil; Wilson, Alan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">688-694</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH) are the two primary enzymes that regulate the tone of endocannabinoid signaling.  Although new PET radiotracers have been discovered for imaging FAAH in vivo, no such radiotracer exists for imaging MAGL.  Here we report the radiosynthesis of five candidate MAGL radiotracers and their ex vivo evaluations in mice and rats.Candidate carbamate and urea MAGL inhibitors were radiolabeled at the carbonyl position by [11C]CO2 fixation.  Radiotracers were administered (tail-vein injection) to rodents and brain uptake of radioactivity measured at early and late time points ex vivo.  Specificity of uptake was explored by pretreatment with unlabeled inhibitors (2 mg/kg, i.p.) 30 min prior to radiotracer administration.All five candidate MAGL radiotracers were prepd. in high specific activity (> 65 GBq/μmol) and radiochem. purity (> 98%).  Moderate brain uptake (0.2-0.8 SUV) was obsd. for each candidate while pretreatment did not reduce uptake for four of the five tested.  For two candidates ([11C]12 and [11C]14), high retention of radioactivity was obsd. in the blood (ca. 10 and 4 SUV at 40 min) which was blocked by pretreatment with unlabeled inhibitors.  The most promising candidate, [11C]18, demonstrated moderate brain uptake (ca. 0.8 SUV) which showed circa 50% blockade by pretreatment with unlabeled 18.One putative and four reported potent and selective MAGL inhibitors have been radiolabeled via [11C]CO2 fixation as radiotracers for this enzyme.  Despite the promising in vitro pharmacol. profile, none of the five candidate radiotracers exhibited in vivo behavior suitable for PET neuroimaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi4CWj3XLZqrVg90H21EOLACvtfcHk0lgLjtkhYiYbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFentb3M&md5=dcedea3b995995c96c88e7fa130378fa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DParkes%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26atitle%3DRadiosynthesis%2520and%2520ex%2520vivo%2520evaluation%2520of%2520%255B11C-carbonyl%255Dcarbamate-%2520and%2520urea-based%2520monoacylglycerol%2520lipase%2520inhibitors%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2014%26volume%3D41%26spage%3D688%26epage%3D694%26doi%3D10.1016%2Fj.nucmedbio.2014.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adibekian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, K.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1038/nchembio.579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1038%2Fnchembio.579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=21572424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtV2ht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=469-478&author=A.+Adibekianauthor=B.+R.+Martinauthor=C.+Wangauthor=K.-L.+Hsuauthor=D.+A.+Bachovchinauthor=S.+Niessenauthor=H.+Hooverauthor=B.+F.+Cravatt&title=Click-generated+triazole+ureas+as+ultrapotent+in+vivo-active+serine+hydrolase+inhibitors&doi=10.1038%2Fnchembio.579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors</span></div><div class="casAuthors">Adibekian, Alexander; Martin, Brent R.; Wang, Chu; Hsu, Ku-Lung; Bachovchin, Daniel A.; Niessen, Sherry; Hoover, Heather; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">469-478</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Serine hydrolases are a diverse enzyme class representing ∼1% of all human proteins.  The biol. functions of most serine hydrolases remain poorly characterized owing to a lack of selective inhibitors to probe their activity in living systems.  Here we show that a substantial no. of serine hydrolases can be irreversibly inactivated by 1,2,3-triazole ureas, which show negligible cross-reactivity with other protein classes.  Rapid lead optimization by click chem.-enabled synthesis and competitive activity-based profiling identified 1,2,3-triazole ureas that selectively inhibit enzymes from diverse branches of the serine hydrolase class, including peptidases (acyl-peptide hydrolase, or APEH), lipases (platelet-activating factor acetylhydrolase-2, or PAFAH2) and uncharacterized hydrolases (α,β-hydrolase-11, or ABHD11), with exceptional potency in cells (sub-nanomolar) and mice (<1 mg kg-1).  We show that APEH inhibition leads to accumulation of N-acetylated proteins and promotes proliferation in T cells.  These data indicate 1,2,3-triazole ureas are a pharmacol. privileged chemotype for serine hydrolase inhibition, combining broad activity across the serine hydrolase class with tunable selectivity for individual enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM_5ZfJ_B1ZrVg90H21EOLACvtfcHk0lhjbXeOU7_xZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtV2ht7s%253D&md5=236ff8d9ef723ed09c00cf1c47b6727d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.579%26sid%3Dliteratum%253Aachs%26aulast%3DAdibekian%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DHsu%26aufirst%3DK.-L.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DHoover%26aufirst%3DH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DClick-generated%2520triazole%2520ureas%2520as%2520ultrapotent%2520in%2520vivo-active%2520serine%2520hydrolase%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D469%26epage%3D478%26doi%3D10.1038%2Fnchembio.579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3008</span>– <span class="NLM_lpage">3026</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3008-3026&author=L.+A.+McAllisterauthor=C.+R.+Butlerauthor=S.+Menteauthor=S.+V.+O%E2%80%99Neilauthor=K.+R.+Fonsecaauthor=J.+R.+Piroauthor=J.+A.+Cianfrognaauthor=T.+L.+Foleyauthor=A.+M.+Gilbertauthor=A.+R.+Harrisauthor=C.+J.+Helalauthor=D.+S.+Johnsonauthor=J.+I.+Montgomeryauthor=D.+M.+Nasonauthor=S.+Noellauthor=J.+Panditauthor=B.+N.+Rogersauthor=T.+A.+Samadauthor=C.+L.+Shafferauthor=R.+G.+da+Silvaauthor=D.+P.+Uccelloauthor=D.+Webbauthor=M.+A.+Brodney&title=Discovery+of+trifluoromethyl+glycol+carbamates+as+potent+and+selective+covalent+monoacylglycerol+lipase+%28MAGL%29+inhibitors+for+treatment+of+neuroinflammation&doi=10.1021%2Facs.jmedchem.8b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation</span></div><div class="casAuthors">McAllister, Laura A.; Butler, Christopher R.; Mente, Scot; O'Neil, Steven V.; Fonseca, Kari R.; Piro, Justin R.; Cianfrogna, Julie A.; Foley, Timothy L.; Gilbert, Adam M.; Harris, Anthony R.; Helal, Christopher J.; Johnson, Douglas S.; Montgomery, Justin I.; Nason, Deane M.; Noell, Stephen; Pandit, Jayvardhan; Rogers, Bruce N.; Samad, Tarek A.; Shaffer, Christopher L.; da Silva, Rafael G.; Uccello, Daniel P.; Webb, Damien; Brodney, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3008-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) inhibition provides a potential treatment approach to neuroinflammation through modulation of both the endocannabinoid pathway and arachidonoyl signaling in the central nervous system (CNS).  Herein we report the discovery of compd. I (PF-06795071), a potent and selective covalent MAGL inhibitor, featuring a novel trifluoromethyl glycol leaving group that confers significant physicochem. property improvements as compared with earlier inhibitor series with more lipophilic leaving groups.  The design strategy focused on identifying an optimized leaving group that delivers MAGL potency, serine hydrolase selectivity, and CNS exposure while simultaneously reducing log D, improving soly., and minimizing chem. lability.  Compd. I achieves excellent CNS exposure, extended 2-AG elevation effect in vivo, and decreased brain inflammatory markers in response to an inflammatory challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEF-xXUaFF7Vg90H21EOLACvtfcHk0lhjbXeOU7_xZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKlurw%253D&md5=984babc4de306b698756e9c2a9fc5c8e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00070%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DL.%2BA.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DMente%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DPiro%26aufirst%3DJ.%2BR.%26aulast%3DCianfrogna%26aufirst%3DJ.%2BA.%26aulast%3DFoley%26aufirst%3DT.%2BL.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DNoell%26aufirst%3DS.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3Dda%2BSilva%26aufirst%3DR.%2BG.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520trifluoromethyl%2520glycol%2520carbamates%2520as%2520potent%2520and%2520selective%2520covalent%2520monoacylglycerol%2520lipase%2520%2528MAGL%2529%2520inhibitors%2520for%2520treatment%2520of%2520neuroinflammation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3008%26epage%3D3026%26doi%3D10.1021%2Facs.jmedchem.8b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">The complete selectivity profiles of compound <b>7</b> in a CEREP broad-spectrum selectivity panel and a serine hydrolase selectivity panel are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R.</span></span> <span> </span><span class="NLM_article-title">In vivo site-directed radiotracers: a mini-review</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+vivo+site-directed+radiotracers%3A+a+mini-review&doi=10.1016%2Fj.nucmedbio.2008.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0lhjbXeOU7_xZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520site-directed%2520radiotracers%253A%2520a%2520mini-review%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815%26doi%3D10.1016%2Fj.nucmedbio.2008.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span> CPD-4645 is a selective
MAGL inhibitor identified from published patent literature, structurally
analogous to the previously reported SAR127303. For additional information,
please see:<span class="NLM_contrib-group"><span class="NLM_string-name">Terrone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauletti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salamone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilmette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezzani, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet</span>. <i>Epilepsia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1111/epi.13950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1111%2Fepi.13950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=29171003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1Wjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=79-91&author=G.+Terroneauthor=A.+Paulettiauthor=A.+Salamoneauthor=M.+Rizziauthor=B.+R.+Villaauthor=L.+Porcuauthor=M.+J.+Sheehanauthor=E.+Guilmetteauthor=C.+R.+Butlerauthor=J.+R.+Piroauthor=T.+A.+Samadauthor=A.+Vezzani&title=Inhibition+of+monoacylglycerol+lipase+terminates+diazepam-resistant+status+epilepticus+in+mice+and+its+effects+are+potentiated+by+a+ketogenic+diet&doi=10.1111%2Fepi.13950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet</span></div><div class="casAuthors">Terrone, Gaetano; Pauletti, Alberto; Salamone, Alessia; Rizzi, Massimo; Villa, Bianca R.; Porcu, Luca; Sheehan, Mark J.; Guilmette, Edward; Butler, Christopher R.; Piro, Justin R.; Samad, Tarek A.; Vezzani, Annamaria</div><div class="citationInfo"><span class="NLM_cas:title">Epilepsia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-91</span>CODEN:
                <span class="NLM_cas:coden">EPILAK</span>;
        ISSN:<span class="NLM_cas:issn">0013-9580</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Objective : Status epilepticus (SE) is a life-threatening and commonly drug-refractory condition.  Novel therapies are needed to rapidly terminate seizures to prevent mortality and morbidity.  Monoacylglycerol lipase (MAGL) is the key enzyme responsible for the hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG) and a major contributor to the brain pool of arachidonic acid (AA).  Inhibiting of monoacylglycerol lipase modulates synaptic activity and neuroinflammation, 2 mediators of excessive neuronal activation underlying seizures.  We studied the effect of a potent and selective irreversible MAGL inhibitor, CPD-4645, on SE that was refractory to diazepam, its neuropathol. sequelae, and the mechanism underlying the drug's effects.  Methods : Diazepam-resistant SE was induced in adult mice fed with std. or ketogenic diet or in cannabinoid receptor type 1 (CB1) receptor knock-out mice.  CPD-4645 (10 mg/kg, s.c.) or vehicle was dosed 1 and 7 h after status epilepticus onset in video-electroencephalog. (EEG) recorded mice.  At the end of SE, mice were examd. in the novel object recognition test followed by neuronal cellloss anal.  Results : CPD-4645 maximal plasma and brain concns. were attained 0.5 h postinjection (half-life = 3.7 h) and elevated brain 2-AG levels by approx. 4-fold.  CPD-4645 administered to std. diet-fed mice progressively reduced spike frequency during 3 h postinjection, thereby shortening SE duration by 47%.  The drug immediately abrogated SE in ketogenic diet-fed mice.  CPD-4645 rescued neuronal cell loss and cognitive deficit and reduced interleukin (IL)-1β and cyclooxygenase 2 (COX-2) brain expression resulting from SE.  The CPD-4645 effect on SE was similar in mice lacking CB1 receptors.  Significance : MAGL represents a novel therapeutic target for treating status epilepticus and improving its sequelae.  CPD-4645 therapeutic effects appear to be predominantly mediated by modulation of neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2MDze8qS8k7Vg90H21EOLACvtfcHk0lgRHQSJzkdDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1Wjug%253D%253D&md5=69623c92048413dd9ec6b1f890f41f2d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fepi.13950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fepi.13950%26sid%3Dliteratum%253Aachs%26aulast%3DTerrone%26aufirst%3DG.%26aulast%3DPauletti%26aufirst%3DA.%26aulast%3DSalamone%26aufirst%3DA.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DVilla%26aufirst%3DB.%2BR.%26aulast%3DPorcu%26aufirst%3DL.%26aulast%3DSheehan%26aufirst%3DM.%2BJ.%26aulast%3DGuilmette%26aufirst%3DE.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DPiro%26aufirst%3DJ.%2BR.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26aulast%3DVezzani%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520monoacylglycerol%2520lipase%2520terminates%2520diazepam-resistant%2520status%2520epilepticus%2520in%2520mice%2520and%2520its%2520effects%2520are%2520potentiated%2520by%2520a%2520ketogenic%2520diet%26jtitle%3DEpilepsia%26date%3D2018%26volume%3D59%26spage%3D79%26epage%3D91%26doi%3D10.1111%2Fepi.13950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peredo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nistér, M.</span></span> <span> </span><span class="NLM_article-title">Optimized protein extraction from cryopreserved brain tissue samples</span>. <i>Acta Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1080/02841860600847061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1080%2F02841860600847061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=17438701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVOmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=10-20&author=C.+Ericssonauthor=I.+Peredoauthor=M.+Nist%C3%A9r&title=Optimized+protein+extraction+from+cryopreserved+brain+tissue+samples&doi=10.1080%2F02841860600847061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Optimized protein extraction from cryopreserved brain tissue samples</span></div><div class="casAuthors">Ericsson, Christer; Peredo, Inti; Nister, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Acta Oncologica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-20</span>CODEN:
                <span class="NLM_cas:coden">ACTOEL</span>;
        ISSN:<span class="NLM_cas:issn">0284-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Optimal std. conditions for protein extn. and solubilization from frozen tissue samples have been examd.  Quant. differences in specific protein amts. or post-translational modifications underlie many, if not all, disease states.  Maximal and standardized extn. and solubilization of protein from diseased or healthy tissue is important to make the whole protein complement available for proteomic anal., and to make the best use of a precious resource.  Minimal degrdn. of the protein amino acid backbone, or of phosphorylated amino acid side chains, during sample prepn. is essential to preserve the anal. utility of the ext.  The authors have investigated parameters of brain tissue disintegration, and of extn./solubilization temp., time and vol. and have reached 98% extn. of brain tissue, corresponding to about 100 μg protein per mg tissue wet wt., by an SDS-based method: Tissue disintegration in the frozen state, by ball mill grinding followed by extn. and solubilization in 2% SDS for 10 min, at 70°C, in a vol. corresponding to ten times the tissue wet wt., with shaking.  The treatment with SDS sample buffer can inhibit protease and phosphatase activity.  Moreover, endogenous enzyme can be inhibited by incubation at high pH.  The resulting protein exts. can be used for both one-dimensional SDS gel-electrophoresis and for two-dimensional isoelec. focusing/SDS electrophoresis.  The proposed std. protocol has the potential to find wide application where protein extn., solubilization, identification and quantitation from cryopreserved clin. samples are desirable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGortpiXdvZp5bVg90H21EOLACvtfcHk0lgRHQSJzkdDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVOmt74%253D&md5=578b6c3b723e24fa84fd588116d2d449</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F02841860600847061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02841860600847061%26sid%3Dliteratum%253Aachs%26aulast%3DEricsson%26aufirst%3DC.%26aulast%3DPeredo%26aufirst%3DI.%26aulast%3DNist%25C3%25A9r%26aufirst%3DM.%26atitle%3DOptimized%2520protein%2520extraction%2520from%2520cryopreserved%2520brain%2520tissue%2520samples%26jtitle%3DActa%2520Oncol.%26date%3D2007%26volume%3D46%26spage%3D10%26epage%3D20%26doi%3D10.1080%2F02841860600847061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span>; <span class="NLM_string-name">McAllister, L. A.</span>; <span class="NLM_string-name">Beck, E. M.</span>; <span class="NLM_string-name">Brodney, M. A.</span>; <span class="NLM_string-name">Gilbert, A. M.</span>; <span class="NLM_string-name">Helal, C. J.</span>; <span class="NLM_string-name">Johnson, D. S.</span>; <span class="NLM_string-name">Montgomery, J. I.</span>; <span class="NLM_string-name">O’Neil, S. V.</span>; <span class="NLM_string-name">Rogers, B. N.</span>; <span class="NLM_string-name">Verhoest, P. R.</span>; <span class="NLM_string-name">Webb, D.</span></span> <span> </span><span class="NLM_article-title">1,1,1-Trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives and 1,1,1-Trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives as MAGL Inhibitors</span>. <span class="NLM_patent">US20170029390</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+R.+Butler&author=L.+A.+McAllister&author=E.+M.+Beck&author=M.+A.+Brodney&author=A.+M.+Gilbert&author=C.+J.+Helal&author=D.+S.+Johnson&author=J.+I.+Montgomery&author=S.+V.+O%E2%80%99Neil&author=B.+N.+Rogers&author=P.+R.+Verhoest&author=D.+Webb&title=1%2C1%2C1-Trifluoro-3-hydroxypropan-2-yl+Carbamate+Derivatives+and+1%2C1%2C1-Trifluoro-4-hydroxybutan-2-yl+Carbamate+Derivatives+as+MAGL+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26atitle%3D1%252C1%252C1-Trifluoro-3-hydroxypropan-2-yl%2520Carbamate%2520Derivatives%2520and%25201%252C1%252C1-Trifluoro-4-hydroxybutan-2-yl%2520Carbamate%2520Derivatives%2520as%2520MAGL%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of (4<i>R</i>)-1-{3-[2-(<sup>18</sup>F)fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([<sup>18</sup>F]T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2362</span>– <span class="NLM_lpage">2375</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01576</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01576" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVSht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2362-2375&author=Y.+Hattoriauthor=K.+Aoyamaauthor=J.+Maedaauthor=N.+Arimuraauthor=Y.+Takahashiauthor=M.+Sasakiauthor=M.+Fujinagaauthor=C.+Sekiauthor=Y.+Nagaiauthor=K.+Kawamuraauthor=T.+Yamasakiauthor=M.-R.+Zhangauthor=M.+Higuchiauthor=T.+Koike&title=Design%2C+synthesis%2C+and+evaluation+of+%284R%29-1-%7B3-%5B2-%2818F%29fluoro-4-methylpyridin-3-yl%5Dphenyl%7D-4-%5B4-%281%2C3-thiazol-2-ylcarbonyl%29piperazin-1-yl%5Dpyrrolidin-2-one+%28%5B18F%5DT-401%29+as+a+novel+positron-emission+tomography+imaging+agent+for+monoacylglycerol+lipase&doi=10.1021%2Facs.jmedchem.8b01576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of (4R)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a Novel Positron-Emission Tomography Imaging Agent for Monoacylglycerol Lipase</span></div><div class="casAuthors">Hattori, Yasushi; Aoyama, Kazunobu; Maeda, Jun; Arimura, Naoto; Takahashi, Yasuko; Sasaki, Masako; Fujinaga, Masayuki; Seki, Chie; Nagai, Yuji; Kawamura, Kazunori; Yamasaki, Tomoteru; Zhang, Ming-Rong; Higuchi, Makoto; Koike, Tatsuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2362-2375</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a cytosolic serine hydrolase involved in endocannabinoid and inflammatory signaling.  Positron-emission tomog. (PET) imaging of MAGL serves to validate target engagement of therapeutic MAGL inhibitors as well as to investigate MAGL levels under normal and disease conditions.  However, PET radioligands with reversible binding kinetics for MAGL, which allow quant. assessment of MAGL, are hitherto unavailable.  In this study, we designed and synthesized fluoro-contg. PET probes starting from a recently identified piperazinyl pyrrolidine-2-one deriv. with reversible binding to MAGL.  By tailoring the lipophilicity of the mol. to optimize nonspecific binding and blood-brain barrier permeability, we successfully identified two compds. that show high uptake to regions enriched with MAGL.  PET imaging of wild-type and MAGL-deficient mice as well as a macaque monkey indicated that [18F]I ((4R)-1-{3-[2-(18F)fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one, [18F]T-401) specifically binds to MAGL with adequate reversibility, yielding a high contrast for MAGL within an appropriate imaging time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppgW6fA1E8WLVg90H21EOLACvtfcHk0liaHmi7xg0wDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVSht7k%253D&md5=4848fa8fce411e960b580b5bd007e0c9</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01576%26sid%3Dliteratum%253Aachs%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DAoyama%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DArimura%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DC.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DHiguchi%26aufirst%3DM.%26aulast%3DKoike%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520%25284R%2529-1-%257B3-%255B2-%252818F%2529fluoro-4-methylpyridin-3-yl%255Dphenyl%257D-4-%255B4-%25281%252C3-thiazol-2-ylcarbonyl%2529piperazin-1-yl%255Dpyrrolidin-2-one%2520%2528%255B18F%255DT-401%2529%2520as%2520a%2520novel%2520positron-emission%2520tomography%2520imaging%2520agent%2520for%2520monoacylglycerol%2520lipase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2362%26epage%3D2375%26doi%3D10.1021%2Facs.jmedchem.8b01576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafroth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasdev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josephson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of reversible and irreversible monoacylglycerol lipase positron emission tomography (PET) tracers using a “tail switching” strategy on a piperazinyl azetidine skeleton</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3336</span>– <span class="NLM_lpage">3353</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01778</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01778" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktV2mtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3336-3353&author=Z.+Chenauthor=W.+Moriauthor=X.+Dengauthor=R.+Chengauthor=D.+Ogasawaraauthor=G.+Zhangauthor=M.+A.+Schafrothauthor=K.+Dahlauthor=H.+Fuauthor=A.+Hatoriauthor=T.+Shaoauthor=Y.+Zhangauthor=T.+Yamasakiauthor=X.+Zhangauthor=J.+Rongauthor=Q.+Yuauthor=K.+Huauthor=M.+Fujinagaauthor=L.+Xieauthor=K.+Kumataauthor=Y.+Gouauthor=J.+Chenauthor=S.+Guauthor=L.+Baoauthor=L.+Wangauthor=T.+L.+Collierauthor=N.+Vasdevauthor=Y.+Shaoauthor=J.-A.+Maauthor=B.+F.+Cravattauthor=C.+Fowlerauthor=L.+Josephsonauthor=M.-R.+Zhangauthor=S.+H.+Liang&title=Design%2C+synthesis%2C+and+evaluation+of+reversible+and+irreversible+monoacylglycerol+lipase+positron+emission+tomography+%28PET%29+tracers+using+a+%E2%80%9Ctail+switching%E2%80%9D+strategy+on+a+piperazinyl+azetidine+skeleton&doi=10.1021%2Facs.jmedchem.8b01778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine Skeleton</span></div><div class="casAuthors">Chen, Zhen; Mori, Wakana; Deng, Xiaoyun; Cheng, Ran; Ogasawara, Daisuke; Zhang, Genwei; Schafroth, Michael A.; Dahl, Kenneth; Fu, Hualong; Hatori, Akiko; Shao, Tuo; Zhang, Yiding; Yamasaki, Tomoteru; Zhang, Xiaofei; Rong, Jian; Yu, Qingzhen; Hu, Kuan; Fujinaga, Masayuki; Xie, Lin; Kumata, Katsushi; Gou, Yuancheng; Chen, Jingjin; Gu, Shuyin; Bao, Liang; Wang, Lu; Collier, Thomas Lee; Vasdev, Neil; Shao, Yihan; Ma, Jun-An; Cravatt, Benjamin F.; Fowler, Christopher; Josephson, Lee; Zhang, Ming-Rong; Liang, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3336-3353</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a serine hydrolase that degrades 2-arachidonoylglycerol (2-AG) in the endocannabinoid system (eCB).  Selective inhibition of MAGL has emerged as a potential therapeutic approach for the treatment of diverse pathol. conditions, including chronic pain, inflammation, cancer, and neurodegeneration.  Herein, we disclose a novel array of reversible and irreversible MAGL inhibitors by means of "tail switching" on a piperazinyl azetidine scaffold.  We developed a lead irreversible-binding MAGL inhibitor 8 and reversible-binding compds. 17 and 37, which are amenable for radiolabeling with 11C or 18F. [11C]8 ([11C]MAGL-2-11) exhibited high brain uptake and excellent binding specificity in the brain toward MAGL.  Reversible radioligands [11C]17 ([11C]PAD) and [18F]37 ([18F]MAGL-4-11) also demonstrated excellent in vivo binding specificity toward MAGL in peripheral organs.  This work may pave the way for the development of MAGL-targeted positron emission tomog. tracers with tunability in reversible and irreversible binding mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq14JLjFrGKxrVg90H21EOLACvtfcHk0liaHmi7xg0wDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktV2mtbs%253D&md5=261c3ea3d090e90c7f3c23701a0c9c34</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01778%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMori%26aufirst%3DW.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchafroth%26aufirst%3DM.%2BA.%26aulast%3DDahl%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRong%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DKumata%26aufirst%3DK.%26aulast%3DGou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DS.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCollier%26aufirst%3DT.%2BL.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.-A.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DFowler%26aufirst%3DC.%26aulast%3DJosephson%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520reversible%2520and%2520irreversible%2520monoacylglycerol%2520lipase%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520tracers%2520using%2520a%2520%25E2%2580%259Ctail%2520switching%25E2%2580%259D%2520strategy%2520on%2520a%2520piperazinyl%2520azetidine%2520skeleton%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3336%26epage%3D3353%26doi%3D10.1021%2Facs.jmedchem.8b01778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attili, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veghel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berben, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savinainen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of [<sup>11</sup>C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.ejmech.2017.04.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=28486208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsVansro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=104-113&author=M.+Ahamedauthor=B.+Attiliauthor=D.+van+Veghelauthor=M.+Oomsauthor=P.+Berbenauthor=S.+Celenauthor=M.+Kooleauthor=L.+Declercqauthor=J.+R.+Savinainenauthor=J.+T.+Laitinenauthor=A.+Verbruggenauthor=G.+Bormans&title=Synthesis+and+preclinical+evaluation+of+%5B11C%5DMA-PB-1+for+in+vivo+imaging+of+brain+monoacylglycerol+lipase+%28MAGL%29&doi=10.1016%2Fj.ejmech.2017.04.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preclinical evaluation of [11C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)</span></div><div class="casAuthors">Ahamed, Muneer; Attili, Bala; van Veghel, Daisy; Ooms, Maarten; Berben, Philippe; Celen, Sofie; Koole, Michel; Declercq, Lieven; Savinainen, Juha R.; Laitinen, Jarmo T.; Verbruggen, Alfons; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104-113</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Synthesis and preclin. evaluation of labeled [11C]MA-PB-1 (I) as an irreversible MAGL (monoacylglycerol lipase) inhibitor PET tracer is reported.  The in-vitro inhibitory activity, ex-vivo distribution, brain kinetics and specificity of compd. I binding were studied.  Ex-vivo biodistribution and microPET showed good brain uptake which could be blocked by pretreatment with both compd. I and a structurally non-related MAGL inhibitor MJN110 (compd. II).  These initial results suggested that compd. I is a suitable tracer for in-vivo imaging of MAGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZZw-mML3QX7Vg90H21EOLACvtfcHk0liheI-6NLSdrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsVansro%253D&md5=8247caa5fc4f5d0bbee21e96c4dfbb24</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.066%26sid%3Dliteratum%253Aachs%26aulast%3DAhamed%26aufirst%3DM.%26aulast%3DAttili%26aufirst%3DB.%26aulast%3Dvan%2BVeghel%26aufirst%3DD.%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DBerben%26aufirst%3DP.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDeclercq%26aufirst%3DL.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520%255B11C%255DMA-PB-1%2520for%2520in%2520vivo%2520imaging%2520of%2520brain%2520monoacylglycerol%2520lipase%2520%2528MAGL%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D136%26spage%3D104%26epage%3D113%26doi%3D10.1016%2Fj.ejmech.2017.04.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krohn, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. C.</span></span> <span> </span><span class="NLM_article-title">Production of [<sup>11</sup>C]CH<sub>3</sub>I by single pass reaction of [<sup>11</sup>C]CH<sub>4</sub> with I<sub>2</sub></span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/S0969-8051(96)00181-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2FS0969-8051%2896%2900181-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=9080480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADyaK2sXhvFCns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1997&pages=93-97&author=J.+M.+Linkauthor=K.+A.+Krohnauthor=J.+C.+Clark&title=Production+of+%5B11C%5DCH3I+by+single+pass+reaction+of+%5B11C%5DCH4+with+I2&doi=10.1016%2FS0969-8051%2896%2900181-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Production of [11C]CH3I by single pass reaction of [11C]CH4 with I2</span></div><div class="casAuthors">Link, Jeanne M.; Krohn, Kenneth A.; Clark, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-97</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We report a single pass gas phase route to [11C]CH3I based on prodn. of I· from I2 at elevated temp.  I· abstrs. H from CH4 to yield ·CH3, which reacts with I2 to form CH3I.  A fiber optic spectrometer was used to measure the I2 vapor concn.  [11C]CH3I yield increased with I2 concn. until excessive amts. of condensed I2 began to trap the 11C.  The yield of [11C]CH3I was >50% from [11C]CH4; its specific activity was 12,000 Ci/mmole.  The synthesis takes only 4 min after 11CH4 prodn. and can be repeated without system cleanup.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp311_GgrPqGLVg90H21EOLACvtfcHk0liheI-6NLSdrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvFCns7k%253D&md5=07dabab577cacdf12510db52563424dc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2896%2900181-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252896%252900181-3%26sid%3Dliteratum%253Aachs%26aulast%3DLink%26aufirst%3DJ.%2BM.%26aulast%3DKrohn%26aufirst%3DK.%2BA.%26aulast%3DClark%26aufirst%3DJ.%2BC.%26atitle%3DProduction%2520of%2520%255B11C%255DCH3I%2520by%2520single%2520pass%2520reaction%2520of%2520%255B11C%255DCH4%2520with%2520I2%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1997%26volume%3D24%26spage%3D93%26epage%3D97%26doi%3D10.1016%2FS0969-8051%2896%2900181-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':[],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lu Hou, Jian Rong, Ahmed Haider, Daisuke Ogasawara, Cassis Varlow, Michael A. Schafroth, Linjing Mu, Jiefeng Gan, Hao Xu, Christopher J. Fowler, Ming-Rong Zhang, Neil Vasdev, Simon Ametamey, Benjamin F. Cravatt, Lu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 123-149. <a href="https://doi.org/10.1021/acs.jmedchem.0c01459" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositron%252BEmission%252BTomography%252BImaging%252Bof%252Bthe%252BEndocannabinoid%252BSystem%25253A%252BOpportunities%252Band%252BChallenges%252Bin%252BRadiotracer%252BDevelopment%26aulast%3DHou%26aufirst%3DLu%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D21082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D123%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhen Chen, Wakana Mori, Hualong Fu, Michael A. Schafroth, Akiko Hatori, Tuo Shao, Genwei Zhang, Richard S. Van, Yiding Zhang, Kuan Hu, Masayuki Fujinaga, Lu Wang, Vasily Belov, Daisuke Ogasawara, Pilar Giffenig, Xiaoyun Deng, Jian Rong, Qingzhen Yu, Xiaofei Zhang, Mikhail I. Papisov, Yihan Shao, Thomas L. Collier, Jun-An Ma, Benjamin F. Cravatt, Lee Josephson, Ming-Rong Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of 18F-Labeled Monoacylglycerol Lipase Inhibitors as Novel Positron Emission Tomography Probes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (19)
                                     , 8866-8872. <a href="https://doi.org/10.1021/acs.jmedchem.9b00936" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00936</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00936%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252B18F-Labeled%252BMonoacylglycerol%252BLipase%252BInhibitors%252Bas%252BNovel%252BPositron%252BEmission%252BTomography%252BProbes%26aulast%3DChen%26aufirst%3DZhen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12062019%26date%3D26092019%26date%3D13092019%26volume%3D62%26issue%3D19%26spage%3D8866%26epage%3D8872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Michael A.  Schafroth</span>, <span class="hlFld-ContribAuthor ">Tuo  Shao</span>, <span class="hlFld-ContribAuthor ">Richard S.  Van</span>, <span class="hlFld-ContribAuthor ">Daisuke  Ogasawara</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Atsuto  Hiraishi</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Jiahui  Chen</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Kuan  Hu</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Jiyun  Sun</span>, <span class="hlFld-ContribAuthor ">Qingzhen  Yu</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Collier</span>, <span class="hlFld-ContribAuthor ">Yihan  Shao</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 1686-1695. <a href="https://doi.org/10.1016/j.apsb.2021.01.021" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDevelopment%252Bof%252Ba%252Bhighly-specific%252B18F-labeled%252Birreversible%252Bpositron%252Bemission%252Btomography%252Btracer%252Bfor%252Bmonoacylglycerol%252Blipase%252Bmapping%26aulast%3DChen%26aufirst%3DZhen%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D1686%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulong  Xu</span>, <span class="hlFld-ContribAuthor ">Zude  Chen</span>, <span class="hlFld-ContribAuthor ">Hsiao‐Ying  Wey</span>, <span class="hlFld-ContribAuthor ">Yingxia  Liang</span>, <span class="hlFld-ContribAuthor ">Rudolph E.  Tanzi</span>, <span class="hlFld-ContribAuthor ">Can  Zhang</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular imaging of NAD
              +
              ‐dependent deacetylase SIRT1 in the brain. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's & Dementia</span><span> <strong>2021,</strong> <em>44 </em><a href="https://doi.org/10.1002/alz.12344" title="DOI URL">https://doi.org/10.1002/alz.12344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/alz.12344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Falz.12344%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520%2526%2520Dementia%26atitle%3DMolecular%252Bimaging%252Bof%252BNAD%252B%25252B%252B%2525E2%252580%252590dependent%252Bdeacetylase%252BSIRT1%252Bin%252Bthe%252Bbrain%26aulast%3DXu%26aufirst%3DYulong%26date%3D2021%26date%3D2021%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garth E.  Terry</span>, <span class="hlFld-ContribAuthor ">Vanessa  Raymont</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Horti</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of the Endocannabinoid System. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 319-426. <a href="https://doi.org/10.1007/978-3-030-53176-8_12" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_12%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252BImaging%252Bof%252Bthe%252BEndocannabinoid%252BSystem%26aulast%3DTerry%26aufirst%3DGarth%2BE.%26date%3D2021%26date%3D2020%26spage%3D319%26epage%3D426%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matteo  Tardelli</span>. </span><span class="cited-content_cbyCitation_article-title">Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastroenterology</span><span> <strong>2020,</strong> <em>26 </em>
                                    (25)
                                     , 3577-3585. <a href="https://doi.org/10.3748/wjg.v26.i25.3577" title="DOI URL">https://doi.org/10.3748/wjg.v26.i25.3577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3748/wjg.v26.i25.3577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3748%2Fwjg.v26.i25.3577%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastroenterology%26atitle%3DMonoacylglycerol%252Blipase%252Breprograms%252Blipid%252Bprecursors%252Bsignaling%252Bin%252Bliver%252Bdisease%26aulast%3DTardelli%26aufirst%3DMatteo%26date%3D2020%26volume%3D26%26issue%3D25%26spage%3D3577%26epage%3D3585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ann M.  Gregus</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Buczynski</span>. </span><span class="cited-content_cbyCitation_article-title">Druggable Targets in Endocannabinoid Signaling. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 177-201. <a href="https://doi.org/10.1007/978-3-030-50621-6_8" title="DOI URL">https://doi.org/10.1007/978-3-030-50621-6_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-50621-6_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-50621-6_8%26sid%3Dliteratum%253Aachs%26atitle%3DDruggable%252BTargets%252Bin%252BEndocannabinoid%252BSignaling%26aulast%3DGregus%26aufirst%3DAnn%2BM.%26date%3D2020%26date%3D2020%26spage%3D177%26epage%3D201%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDruggable%252BLipid%252BSignaling%252BPathways%26aulast%3DKihara%26aufirst%3DYasuyuki%26date%3D2020%26volume%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structures of representative literature MAGL inhibitor chemotypes; (B) analysis of CNS PET parameters and serine hydrolase selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Serine hydrolase selectivity profile of compound <b>7</b> (10 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup>Reagents and conditions: (a) for compound <b>9</b>, (6-methoxypyridin-3-yl)boronic acid, Cu(OAc)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/pyridine, 40 °C; for compound <b>10</b>, 2-chloro-5-methoxypyridine, Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 120 °C; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt); (c) 1,1′-[carbonylbis(oxy)]dipyrrolidine-2,5-dione or bis(pentafluorophenyl) carbonate, <b>19</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN or tetrahydrofuran (THF), rt; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup>Reagents and conditions: (a) 5-bromo-2-fluoropyridine, Cs<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF), 150 °C, 86%; (b) bis(pinacolato)diboron, Pd(dppf)Cl<sub>2</sub>, KOAc, toluene, 110 °C, 97%; (c) NaOH, H<sub>2</sub>O<sub>2</sub>, THF/H<sub>2</sub>O, quantitative; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (e) bis(pentafluorophenyl)carbonate, <b>19</b>, Et<sub>3</sub>N, CH<sub>3</sub>CN, 50% over two steps.</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup>Reagents and conditions: (a) CT<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, radiochemical purity 99.2%, specific activity 77.43 Ci/mmol; (c) [<sup>11</sup>C]CH<sub>3</sub>OTf, Cs<sub>2</sub>CO<sub>3</sub>, DMF, followed by TFA, 100 °C, 5 min, radiochemical purity >98%, radiochemical yield 25%, molar activity >1000 GBq/μmol.</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Specific binding assessment of [<sup>3</sup>H]<b>7</b> in rat brain homogenates; (B) saturation binding of [<sup>3</sup>H]<b>7</b> in rat and NHP brain tissues for cross-species <i>B</i><sub>max</sub> comparison. TB: total binding; NSB: nonspecific binding; %SB: percentage of specific binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo target occupancy study of [<sup>3</sup>H]<b>7</b> in Sprague-Dawley rats: (A) specific binding in three representative brain regions and the kidney; (B) dose–response inhibition of [<sup>3</sup>H]<b>7</b> binding by CPD-4645 (0.1, 0.32, 1, 3.2, and 10 mg/kg sc, 25 min, <i>n</i> = 4 per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MRI (A) and PET images of [<sup>11</sup>C]<b>7</b> in NHP summed from 0 to 123 min under (B) baseline and (C) blocking (pretreatment with compound A, 1.27 mg/kg, iv) conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/medium/jm9b00847_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Whole-brain time–activity curves for [<sup>11</sup>C]<b>7</b> under baseline and pretreatment conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00847/20190920/images/large/jm9b00847_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00847&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabner, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schicho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taschler, U.</span></span> <span> </span><span class="NLM_article-title">Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.pharmthera.2017.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=28213089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2017&pages=35-46&author=G.+F.+Grabnerauthor=R.+Zimmermannauthor=R.+Schichoauthor=U.+Taschler&title=Monoglyceride+lipase+as+a+drug+target%3A+At+the+crossroads+of+arachidonic+acid+metabolism+and+endocannabinoid+signaling&doi=10.1016%2Fj.pharmthera.2017.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling</span></div><div class="casAuthors">Grabner, Gernot F.; Zimmermann, Robert; Schicho, Rudolf; Taschler, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Monoglyerides (MGs) are short-lived, intermediary lipids deriving from the degrdn. of phospho- and neutral lipids, and monoglyceride lipase (MGL), also designated as monoacylglycerol lipase (MAGL), is the major enzyme catalyzing the hydrolysis of MGs into glycerol and fatty acids.  This distinct function enables MGL to regulate a no. of physiol. and pathophysiol. processes since both MGs and fatty acids can act as signaling lipids or precursors thereof.  The most prominent MG species acting as signaling lipid is 2-arachidonoyl glycerol (2-AG) which is the most abundant endogenous agonist of cannabinoid receptors in the body.  Importantly, recent observations demonstrate that 2-AG represents a quant. important source for arachidonic acid, the precursor of prostaglandins and other inflammatory mediators.  Accordingly, MGL-mediated 2-AG degrdn. affects lipid signaling by cannabinoid receptor-dependent and independent mechanisms.  Recent genetic and pharmacol. studies gave important insights into MGL's role in (patho-)physiol. processes, and the enzyme is now considered as a promising drug target for a no. of disorders including cancer, neurodegenerative and inflammatory diseases.  This review summarizes the basics of MG (2-AG) metab. and provides an overview on the therapeutic potential of MGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGvyCs_XBdLVg90H21EOLACvtfcHk0ljHODoY2gLK2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kmt7k%253D&md5=af9f9beaa78954ad700885508e739900</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DGrabner%26aufirst%3DG.%2BF.%26aulast%3DZimmermann%26aufirst%3DR.%26aulast%3DSchicho%26aufirst%3DR.%26aulast%3DTaschler%26aufirst%3DU.%26atitle%3DMonoglyceride%2520lipase%2520as%2520a%2520drug%2520target%253A%2520At%2520the%2520crossroads%2520of%2520arachidonic%2520acid%2520metabolism%2520and%2520endocannabinoid%2520signaling%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D175%26spage%3D35%26epage%3D46%26doi%3D10.1016%2Fj.pharmthera.2017.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blankman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcondes, M. C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1126/science.1209200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1126%2Fscience.1209200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=22021672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=809-813&author=D.+K.+Nomuraauthor=B.+E.+Morrisonauthor=J.+L.+Blankmanauthor=J.+Z.+Longauthor=S.+G.+Kinseyauthor=M.+C.+G.+Marcondesauthor=A.+M.+Wardauthor=Y.+K.+Hahnauthor=A.+H.+Lichtmanauthor=B.+Contiauthor=B.+F.+Cravatt&title=Endocannabinoid+hydrolysis+generates+brain+prostaglandins+that+promote+neuroinflammation&doi=10.1126%2Fscience.1209200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span></div><div class="casAuthors">Nomura, Daniel K.; Morrison, Bradley E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Kinsey, Steven G.; Marcondes, Maria Cecilia G.; Ward, Anna M.; Hahn, Yun Kyung; Lichtman, Aron H.; Conti, Bruno; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6057</span>),
    <span class="NLM_cas:pages">809-813</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Phospholipase A2(PLA2) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins.  Here, we show that a distinct pathway exists in brain, where monoacyl-glycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins.  MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model.  These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA2.  These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRRB-JEf2GrVg90H21EOLACvtfcHk0ljHODoY2gLK2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ&md5=17967f2d83876f57e4bc901df2e7dc68</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1209200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1209200%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DMorrison%26aufirst%3DB.%2BE.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DMarcondes%26aufirst%3DM.%2BC.%2BG.%26aulast%3DWard%26aufirst%3DA.%2BM.%26aulast%3DHahn%26aufirst%3DY.%2BK.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DConti%26aufirst%3DB.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEndocannabinoid%2520hydrolysis%2520generates%2520brain%2520prostaglandins%2520that%2520promote%2520neuroinflammation%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D809%26epage%3D813%26doi%3D10.1126%2Fscience.1209200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Btesh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strassle, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piesla, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uveges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouranova, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, T. A.</span></span> <span> </span><span class="NLM_article-title">Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">996</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1124/mol.110.068304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1124%2Fmol.110.068304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=20855465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=996-1003&author=P.+K.+Chandaauthor=Y.+Gaoauthor=L.+Markauthor=J.+Bteshauthor=B.+W.+Strassleauthor=P.+Luauthor=M.+J.+Pieslaauthor=M.-Y.+Zhangauthor=B.+Binghamauthor=A.+Uvegesauthor=D.+Kowalauthor=D.+Garbeauthor=E.+V.+Kouranovaauthor=R.+H.+Ringauthor=B.+Batesauthor=M.+N.+Pangalosauthor=J.+D.+Kennedyauthor=G.+T.+Whitesideauthor=T.+A.+Samad&title=Monoacylglycerol+lipase+activity+is+a+critical+modulator+of+the+tone+and+integrity+of+the+endocannabinoid+system&doi=10.1124%2Fmol.110.068304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system</span></div><div class="casAuthors">Chanda, Pranab K.; Gao, Ying; Mark, Lilly; Btesh, Joan; Strassle, Brian W.; Lu, Peimin; Piesla, Michael J.; Zhang, Mei-Yi; Bingham, Brendan; Uveges, Albert; Kowal, Dianne; Garbe, David; Kouranova, Evguenia V.; Ring, Robert H.; Bates, Brian; Pangalos, Menelas N.; Kennedy, Jeffrey D.; Whiteside, Garth T.; Samad, Tarek A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">996-1003</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Endocannabinoids are lipid mols. that serve as natural ligands for the cannabinoid receptors CB1 and CB2.  They modulate a diverse set of physiol. processes such as pain, cognition, appetite, and emotional states, and their levels and functions are tightly regulated by enzymic biosynthesis and degrdn.  2-Arachidonoylglycerol (2-AG) is the most abundant endocannabinoid in the brain and is believed to be hydrolyzed primarily by the serine hydrolase monoacylglycerol lipase (MAGL).  Although 2-AG binds and activates cannabinoid receptors in vitro, when administered in vivo, it induces only transient cannabimimetic effects as a result of its rapid catabolism.  Here we show using a mouse model with a targeted disruption of the MAGL gene that MAGL is the major modulator of 2-AG hydrolysis in vivo.  Mice lacking MAGL exhibit dramatically reduced 2-AG hydrolase activity and highly elevated 2-AG levels in the nervous system.  A lack of MAGL activity and subsequent long-term elevation of 2-AG levels lead to desensitization of brain CB1 receptors with a significant redn. of cannabimimetic effects of CB1 agonists.  Also consistent with CB1 desensitization, MAGL-deficient mice do not show alterations in neuropathic and inflammatory pain sensitivity.  These findings provide the first genetic in vivo evidence that MAGL is the major regulator of 2-AG levels and signaling and reveal a pivotal role for 2-AG in modulating CB1 receptor sensitization and endocannabinoid tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXec6NludiW7Vg90H21EOLACvtfcHk0ljHODoY2gLK2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7jF&md5=f6c38107c51f0c6d0f76241043ff988d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.068304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.068304%26sid%3Dliteratum%253Aachs%26aulast%3DChanda%26aufirst%3DP.%2BK.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DMark%26aufirst%3DL.%26aulast%3DBtesh%26aufirst%3DJ.%26aulast%3DStrassle%26aufirst%3DB.%2BW.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DPiesla%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DM.-Y.%26aulast%3DBingham%26aufirst%3DB.%26aulast%3DUveges%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DGarbe%26aufirst%3DD.%26aulast%3DKouranova%26aufirst%3DE.%2BV.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DBates%26aufirst%3DB.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DKennedy%26aufirst%3DJ.%2BD.%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26atitle%3DMonoacylglycerol%2520lipase%2520activity%2520is%2520a%2520critical%2520modulator%2520of%2520the%2520tone%2520and%2520integrity%2520of%2520the%2520endocannabinoid%2520system%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D996%26epage%3D1003%26doi%3D10.1124%2Fmol.110.068304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, T. A.</span></span> <span> </span><span class="NLM_article-title">A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer’s disease</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2012.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.celrep.2012.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=22813736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=617-623&author=J.+R.+Piroauthor=D.+I.+Benjaminauthor=J.+M.+Duerrauthor=Y.+Piauthor=C.+Gonzalesauthor=K.+M.+Woodauthor=J.+W.+Schwartzauthor=D.+K.+Nomuraauthor=T.+A.+Samad&title=A+dysregulated+endocannabinoid-eicosanoid+network+supports+pathogenesis+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.celrep.2012.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Piro, Justin R.; Benjamin, Daniel I.; Duerr, James M.; Pi, YeQing; Gonzales, Cathleen; Wood, Kathleen M.; Schwartz, Joel W.; Nomura, Daniel K.; Samad, Tarek A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">617-623</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although inflammation in the brain is meant as a defense mechanism against neurotoxic stimuli, increasing evidence suggests that uncontrolled, chronic, and persistent inflammation contributes to neurodegeneration.  Most neurodegenerative diseases have now been assocd. with chronic inflammation, including Alzheimer's disease (AD).  Whether anti-inflammatory approaches can be used to treat AD, however, is a major unanswered question.  We recently demonstrated that monoacylglycerol lipase (MAGL) hydrolyzes endocannabinoids to generate the primary arachidonic acid pool for neuroinflammatory prostaglandins.  In this study, we show that genetic inactivation of MAGL attenuates neuroinflammation and lowers amyloid β levels and plaques in an AD mouse model.  We also find that pharmacol. blockade of MAGL recapitulates the cytokine-lowering effects through reduced prostaglandin prodn., rather than enhanced endocannabinoid signaling.  Our findings thus reveal a role of MAGL in modulating neuroinflammation and amyloidosis in AD etiol. and put forth MAGL inhibitors as a potential next-generation strategy for combating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhEmpHXwNVC7Vg90H21EOLACvtfcHk0lgKb-TjTVY2Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrsrvM&md5=a84bec802e0b547d6e06052f39d1db0f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DPiro%26aufirst%3DJ.%2BR.%26aulast%3DBenjamin%26aufirst%3DD.%2BI.%26aulast%3DDuerr%26aufirst%3DJ.%2BM.%26aulast%3DPi%26aufirst%3DY.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BW.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26atitle%3DA%2520dysregulated%2520endocannabinoid-eicosanoid%2520network%2520supports%2520pathogenesis%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D1%26spage%3D617%26epage%3D623%26doi%3D10.1016%2Fj.celrep.2012.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span> <span> </span><span class="NLM_article-title">Monoacylglycerol lipase – a target for drug development?</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">1568</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01950.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1111%2Fj.1476-5381.2012.01950.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=22428756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=1568-1585&author=C.+J.+Fowler&title=Monoacylglycerol+lipase+%E2%80%93+a+target+for+drug+development%3F&doi=10.1111%2Fj.1476-5381.2012.01950.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacylglycerol lipase - a target for drug development?</span></div><div class="casAuthors">Fowler, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1568-1585</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid (eCB) system is involved in processes as diverse as control of appetite, perception of pain and the limitation of cancer cell growth and invasion.  The enzymes responsible for eCB breakdown are attractive pharmacol. targets, and fatty acid amide hydrolase inhibitors, which potentiate the levels of the eCB anandamide, are now undergoing pharmaceutical development.  "Drugable" selective inhibitors of monoacylglycerol lipase, a key enzyme regulating the levels of the other main eCB, 2-arachidonoylglycerol, were however not identified until very recently.  Their availability has resulted in a large expansion of our knowledge concerning the pharmacol. consequences of monoacylglycerol lipase inhibition and hence the role(s) played by the enzyme in the body.  In this review, the pharmacol. of monoacylglycerol lipase will be discussed, together with an anal. of the therapeutic potential of monoacylglycerol lipase inhibitors as analgesics and anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2hj7DUJaO97Vg90H21EOLACvtfcHk0lgKb-TjTVY2Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOku7rM&md5=b06b843ca0023abbe4e8cb6be83bcd52</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01950.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01950.x%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DMonoacylglycerol%2520lipase%2520%25E2%2580%2593%2520a%2520target%2520for%2520drug%2520development%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D1568%26epage%3D1585%26doi%3D10.1111%2Fj.1476-5381.2012.01950.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mulvihill, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of monoacylglycerol lipase inhibitors</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2012.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.lfs.2012.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=23142242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKqsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2013&pages=492-497&author=M.+M.+Mulvihillauthor=D.+K.+Nomura&title=Therapeutic+potential+of+monoacylglycerol+lipase+inhibitors&doi=10.1016%2Fj.lfs.2012.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of monoacylglycerol lipase inhibitors</span></div><div class="casAuthors">Mulvihill, Melinda M.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">492-497</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Marijuana and aspirin have been used for millennia to treat a wide range of maladies including pain and inflammation.  Both cannabinoids, like marijuana, that exert anti-inflammatory action through stimulating cannabinoid receptors, and cyclooxygenase (COX) inhibitors, like aspirin, that suppress pro-inflammatory eicosanoid prodn. have shown beneficial outcomes in mouse models of neurodegenerative diseases and cancer.  Both cannabinoids and COX inhibitors, however, have untoward effects that discourage their chronic usage, including cognitive deficits and gastrointestinal toxicity, resp.  Recent studies have uncovered that the serine hydrolase monoacylglycerol lipase (MAGL) links the endocannabinoid and eicosanoid systems together through hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG) to provide the major arachidonic acid (AA) precursor pools for pro-inflammatory eicosanoid synthesis in specific tissues.  Studies in recent years have shown that MAGL inhibitors elicit anti-nociceptive, anxiolytic, and anti-emetic responses and attenuate pptd. withdrawal symptoms in addiction paradigms through enhancing endocannabinoid signaling.  MAGL inhibitors have also been shown to exert anti-inflammatory action in the brain and protect against neurodegeneration through lowering eicosanoid prodn.  In cancer, MAGL inhibitors have been shown to have anti-cancer properties not only through modulating the endocannabinoid-eicosanoid network, but also by controlling fatty acid release for the synthesis of protumorigenic signaling lipids.  Thus, MAGL serves as a crit. node in simultaneously coordinating multiple lipid signaling pathways in both physiol. and disease contexts.  This review will discuss the diverse (patho)physiol. roles of MAGL and the therapeutic potential of MAGL inhibitors in treating a vast array of complex human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojyVx1YSerrVg90H21EOLACvtfcHk0lgKb-TjTVY2Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKqsL7O&md5=cb44625201730a7849701df80fadb708</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2012.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2012.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DM.%2BM.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DTherapeutic%2520potential%2520of%2520monoacylglycerol%2520lipase%2520inhibitors%26jtitle%3DLife%2520Sci.%26date%3D2013%26volume%3D92%26spage%3D492%26epage%3D497%26doi%3D10.1016%2Fj.lfs.2012.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span> For a recent review
on MAGL PET ligand development, please see:<span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phenix, C. P.</span></span> <span> </span><span class="NLM_article-title">Molecular imaging of hydrolytic enzymes using PET and SPECT</span>. <i>Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>, <span class="NLM_elocation-id">1536012117717852</span> <span class="refDoi"> DOI: 10.1177/1536012117717852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1177%2F1536012117717852" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&author=B.+P.+Rempelauthor=E.+W.+Priceauthor=C.+P.+Phenix&title=Molecular+imaging+of+hydrolytic+enzymes+using+PET+and+SPECT&doi=10.1177%2F1536012117717852"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1177%2F1536012117717852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1536012117717852%26sid%3Dliteratum%253Aachs%26aulast%3DRempel%26aufirst%3DB.%2BP.%26aulast%3DPrice%26aufirst%3DE.%2BW.%26aulast%3DPhenix%26aufirst%3DC.%2BP.%26atitle%3DMolecular%2520imaging%2520of%2520hydrolytic%2520enzymes%2520using%2520PET%2520and%2520SPECT%26jtitle%3DMol.%2520Imaging%26date%3D2017%26volume%3D16%26doi%3D10.1177%2F1536012117717852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. J.</span></span> <span> </span><span class="NLM_article-title">Positron emission tomography and single-photon emission computed tomography in central nervous system drug development</span>. <i>NeuroRx</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1602/neurorx.2.2.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1602%2Fneurorx.2.2.226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=15897947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntVeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=226-236&author=D.+J.+Brooks&title=Positron+emission+tomography+and+single-photon+emission+computed+tomography+in+central+nervous+system+drug+development&doi=10.1602%2Fneurorx.2.2.226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography and single-photon emission computed tomography in central nervous system drug development</span></div><div class="casAuthors">Brooks David J</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-36</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">In this review, the value of functional imaging [positron emission tomography (PET)/single-photon emission computed tomography (SPECT)] in drug development is considered.  Radionuclide imaging can help establish the diagnosis of neurodegenerative disorders where this is in doubt and provides a potential biomarker for following drug effects on disease progression.  PET and SPECT can help understand mechanisms of disease and determine the functional effects of therapeutic approaches on neurotransmission and metabolism.  Synthesizing radiotracer analogs of novel drugs can provide proof of principle that these agents reach their enzyme or receptor targets and delineate their regional brain distribution.  If such radiotracers do not prove to have ideal properties for imaging, the concept of microdosing potentially allows multiple other drug analogs to be tested with less stringent regulatory requirements than for novel medicinals.  Finally, PET tracers can provide receptor and enzyme active site dose occupancy profiles, thereby guiding dosage selection for phase 1 and phase 2 trials.  The eventual hope is that radiotracer imaging will provide a surrogate marker for drug efficacy, although this has yet to be realized, and progress the concept of personalized medicine where receptor/enzyme binding profiles help predict therapeutic outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8zmuJRBq_D-3MPKNEWB5RfW6udTcc2eYULq7qPrt1Z7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntVeisQ%253D%253D&md5=fe2cc9f1d9f2418894a104de364126c6</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.2.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.2.226%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DPositron%2520emission%2520tomography%2520and%2520single-photon%2520emission%2520computed%2520tomography%2520in%2520central%2520nervous%2520system%2520drug%2520development%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D226%26epage%3D236%26doi%3D10.1602%2Fneurorx.2.2.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauscher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gründer, G.</span></span> <span> </span><span class="NLM_article-title">The role of imaging in proof of concept for CNS drug discovery and development</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1038/npp.2008.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1038%2Fnpp.2008.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=18843264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=187-203&author=D.+F.+Wongauthor=J.+Tauscherauthor=G.+Gr%C3%BCnder&title=The+role+of+imaging+in+proof+of+concept+for+CNS+drug+discovery+and+development&doi=10.1038%2Fnpp.2008.166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development</span></div><div class="casAuthors">Wong, Dean F.; Tauscher, Johannes; Grunder, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-203</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuroimaging, particularly that of neuroreceptor radioisotope and functional magnetic resonance imaging (fMRI), has played a fundamental role in neuropharmacol. and neurophysiol.  Because of the unique and pioneering role, esp. of the radiolabeling of central nervous system (CNS) drugs for receptor and neurotransmitter system imaging, there is an increasingly major role to aid in CNS drug development.  One component is providing evidence for proof of concept of the target for which candidate drugs are being tested for receptor occupancy mechanism of action and ultimately rational drug dosing.  There is also a role for other areas of neuroimaging, including fMRI and magnetic resonance spectroscopy in other magnetic resonance-based techniques that, together with radioisotope imaging, represent CNS mol. imaging.  ' The role of these approaches and a review of the recent advances in such neuroimaging for proof-of-concept studies is the subject for this paper.  Moreover, hypothetical examples and possible algorithms for early discovery/phase I development using neuroimaging provide specific working approaches.  In summary, this article reviews the vital biomarker approach of neuroimaging in proof of concept studies.  Neuropsychopharmacol. (2009) 34, 187-203; doi:10.1038/npp.2008.166; published online 8 Oct. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8I0KCciAqxbVg90H21EOLACvtfcHk0liYZpmIwsHBLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN&md5=c5c7b9b30303e57ceabf287e7eec35b6</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2008.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2008.166%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520imaging%2520in%2520proof%2520of%2520concept%2520for%2520CNS%2520drug%2520discovery%2520and%2520development%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D187%26epage%3D203%26doi%3D10.1038%2Fnpp.2008.166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Imaging Techniques for Central Nervous System (CNS) Drug Discovery</span>. In  <i>Blood–Brain Barrier in Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span>, <span class="NLM_string-name">Kerns, E. H.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New Jersey</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">384</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1002%2F9781118788523.ch17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=365-384&author=L.+Zhang&author=A.+Villalobosauthor=D.+Li&author=E.+H.+Kerns&title=Blood%E2%80%93Brain+Barrier+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1002%2F9781118788523.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118788523.ch17%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DImaging%2520Techniques%2520for%2520Central%2520Nervous%2520System%2520%2528CNS%2529%2520Drug%2520Discovery%26btitle%3DBlood%25E2%2580%2593Brain%2520Barrier%2520in%2520Drug%2520Discovery%26aulast%3DLi%26aufirst%3DD.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2015%26spage%3D365%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span> <span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4568</span>– <span class="NLM_lpage">4579</span>, <span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0ljD3YbJSrXgxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuszpit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciabola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of a novel phosphodiesterase (PDE) 4B-preferring radioligand for positron emission tomography (PET) imaging</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8538</span>– <span class="NLM_lpage">8551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOmu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8538-8551&author=L.+Zhangauthor=L.+Chenauthor=E.+M.+Beckauthor=T.+A.+Chappieauthor=R.+V.+Coelhoauthor=S.+D.+Doranauthor=K.-H.+Fanauthor=C.+J.+Helalauthor=J.+M.+Humphreyauthor=Z.+Hughesauthor=K.+Kuszpitauthor=E.+A.+Lachapelleauthor=J.+T.+Lazzaroauthor=C.+Leeauthor=R.+J.+Matherauthor=N.+C.+Patelauthor=M.+B.+Skaddanauthor=S.+Sciabolaauthor=P.+R.+Verhoestauthor=J.+M.+Youngauthor=K.+Zasadnyauthor=A.+Villalobos&title=The+discovery+of+a+novel+phosphodiesterase+%28PDE%29+4B-preferring+radioligand+for+positron+emission+tomography+%28PET%29+imaging&doi=10.1021%2Facs.jmedchem.7b01050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging</span></div><div class="casAuthors">Zhang, Lei; Chen, Laigao; Beck, Elizabeth M.; Chappie, Thomas A.; Coelho, Richard V.; Doran, Shawn D.; Fan, Kuo-Hsien; Humphrey, John M.; Hughes, Zoe; Kuszpit, Kyle; Lachapelle, Erik A.; Lazzaro, John T.; Mather, Robert J.; Patel, Nandini C.; Skaddan, Marc B.; Sciabola, Simone; Verhoest, Patrick R.; Young, Joseph M.; Zasadny, Kenneth; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8538-8551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort in identifying phosphodiesterase (PDE) 4B-preferring inhibitors for the treatment of central nervous system (CNS) disorders, we sought to identify a positron emission tomog. (PET) ligand to enable target occupancy measurement in vivo.  Through a systematic and cost-effective PET discovery process, involving expression level (Bmax) and biodistribution detn., a PET-specific structure-activity relationship (SAR) effort, and specific binding assessment using a LC-MS/MS "cold tracer" method, we have identified 8 (PF-06445974) as a promising PET lead.  Compd. 8 has exquisite potency at PDE4B, good selectivity over PDE4D, excellent brain permeability, and a high level of specific binding in the "cold tracer" study.  In subsequent non-human primate (NHP) PET imaging studies, [18F]8 showed rapid brain uptake and high target specificity, indicating that [18F]8 is a promising PDE4B-preferring radioligand for clin. PET imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAKXd3Cu5nRLVg90H21EOLACvtfcHk0ljD3YbJSrXgxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOmu7fI&md5=cecad407201ce6c59ac5a3257e921d07</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01050%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DCoelho%26aufirst%3DR.%2BV.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DFan%26aufirst%3DK.-H.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DZ.%26aulast%3DKuszpit%26aufirst%3DK.%26aulast%3DLachapelle%26aufirst%3DE.%2BA.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520a%2520novel%2520phosphodiesterase%2520%2528PDE%2529%25204B-preferring%2520radioligand%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8538%26epage%3D8551%26doi%3D10.1021%2Facs.jmedchem.7b01050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schildknegt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel positron emission tomography (PET) ligand for imaging β-site amyloid precursor protein cleaving enzyme 1 (BACE-1) in brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3296</span>– <span class="NLM_lpage">3308</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01769</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01769" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlyqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3296-3308&author=L.+Zhangauthor=L.+Chenauthor=J.+K.+Dutraauthor=E.+M.+Beckauthor=S.+Nagauthor=A.+Takanoauthor=N.+Aminiauthor=R.+Arakawaauthor=M.+A.+Brodneyauthor=L.+M.+Buzonauthor=S.+D.+Doranauthor=L.+F.+Lanyonauthor=T.+J.+McCarthyauthor=K.+R.+Balesauthor=C.+E.+Nolanauthor=B.+T.+O%E2%80%99Neillauthor=K.+Schildknegtauthor=C.+Halldinauthor=A.+Villalobos&title=Identification+of+a+novel+positron+emission+tomography+%28PET%29+ligand+for+imaging+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE-1%29+in+brain&doi=10.1021%2Facs.jmedchem.7b01769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain</span></div><div class="casAuthors">Zhang, Lei; Chen, Laigao; Dutra, Jason K.; Beck, Elizabeth M.; Nag, Sangram; Takano, Akihiro; Amini, Nahid; Arakawa, Ryosuke; Brodney, Michael A.; Buzon, Leanne M.; Doran, Shawn D.; Lanyon, Lorraine F.; McCarthy, Timothy J.; Bales, Kelly R.; Nolan, Charles E.; O'Neill, Brian T.; Schildknegt, Klaas; Halldin, Christer; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3296-3308</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by accumulation of β-amyloid (Aβ) plaques and neurofibrillary tau tangles in the brain. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) plays a key role in the generation of Aβ fragments via extracellular cleavage of the amyloid precursor protein (APP).  We became interested in developing a BACE1 PET ligand to facilitate clin. assessment of BACE1 inhibitors and explore its potential in the profiling and selection of patients for AD trials.  Using a set of PET ligand design parameters, compd. 3 (PF-06684511) was rapidly identified as a lead with favorable in vitro attributes and structural handles for PET radiolabeling.  Further evaluation in an LC-MS/MS "cold tracer" study in rodents revealed high specific binding to BACE1 in brain.  Upon radiolabeling, [18F]3 demonstrated favorable brain uptake and high in vivo specificity in nonhuman primate (NHP), suggesting its potential for imaging BACE1 in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG1yVp-f2aurVg90H21EOLACvtfcHk0li2-szXXRt7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyqu78%253D&md5=97501718b6e3db68047b7dae264a48bd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01769%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DNag%26aufirst%3DS.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DArakawa%26aufirst%3DR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DLanyon%26aufirst%3DL.%2BF.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DSchildknegt%26aufirst%3DK.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520a%2520novel%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligand%2520for%2520imaging%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE-1%2529%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3296%26epage%3D3308%26doi%3D10.1021%2Facs.jmedchem.7b01769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niphakis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cognetta, A. B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buczynski, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.chembiol.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=22542104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=579-588&author=J.+W.+Changauthor=M.+J.+Niphakisauthor=K.+M.+Lumauthor=A.+B.+Cognettaauthor=C.+Wangauthor=M.+L.+Matthewsauthor=S.+Niessenauthor=M.+W.+Buczynskiauthor=L.+H.+Parsonsauthor=B.+F.+Cravatt&title=Highly+selective+inhibitors+of+monoacylglycerol+lipase+bearing+a+reactive+group+that+is+bioisosteric+with+endocannabinoid+substrates&doi=10.1016%2Fj.chembiol.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span></div><div class="casAuthors">Chang, Jae Won; Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B.; Wang, Chu; Matthews, Megan L.; Niessen, Sherry; Buczynski, Matthew W.; Parsons, Loren H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), resp.  The recent discovery of O-aryl carbamates such as JZL184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo.  Nonetheless, JZL184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biol. studies.  Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH.  These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWEmTTUlQHCLVg90H21EOLACvtfcHk0li2-szXXRt7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D&md5=d318d890c4c799d1579daab2e2c201f4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMatthews%26aufirst%3DM.%2BL.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DHighly%2520selective%2520inhibitors%2520of%2520monoacylglycerol%2520lipase%2520bearing%2520a%2520reactive%2520group%2520that%2520is%2520bioisosteric%2520with%2520endocannabinoid%2520substrates%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D579%26epage%3D588%26doi%3D10.1016%2Fj.chembiol.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotstein, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasdev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of sulfonamido-based [<sup>11</sup>C-<i>carbonyl</i>]-carbamates and ureas for imaging monoacylglycerol lipase</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1145</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.7150/thno.15257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.7150%2Fthno.15257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=27279908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Cis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1145-1159&author=L.+Wangauthor=W.+Moriauthor=R.+Chengauthor=J.+Yuiauthor=A.+Hatoriauthor=L.+Maauthor=Y.+Zhangauthor=B.+H.+Rotsteinauthor=M.+Fujinagaauthor=Y.+Shimodaauthor=T.+Yamasakiauthor=L.+Xieauthor=Y.+Nagaiauthor=T.+Minamimotoauthor=M.+Higuchiauthor=N.+Vasdevauthor=M.-R.+Zhangauthor=S.+H.+Liang&title=Synthesis+and+preclinical+evaluation+of+sulfonamido-based+%5B11C-carbonyl%5D-carbamates+and+ureas+for+imaging+monoacylglycerol+lipase&doi=10.7150%2Fthno.15257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preclinical evaluation of sulfonamidobased [11C-carbonyl]-carbamates and ureas for imaging monoacylglycerol lipase</span></div><div class="casAuthors">Wang, Lu; Mori, Wakana; Cheng, Ran; Yui, Joji; Hatori, Akiko; Ma, Longle; Zhang, Yiding; Rotstein, Benjamin H.; Fujinaga, Masayuki; Shimoda, Yoko; Yamasaki, Tomoteru; Xie, Lin; Nagai, Yuji; Minamimoto, Takafumi; Higuchi, Makoto; Vasdev, Neil; Zhang, Ming-Rong; Liang, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1145-1159</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a 33 kDa member of the serine hydrolase superfamily that preferentially degrades 2-arachidonoylglycerol (2-AG) to arachidonic acid in the endocannabinoid system.  Inhibition of MAGL is not only of interest for probing the cannabinoid pathway but also as a therapeutic and diagnostic target for neuroinflammation.  Limited attempts have been made to image MAGL in vivo and a suitable PET ligand for this target has yet to be identified and is urgently sought to guide small mol. drug development in this pathway.  Herein we synthesized and evaluated the physiochem. properties of an array of eleven sulfonamido-based carbamates and ureas with a series of terminal aryl moieties, linkers and leaving groups.  The most potent compds. were a novel MAGL inhibitor, N-((1-(1H-1,2,4-triazole-1-carbonyl)piperidin-4-yl) methyl)-4-chlorobenzenesulfonamide (TZPU; IC50 = 35.9 nM), and the known inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(((4-chlorophenyl)sulfonamido) methyl)piperidine-1- carboxylate (SAR127303; IC50 = 39.3 nM), which were also shown to be selective for MAGL over fatty acid amide hydrolase (FAAH), and cannabinoid receptors (CB1 & CB2).  Both of these compds. were radiolabeled with carbon-11 via [11C]COCl2, followed by comprehensive ex vivo biodistribution and in vivo PET imaging studies in normal rats to det. their brain permeability, specificity, clearance and metab.  Whereas TZPU did not show adequate specificity to warrant further evaluation, [11C]SAR127303 was advanced for preliminary PET neuroimaging studies in nonhuman primate.  The tracer showed good brain permeability (ca. 1 SUV) and heterogeneous regional brain distribution which is consistent with the distribution of MAGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5MOdhV6XvFbVg90H21EOLACvtfcHk0li2-szXXRt7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Cis78%253D&md5=eb8493b2b83af17721a22d03151b7ba2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.7150%2Fthno.15257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.15257%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DRotstein%26aufirst%3DB.%2BH.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DShimoda%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DMinamimoto%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520sulfonamido-based%2520%255B11C-carbonyl%255D-carbamates%2520and%2520ureas%2520for%2520imaging%2520monoacylglycerol%2520lipase%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26spage%3D1145%26epage%3D1159%26doi%3D10.7150%2Fthno.15257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Griebel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeské, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Françon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Even, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Grancha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolstykh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houtmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallée, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augé, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergis, O. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avenet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikol, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escoubet, J.</span></span> <span> </span><span class="NLM_article-title">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">7642</span> <span class="refDoi"> DOI: 10.1038/srep07642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1038%2Fsrep07642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=25560837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&author=G.+Griebelauthor=P.+Pichatauthor=S.+Beesk%C3%A9author=T.+Leroyauthor=N.+Redonauthor=A.+Jacquetauthor=D.+Fran%C3%A7onauthor=L.+Bertauthor=L.+Evenauthor=M.+Lopez-Granchaauthor=T.+Tolstykhauthor=F.+Sunauthor=Q.+Yuauthor=S.+Brittainauthor=H.+Arltauthor=T.+Heauthor=B.+Zhangauthor=D.+Wiederschainauthor=T.+Bertrandauthor=J.+Houtmannauthor=A.+Rakauthor=F.+Vall%C3%A9eauthor=N.+Michotauthor=F.+Aug%C3%A9author=V.+Menetauthor=O.+E.+Bergisauthor=P.+Georgeauthor=P.+Avenetauthor=V.+Mikolauthor=M.+Didierauthor=J.+Escoubet&title=Selective+blockade+of+the+hydrolysis+of+the+endocannabinoid+2-arachidonoylglycerol+impairs+learning+and+memory+performance+while+producing+antinociceptive+activity+in+rodents&doi=10.1038%2Fsrep07642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span></div><div class="casAuthors">Griebel, Guy; Pichat, Philippe; Beeske, Sandra; Leroy, Thibaud; Redon, Nicolas; Jacquet, Agnes; Francon, Dominique; Bert, Lionel; Even, Luc; Lopez-Grancha, Mati; Tolstykh, Tatiana; Sun, Fangxian; Yu, Qunyan; Brittain, Scott; Arlt, Heike; He, Timothy; Zhang, Bailin; Wiederschain, Dmitri; Bertrand, Thomas; Houtmann, Jacques; Rak, Alexey; Vallee, Francois; Michot, Nadine; Auge, Franck; Menet, Veronique; Bergis, Olivier E.; George, Pascal; Avenet, Patrick; Mikol, Vincent; Didier, Michel; Escoubet, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7642</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) represents a primary degrdn. enzyme of the endogenous cannabinoid (eCB), 2-arachidonoyglycerol (2-AG).  This study reports a potent covalent MAGL inhibitor, SAR127303.  The compd. behaves as a selective and competitive inhibitor of mouse and human MAGL, which potently elevates hippocampal levels of 2-AG in mice.  In vivo, SAR127303 produces antinociceptive effects in assays of inflammatory and visceral pain.  In addn., the drug alters learning performance in several assays related to episodic, working and spatial memory.  Moreover, long term potentiation (LTP) of CA1 synaptic transmission and acetylcholine release in the hippocampus, two hallmarks of memory function, are both decreased by SAR127303.  Although inactive in acute seizure tests, repeated administration of SAR127303 delays the acquisition and decreases kindled seizures in mice, indicating that the drug slows down epileptogenesis, a finding deserving further investigation to evaluate the potential of MAGL inhibitors as antiepileptics.  However, the observation that 2-AG hydrolysis blockade alters learning and memory performance, suggests that such drugs may have limited value as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiPpgk18M26bVg90H21EOLACvtfcHk0lhbrsg4cH9gtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL&md5=4160ed016b730ea80abb5c093e66a284</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2Fsrep07642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07642%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DPichat%26aufirst%3DP.%26aulast%3DBeesk%25C3%25A9%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DT.%26aulast%3DRedon%26aufirst%3DN.%26aulast%3DJacquet%26aufirst%3DA.%26aulast%3DFran%25C3%25A7on%26aufirst%3DD.%26aulast%3DBert%26aufirst%3DL.%26aulast%3DEven%26aufirst%3DL.%26aulast%3DLopez-Grancha%26aufirst%3DM.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DBrittain%26aufirst%3DS.%26aulast%3DArlt%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DAug%25C3%25A9%26aufirst%3DF.%26aulast%3DMenet%26aufirst%3DV.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DDidier%26aufirst%3DM.%26aulast%3DEscoubet%26aufirst%3DJ.%26atitle%3DSelective%2520blockade%2520of%2520the%2520hydrolysis%2520of%2520the%2520endocannabinoid%25202-arachidonoylglycerol%2520impairs%2520learning%2520and%2520memory%2520performance%2520while%2520producing%2520antinociceptive%2520activity%2520in%2520rodents%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26doi%3D10.1038%2Fsrep07642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Placzek, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Bittner, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span> <span> </span><span class="NLM_article-title">A novel radiotracer for imaging monoacylglycerol lipase in the brain using positron emission tomography</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.5b00293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=484-489&author=C.+Wangauthor=M.+S.+Placzekauthor=G.+C.+Van+de+Bittnerauthor=F.+A.+Schroederauthor=J.+M.+Hooker&title=A+novel+radiotracer+for+imaging+monoacylglycerol+lipase+in+the+brain+using+positron+emission+tomography&doi=10.1021%2Facschemneuro.5b00293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography</span></div><div class="casAuthors">Wang, Changning; Placzek, Michael S.; Van de Bittner, Genevieve C.; Schroeder, Frederick A.; Hooker, Jacob M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">484-489</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a serine hydrolase that hydrolyzes monoacylglycerols to glycerol and fatty acid and plays an important role in neuroinflammation.  MAGL inhibitors are a class of mols. with therapeutic potential for human diseases of the central nervous system (CNS), in areas such as pain and inflammation, immunol. disorders, and neurol. and psychiatric conditions.  Development of a noninvasive imaging probe would elucidate the distribution and functional roles of MAGL in the brain and accelerate medical research and drug discovery in this domain.  Herein, we describe the synthesis and pilot rodent imaging of a novel MAGL imaging agent, [11C]SAR127303.  Our imaging results demonstrate the high specificity, good selectivity, and appropriate kinetics and distribution of [11C]SAR127303, validating its utility for imaging MAGL in the brain.  Our findings support the translational potential for human CNS MAGL imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKwFMlYYqhfbVg90H21EOLACvtfcHk0lhbrsg4cH9gtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7nP&md5=0cc854816045539b5ccb7b5d7819372b</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00293%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DPlaczek%26aufirst%3DM.%2BS.%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%2BC.%26aulast%3DSchroeder%26aufirst%3DF.%2BA.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26atitle%3DA%2520novel%2520radiotracer%2520for%2520imaging%2520monoacylglycerol%2520lipase%2520in%2520the%2520brain%2520using%2520positron%2520emission%2520tomography%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D484%26epage%3D489%26doi%3D10.1021%2Facschemneuro.5b00293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasdev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and ex vivo evaluation of [<sup>11</sup>C-<i>carbonyl</i>]carbamate- and urea-based monoacylglycerol lipase inhibitors</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.nucmedbio.2014.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=24969632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFentb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=688-694&author=J.+W.+Hicksauthor=J.+Parkesauthor=J.+Tongauthor=S.+Houleauthor=N.+Vasdevauthor=A.+A.+Wilson&title=Radiosynthesis+and+ex+vivo+evaluation+of+%5B11C-carbonyl%5Dcarbamate-+and+urea-based+monoacylglycerol+lipase+inhibitors&doi=10.1016%2Fj.nucmedbio.2014.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and ex vivo evaluation of [11C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors</span></div><div class="casAuthors">Hicks, Justin W.; Parkes, Jun; Tong, Junchao; Houle, Sylvain; Vasdev, Neil; Wilson, Alan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">688-694</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH) are the two primary enzymes that regulate the tone of endocannabinoid signaling.  Although new PET radiotracers have been discovered for imaging FAAH in vivo, no such radiotracer exists for imaging MAGL.  Here we report the radiosynthesis of five candidate MAGL radiotracers and their ex vivo evaluations in mice and rats.Candidate carbamate and urea MAGL inhibitors were radiolabeled at the carbonyl position by [11C]CO2 fixation.  Radiotracers were administered (tail-vein injection) to rodents and brain uptake of radioactivity measured at early and late time points ex vivo.  Specificity of uptake was explored by pretreatment with unlabeled inhibitors (2 mg/kg, i.p.) 30 min prior to radiotracer administration.All five candidate MAGL radiotracers were prepd. in high specific activity (> 65 GBq/μmol) and radiochem. purity (> 98%).  Moderate brain uptake (0.2-0.8 SUV) was obsd. for each candidate while pretreatment did not reduce uptake for four of the five tested.  For two candidates ([11C]12 and [11C]14), high retention of radioactivity was obsd. in the blood (ca. 10 and 4 SUV at 40 min) which was blocked by pretreatment with unlabeled inhibitors.  The most promising candidate, [11C]18, demonstrated moderate brain uptake (ca. 0.8 SUV) which showed circa 50% blockade by pretreatment with unlabeled 18.One putative and four reported potent and selective MAGL inhibitors have been radiolabeled via [11C]CO2 fixation as radiotracers for this enzyme.  Despite the promising in vitro pharmacol. profile, none of the five candidate radiotracers exhibited in vivo behavior suitable for PET neuroimaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi4CWj3XLZqrVg90H21EOLACvtfcHk0lhj5sCD0rrWUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFentb3M&md5=dcedea3b995995c96c88e7fa130378fa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DParkes%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26atitle%3DRadiosynthesis%2520and%2520ex%2520vivo%2520evaluation%2520of%2520%255B11C-carbonyl%255Dcarbamate-%2520and%2520urea-based%2520monoacylglycerol%2520lipase%2520inhibitors%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2014%26volume%3D41%26spage%3D688%26epage%3D694%26doi%3D10.1016%2Fj.nucmedbio.2014.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adibekian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, K.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1038/nchembio.579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1038%2Fnchembio.579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=21572424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtV2ht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=469-478&author=A.+Adibekianauthor=B.+R.+Martinauthor=C.+Wangauthor=K.-L.+Hsuauthor=D.+A.+Bachovchinauthor=S.+Niessenauthor=H.+Hooverauthor=B.+F.+Cravatt&title=Click-generated+triazole+ureas+as+ultrapotent+in+vivo-active+serine+hydrolase+inhibitors&doi=10.1038%2Fnchembio.579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors</span></div><div class="casAuthors">Adibekian, Alexander; Martin, Brent R.; Wang, Chu; Hsu, Ku-Lung; Bachovchin, Daniel A.; Niessen, Sherry; Hoover, Heather; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">469-478</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Serine hydrolases are a diverse enzyme class representing ∼1% of all human proteins.  The biol. functions of most serine hydrolases remain poorly characterized owing to a lack of selective inhibitors to probe their activity in living systems.  Here we show that a substantial no. of serine hydrolases can be irreversibly inactivated by 1,2,3-triazole ureas, which show negligible cross-reactivity with other protein classes.  Rapid lead optimization by click chem.-enabled synthesis and competitive activity-based profiling identified 1,2,3-triazole ureas that selectively inhibit enzymes from diverse branches of the serine hydrolase class, including peptidases (acyl-peptide hydrolase, or APEH), lipases (platelet-activating factor acetylhydrolase-2, or PAFAH2) and uncharacterized hydrolases (α,β-hydrolase-11, or ABHD11), with exceptional potency in cells (sub-nanomolar) and mice (<1 mg kg-1).  We show that APEH inhibition leads to accumulation of N-acetylated proteins and promotes proliferation in T cells.  These data indicate 1,2,3-triazole ureas are a pharmacol. privileged chemotype for serine hydrolase inhibition, combining broad activity across the serine hydrolase class with tunable selectivity for individual enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM_5ZfJ_B1ZrVg90H21EOLACvtfcHk0lhj5sCD0rrWUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtV2ht7s%253D&md5=236ff8d9ef723ed09c00cf1c47b6727d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.579%26sid%3Dliteratum%253Aachs%26aulast%3DAdibekian%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DHsu%26aufirst%3DK.-L.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DHoover%26aufirst%3DH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DClick-generated%2520triazole%2520ureas%2520as%2520ultrapotent%2520in%2520vivo-active%2520serine%2520hydrolase%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D469%26epage%3D478%26doi%3D10.1038%2Fnchembio.579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3008</span>– <span class="NLM_lpage">3026</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3008-3026&author=L.+A.+McAllisterauthor=C.+R.+Butlerauthor=S.+Menteauthor=S.+V.+O%E2%80%99Neilauthor=K.+R.+Fonsecaauthor=J.+R.+Piroauthor=J.+A.+Cianfrognaauthor=T.+L.+Foleyauthor=A.+M.+Gilbertauthor=A.+R.+Harrisauthor=C.+J.+Helalauthor=D.+S.+Johnsonauthor=J.+I.+Montgomeryauthor=D.+M.+Nasonauthor=S.+Noellauthor=J.+Panditauthor=B.+N.+Rogersauthor=T.+A.+Samadauthor=C.+L.+Shafferauthor=R.+G.+da+Silvaauthor=D.+P.+Uccelloauthor=D.+Webbauthor=M.+A.+Brodney&title=Discovery+of+trifluoromethyl+glycol+carbamates+as+potent+and+selective+covalent+monoacylglycerol+lipase+%28MAGL%29+inhibitors+for+treatment+of+neuroinflammation&doi=10.1021%2Facs.jmedchem.8b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation</span></div><div class="casAuthors">McAllister, Laura A.; Butler, Christopher R.; Mente, Scot; O'Neil, Steven V.; Fonseca, Kari R.; Piro, Justin R.; Cianfrogna, Julie A.; Foley, Timothy L.; Gilbert, Adam M.; Harris, Anthony R.; Helal, Christopher J.; Johnson, Douglas S.; Montgomery, Justin I.; Nason, Deane M.; Noell, Stephen; Pandit, Jayvardhan; Rogers, Bruce N.; Samad, Tarek A.; Shaffer, Christopher L.; da Silva, Rafael G.; Uccello, Daniel P.; Webb, Damien; Brodney, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3008-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) inhibition provides a potential treatment approach to neuroinflammation through modulation of both the endocannabinoid pathway and arachidonoyl signaling in the central nervous system (CNS).  Herein we report the discovery of compd. I (PF-06795071), a potent and selective covalent MAGL inhibitor, featuring a novel trifluoromethyl glycol leaving group that confers significant physicochem. property improvements as compared with earlier inhibitor series with more lipophilic leaving groups.  The design strategy focused on identifying an optimized leaving group that delivers MAGL potency, serine hydrolase selectivity, and CNS exposure while simultaneously reducing log D, improving soly., and minimizing chem. lability.  Compd. I achieves excellent CNS exposure, extended 2-AG elevation effect in vivo, and decreased brain inflammatory markers in response to an inflammatory challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEF-xXUaFF7Vg90H21EOLACvtfcHk0lhj5sCD0rrWUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKlurw%253D&md5=984babc4de306b698756e9c2a9fc5c8e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00070%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DL.%2BA.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DMente%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DPiro%26aufirst%3DJ.%2BR.%26aulast%3DCianfrogna%26aufirst%3DJ.%2BA.%26aulast%3DFoley%26aufirst%3DT.%2BL.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DNoell%26aufirst%3DS.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3Dda%2BSilva%26aufirst%3DR.%2BG.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520trifluoromethyl%2520glycol%2520carbamates%2520as%2520potent%2520and%2520selective%2520covalent%2520monoacylglycerol%2520lipase%2520%2528MAGL%2529%2520inhibitors%2520for%2520treatment%2520of%2520neuroinflammation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3008%26epage%3D3026%26doi%3D10.1021%2Facs.jmedchem.8b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">The complete selectivity profiles of compound <b>7</b> in a CEREP broad-spectrum selectivity panel and a serine hydrolase selectivity panel are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R.</span></span> <span> </span><span class="NLM_article-title">In vivo site-directed radiotracers: a mini-review</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+vivo+site-directed+radiotracers%3A+a+mini-review&doi=10.1016%2Fj.nucmedbio.2008.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0lhbBPppDsg9wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520site-directed%2520radiotracers%253A%2520a%2520mini-review%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815%26doi%3D10.1016%2Fj.nucmedbio.2008.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span> CPD-4645 is a selective
MAGL inhibitor identified from published patent literature, structurally
analogous to the previously reported SAR127303. For additional information,
please see:<span class="NLM_contrib-group"><span class="NLM_string-name">Terrone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauletti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salamone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilmette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezzani, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet</span>. <i>Epilepsia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1111/epi.13950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1111%2Fepi.13950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=29171003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1Wjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=79-91&author=G.+Terroneauthor=A.+Paulettiauthor=A.+Salamoneauthor=M.+Rizziauthor=B.+R.+Villaauthor=L.+Porcuauthor=M.+J.+Sheehanauthor=E.+Guilmetteauthor=C.+R.+Butlerauthor=J.+R.+Piroauthor=T.+A.+Samadauthor=A.+Vezzani&title=Inhibition+of+monoacylglycerol+lipase+terminates+diazepam-resistant+status+epilepticus+in+mice+and+its+effects+are+potentiated+by+a+ketogenic+diet&doi=10.1111%2Fepi.13950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet</span></div><div class="casAuthors">Terrone, Gaetano; Pauletti, Alberto; Salamone, Alessia; Rizzi, Massimo; Villa, Bianca R.; Porcu, Luca; Sheehan, Mark J.; Guilmette, Edward; Butler, Christopher R.; Piro, Justin R.; Samad, Tarek A.; Vezzani, Annamaria</div><div class="citationInfo"><span class="NLM_cas:title">Epilepsia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-91</span>CODEN:
                <span class="NLM_cas:coden">EPILAK</span>;
        ISSN:<span class="NLM_cas:issn">0013-9580</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Objective : Status epilepticus (SE) is a life-threatening and commonly drug-refractory condition.  Novel therapies are needed to rapidly terminate seizures to prevent mortality and morbidity.  Monoacylglycerol lipase (MAGL) is the key enzyme responsible for the hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG) and a major contributor to the brain pool of arachidonic acid (AA).  Inhibiting of monoacylglycerol lipase modulates synaptic activity and neuroinflammation, 2 mediators of excessive neuronal activation underlying seizures.  We studied the effect of a potent and selective irreversible MAGL inhibitor, CPD-4645, on SE that was refractory to diazepam, its neuropathol. sequelae, and the mechanism underlying the drug's effects.  Methods : Diazepam-resistant SE was induced in adult mice fed with std. or ketogenic diet or in cannabinoid receptor type 1 (CB1) receptor knock-out mice.  CPD-4645 (10 mg/kg, s.c.) or vehicle was dosed 1 and 7 h after status epilepticus onset in video-electroencephalog. (EEG) recorded mice.  At the end of SE, mice were examd. in the novel object recognition test followed by neuronal cellloss anal.  Results : CPD-4645 maximal plasma and brain concns. were attained 0.5 h postinjection (half-life = 3.7 h) and elevated brain 2-AG levels by approx. 4-fold.  CPD-4645 administered to std. diet-fed mice progressively reduced spike frequency during 3 h postinjection, thereby shortening SE duration by 47%.  The drug immediately abrogated SE in ketogenic diet-fed mice.  CPD-4645 rescued neuronal cell loss and cognitive deficit and reduced interleukin (IL)-1β and cyclooxygenase 2 (COX-2) brain expression resulting from SE.  The CPD-4645 effect on SE was similar in mice lacking CB1 receptors.  Significance : MAGL represents a novel therapeutic target for treating status epilepticus and improving its sequelae.  CPD-4645 therapeutic effects appear to be predominantly mediated by modulation of neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2MDze8qS8k7Vg90H21EOLACvtfcHk0lhbBPppDsg9wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1Wjug%253D%253D&md5=69623c92048413dd9ec6b1f890f41f2d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fepi.13950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fepi.13950%26sid%3Dliteratum%253Aachs%26aulast%3DTerrone%26aufirst%3DG.%26aulast%3DPauletti%26aufirst%3DA.%26aulast%3DSalamone%26aufirst%3DA.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DVilla%26aufirst%3DB.%2BR.%26aulast%3DPorcu%26aufirst%3DL.%26aulast%3DSheehan%26aufirst%3DM.%2BJ.%26aulast%3DGuilmette%26aufirst%3DE.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DPiro%26aufirst%3DJ.%2BR.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26aulast%3DVezzani%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520monoacylglycerol%2520lipase%2520terminates%2520diazepam-resistant%2520status%2520epilepticus%2520in%2520mice%2520and%2520its%2520effects%2520are%2520potentiated%2520by%2520a%2520ketogenic%2520diet%26jtitle%3DEpilepsia%26date%3D2018%26volume%3D59%26spage%3D79%26epage%3D91%26doi%3D10.1111%2Fepi.13950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peredo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nistér, M.</span></span> <span> </span><span class="NLM_article-title">Optimized protein extraction from cryopreserved brain tissue samples</span>. <i>Acta Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1080/02841860600847061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1080%2F02841860600847061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=17438701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVOmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=10-20&author=C.+Ericssonauthor=I.+Peredoauthor=M.+Nist%C3%A9r&title=Optimized+protein+extraction+from+cryopreserved+brain+tissue+samples&doi=10.1080%2F02841860600847061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Optimized protein extraction from cryopreserved brain tissue samples</span></div><div class="casAuthors">Ericsson, Christer; Peredo, Inti; Nister, Monica</div><div class="citationInfo"><span class="NLM_cas:title">Acta Oncologica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-20</span>CODEN:
                <span class="NLM_cas:coden">ACTOEL</span>;
        ISSN:<span class="NLM_cas:issn">0284-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Optimal std. conditions for protein extn. and solubilization from frozen tissue samples have been examd.  Quant. differences in specific protein amts. or post-translational modifications underlie many, if not all, disease states.  Maximal and standardized extn. and solubilization of protein from diseased or healthy tissue is important to make the whole protein complement available for proteomic anal., and to make the best use of a precious resource.  Minimal degrdn. of the protein amino acid backbone, or of phosphorylated amino acid side chains, during sample prepn. is essential to preserve the anal. utility of the ext.  The authors have investigated parameters of brain tissue disintegration, and of extn./solubilization temp., time and vol. and have reached 98% extn. of brain tissue, corresponding to about 100 μg protein per mg tissue wet wt., by an SDS-based method: Tissue disintegration in the frozen state, by ball mill grinding followed by extn. and solubilization in 2% SDS for 10 min, at 70°C, in a vol. corresponding to ten times the tissue wet wt., with shaking.  The treatment with SDS sample buffer can inhibit protease and phosphatase activity.  Moreover, endogenous enzyme can be inhibited by incubation at high pH.  The resulting protein exts. can be used for both one-dimensional SDS gel-electrophoresis and for two-dimensional isoelec. focusing/SDS electrophoresis.  The proposed std. protocol has the potential to find wide application where protein extn., solubilization, identification and quantitation from cryopreserved clin. samples are desirable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGortpiXdvZp5bVg90H21EOLACvtfcHk0lis9FsLVvqPvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVOmt74%253D&md5=578b6c3b723e24fa84fd588116d2d449</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F02841860600847061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02841860600847061%26sid%3Dliteratum%253Aachs%26aulast%3DEricsson%26aufirst%3DC.%26aulast%3DPeredo%26aufirst%3DI.%26aulast%3DNist%25C3%25A9r%26aufirst%3DM.%26atitle%3DOptimized%2520protein%2520extraction%2520from%2520cryopreserved%2520brain%2520tissue%2520samples%26jtitle%3DActa%2520Oncol.%26date%3D2007%26volume%3D46%26spage%3D10%26epage%3D20%26doi%3D10.1080%2F02841860600847061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span>; <span class="NLM_string-name">McAllister, L. A.</span>; <span class="NLM_string-name">Beck, E. M.</span>; <span class="NLM_string-name">Brodney, M. A.</span>; <span class="NLM_string-name">Gilbert, A. M.</span>; <span class="NLM_string-name">Helal, C. J.</span>; <span class="NLM_string-name">Johnson, D. S.</span>; <span class="NLM_string-name">Montgomery, J. I.</span>; <span class="NLM_string-name">O’Neil, S. V.</span>; <span class="NLM_string-name">Rogers, B. N.</span>; <span class="NLM_string-name">Verhoest, P. R.</span>; <span class="NLM_string-name">Webb, D.</span></span> <span> </span><span class="NLM_article-title">1,1,1-Trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives and 1,1,1-Trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives as MAGL Inhibitors</span>. <span class="NLM_patent">US20170029390</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+R.+Butler&author=L.+A.+McAllister&author=E.+M.+Beck&author=M.+A.+Brodney&author=A.+M.+Gilbert&author=C.+J.+Helal&author=D.+S.+Johnson&author=J.+I.+Montgomery&author=S.+V.+O%E2%80%99Neil&author=B.+N.+Rogers&author=P.+R.+Verhoest&author=D.+Webb&title=1%2C1%2C1-Trifluoro-3-hydroxypropan-2-yl+Carbamate+Derivatives+and+1%2C1%2C1-Trifluoro-4-hydroxybutan-2-yl+Carbamate+Derivatives+as+MAGL+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26atitle%3D1%252C1%252C1-Trifluoro-3-hydroxypropan-2-yl%2520Carbamate%2520Derivatives%2520and%25201%252C1%252C1-Trifluoro-4-hydroxybutan-2-yl%2520Carbamate%2520Derivatives%2520as%2520MAGL%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of (4<i>R</i>)-1-{3-[2-(<sup>18</sup>F)fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([<sup>18</sup>F]T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2362</span>– <span class="NLM_lpage">2375</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01576</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01576" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVSht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2362-2375&author=Y.+Hattoriauthor=K.+Aoyamaauthor=J.+Maedaauthor=N.+Arimuraauthor=Y.+Takahashiauthor=M.+Sasakiauthor=M.+Fujinagaauthor=C.+Sekiauthor=Y.+Nagaiauthor=K.+Kawamuraauthor=T.+Yamasakiauthor=M.-R.+Zhangauthor=M.+Higuchiauthor=T.+Koike&title=Design%2C+synthesis%2C+and+evaluation+of+%284R%29-1-%7B3-%5B2-%2818F%29fluoro-4-methylpyridin-3-yl%5Dphenyl%7D-4-%5B4-%281%2C3-thiazol-2-ylcarbonyl%29piperazin-1-yl%5Dpyrrolidin-2-one+%28%5B18F%5DT-401%29+as+a+novel+positron-emission+tomography+imaging+agent+for+monoacylglycerol+lipase&doi=10.1021%2Facs.jmedchem.8b01576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of (4R)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a Novel Positron-Emission Tomography Imaging Agent for Monoacylglycerol Lipase</span></div><div class="casAuthors">Hattori, Yasushi; Aoyama, Kazunobu; Maeda, Jun; Arimura, Naoto; Takahashi, Yasuko; Sasaki, Masako; Fujinaga, Masayuki; Seki, Chie; Nagai, Yuji; Kawamura, Kazunori; Yamasaki, Tomoteru; Zhang, Ming-Rong; Higuchi, Makoto; Koike, Tatsuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2362-2375</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a cytosolic serine hydrolase involved in endocannabinoid and inflammatory signaling.  Positron-emission tomog. (PET) imaging of MAGL serves to validate target engagement of therapeutic MAGL inhibitors as well as to investigate MAGL levels under normal and disease conditions.  However, PET radioligands with reversible binding kinetics for MAGL, which allow quant. assessment of MAGL, are hitherto unavailable.  In this study, we designed and synthesized fluoro-contg. PET probes starting from a recently identified piperazinyl pyrrolidine-2-one deriv. with reversible binding to MAGL.  By tailoring the lipophilicity of the mol. to optimize nonspecific binding and blood-brain barrier permeability, we successfully identified two compds. that show high uptake to regions enriched with MAGL.  PET imaging of wild-type and MAGL-deficient mice as well as a macaque monkey indicated that [18F]I ((4R)-1-{3-[2-(18F)fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one, [18F]T-401) specifically binds to MAGL with adequate reversibility, yielding a high contrast for MAGL within an appropriate imaging time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppgW6fA1E8WLVg90H21EOLACvtfcHk0lis9FsLVvqPvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVSht7k%253D&md5=4848fa8fce411e960b580b5bd007e0c9</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01576%26sid%3Dliteratum%253Aachs%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DAoyama%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DArimura%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DC.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DHiguchi%26aufirst%3DM.%26aulast%3DKoike%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520%25284R%2529-1-%257B3-%255B2-%252818F%2529fluoro-4-methylpyridin-3-yl%255Dphenyl%257D-4-%255B4-%25281%252C3-thiazol-2-ylcarbonyl%2529piperazin-1-yl%255Dpyrrolidin-2-one%2520%2528%255B18F%255DT-401%2529%2520as%2520a%2520novel%2520positron-emission%2520tomography%2520imaging%2520agent%2520for%2520monoacylglycerol%2520lipase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2362%26epage%3D2375%26doi%3D10.1021%2Facs.jmedchem.8b01576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafroth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasdev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josephson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of reversible and irreversible monoacylglycerol lipase positron emission tomography (PET) tracers using a “tail switching” strategy on a piperazinyl azetidine skeleton</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3336</span>– <span class="NLM_lpage">3353</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01778</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01778" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktV2mtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3336-3353&author=Z.+Chenauthor=W.+Moriauthor=X.+Dengauthor=R.+Chengauthor=D.+Ogasawaraauthor=G.+Zhangauthor=M.+A.+Schafrothauthor=K.+Dahlauthor=H.+Fuauthor=A.+Hatoriauthor=T.+Shaoauthor=Y.+Zhangauthor=T.+Yamasakiauthor=X.+Zhangauthor=J.+Rongauthor=Q.+Yuauthor=K.+Huauthor=M.+Fujinagaauthor=L.+Xieauthor=K.+Kumataauthor=Y.+Gouauthor=J.+Chenauthor=S.+Guauthor=L.+Baoauthor=L.+Wangauthor=T.+L.+Collierauthor=N.+Vasdevauthor=Y.+Shaoauthor=J.-A.+Maauthor=B.+F.+Cravattauthor=C.+Fowlerauthor=L.+Josephsonauthor=M.-R.+Zhangauthor=S.+H.+Liang&title=Design%2C+synthesis%2C+and+evaluation+of+reversible+and+irreversible+monoacylglycerol+lipase+positron+emission+tomography+%28PET%29+tracers+using+a+%E2%80%9Ctail+switching%E2%80%9D+strategy+on+a+piperazinyl+azetidine+skeleton&doi=10.1021%2Facs.jmedchem.8b01778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine Skeleton</span></div><div class="casAuthors">Chen, Zhen; Mori, Wakana; Deng, Xiaoyun; Cheng, Ran; Ogasawara, Daisuke; Zhang, Genwei; Schafroth, Michael A.; Dahl, Kenneth; Fu, Hualong; Hatori, Akiko; Shao, Tuo; Zhang, Yiding; Yamasaki, Tomoteru; Zhang, Xiaofei; Rong, Jian; Yu, Qingzhen; Hu, Kuan; Fujinaga, Masayuki; Xie, Lin; Kumata, Katsushi; Gou, Yuancheng; Chen, Jingjin; Gu, Shuyin; Bao, Liang; Wang, Lu; Collier, Thomas Lee; Vasdev, Neil; Shao, Yihan; Ma, Jun-An; Cravatt, Benjamin F.; Fowler, Christopher; Josephson, Lee; Zhang, Ming-Rong; Liang, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3336-3353</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a serine hydrolase that degrades 2-arachidonoylglycerol (2-AG) in the endocannabinoid system (eCB).  Selective inhibition of MAGL has emerged as a potential therapeutic approach for the treatment of diverse pathol. conditions, including chronic pain, inflammation, cancer, and neurodegeneration.  Herein, we disclose a novel array of reversible and irreversible MAGL inhibitors by means of "tail switching" on a piperazinyl azetidine scaffold.  We developed a lead irreversible-binding MAGL inhibitor 8 and reversible-binding compds. 17 and 37, which are amenable for radiolabeling with 11C or 18F. [11C]8 ([11C]MAGL-2-11) exhibited high brain uptake and excellent binding specificity in the brain toward MAGL.  Reversible radioligands [11C]17 ([11C]PAD) and [18F]37 ([18F]MAGL-4-11) also demonstrated excellent in vivo binding specificity toward MAGL in peripheral organs.  This work may pave the way for the development of MAGL-targeted positron emission tomog. tracers with tunability in reversible and irreversible binding mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq14JLjFrGKxrVg90H21EOLACvtfcHk0lis9FsLVvqPvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktV2mtbs%253D&md5=261c3ea3d090e90c7f3c23701a0c9c34</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01778%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMori%26aufirst%3DW.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchafroth%26aufirst%3DM.%2BA.%26aulast%3DDahl%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRong%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DKumata%26aufirst%3DK.%26aulast%3DGou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DS.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCollier%26aufirst%3DT.%2BL.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.-A.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DFowler%26aufirst%3DC.%26aulast%3DJosephson%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520reversible%2520and%2520irreversible%2520monoacylglycerol%2520lipase%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520tracers%2520using%2520a%2520%25E2%2580%259Ctail%2520switching%25E2%2580%259D%2520strategy%2520on%2520a%2520piperazinyl%2520azetidine%2520skeleton%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3336%26epage%3D3353%26doi%3D10.1021%2Facs.jmedchem.8b01778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attili, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veghel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berben, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savinainen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of [<sup>11</sup>C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2Fj.ejmech.2017.04.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=28486208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsVansro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=104-113&author=M.+Ahamedauthor=B.+Attiliauthor=D.+van+Veghelauthor=M.+Oomsauthor=P.+Berbenauthor=S.+Celenauthor=M.+Kooleauthor=L.+Declercqauthor=J.+R.+Savinainenauthor=J.+T.+Laitinenauthor=A.+Verbruggenauthor=G.+Bormans&title=Synthesis+and+preclinical+evaluation+of+%5B11C%5DMA-PB-1+for+in+vivo+imaging+of+brain+monoacylglycerol+lipase+%28MAGL%29&doi=10.1016%2Fj.ejmech.2017.04.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preclinical evaluation of [11C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)</span></div><div class="casAuthors">Ahamed, Muneer; Attili, Bala; van Veghel, Daisy; Ooms, Maarten; Berben, Philippe; Celen, Sofie; Koole, Michel; Declercq, Lieven; Savinainen, Juha R.; Laitinen, Jarmo T.; Verbruggen, Alfons; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104-113</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Synthesis and preclin. evaluation of labeled [11C]MA-PB-1 (I) as an irreversible MAGL (monoacylglycerol lipase) inhibitor PET tracer is reported.  The in-vitro inhibitory activity, ex-vivo distribution, brain kinetics and specificity of compd. I binding were studied.  Ex-vivo biodistribution and microPET showed good brain uptake which could be blocked by pretreatment with both compd. I and a structurally non-related MAGL inhibitor MJN110 (compd. II).  These initial results suggested that compd. I is a suitable tracer for in-vivo imaging of MAGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZZw-mML3QX7Vg90H21EOLACvtfcHk0li0DM7cUwnnIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsVansro%253D&md5=8247caa5fc4f5d0bbee21e96c4dfbb24</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.066%26sid%3Dliteratum%253Aachs%26aulast%3DAhamed%26aufirst%3DM.%26aulast%3DAttili%26aufirst%3DB.%26aulast%3Dvan%2BVeghel%26aufirst%3DD.%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DBerben%26aufirst%3DP.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDeclercq%26aufirst%3DL.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520%255B11C%255DMA-PB-1%2520for%2520in%2520vivo%2520imaging%2520of%2520brain%2520monoacylglycerol%2520lipase%2520%2528MAGL%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D136%26spage%3D104%26epage%3D113%26doi%3D10.1016%2Fj.ejmech.2017.04.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krohn, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. C.</span></span> <span> </span><span class="NLM_article-title">Production of [<sup>11</sup>C]CH<sub>3</sub>I by single pass reaction of [<sup>11</sup>C]CH<sub>4</sub> with I<sub>2</sub></span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/S0969-8051(96)00181-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=10.1016%2FS0969-8051%2896%2900181-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=9080480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;key=1%3ACAS%3A528%3ADyaK2sXhvFCns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1997&pages=93-97&author=J.+M.+Linkauthor=K.+A.+Krohnauthor=J.+C.+Clark&title=Production+of+%5B11C%5DCH3I+by+single+pass+reaction+of+%5B11C%5DCH4+with+I2&doi=10.1016%2FS0969-8051%2896%2900181-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Production of [11C]CH3I by single pass reaction of [11C]CH4 with I2</span></div><div class="casAuthors">Link, Jeanne M.; Krohn, Kenneth A.; Clark, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-97</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We report a single pass gas phase route to [11C]CH3I based on prodn. of I· from I2 at elevated temp.  I· abstrs. H from CH4 to yield ·CH3, which reacts with I2 to form CH3I.  A fiber optic spectrometer was used to measure the I2 vapor concn.  [11C]CH3I yield increased with I2 concn. until excessive amts. of condensed I2 began to trap the 11C.  The yield of [11C]CH3I was >50% from [11C]CH4; its specific activity was 12,000 Ci/mmole.  The synthesis takes only 4 min after 11CH4 prodn. and can be repeated without system cleanup.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp311_GgrPqGLVg90H21EOLACvtfcHk0li0DM7cUwnnIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvFCns7k%253D&md5=07dabab577cacdf12510db52563424dc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2896%2900181-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252896%252900181-3%26sid%3Dliteratum%253Aachs%26aulast%3DLink%26aufirst%3DJ.%2BM.%26aulast%3DKrohn%26aufirst%3DK.%2BA.%26aulast%3DClark%26aufirst%3DJ.%2BC.%26atitle%3DProduction%2520of%2520%255B11C%255DCH3I%2520by%2520single%2520pass%2520reaction%2520of%2520%255B11C%255DCH4%2520with%2520I2%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1997%26volume%3D24%26spage%3D93%26epage%3D97%26doi%3D10.1016%2FS0969-8051%2896%2900181-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00847">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_31111"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00847">10.1021/acs.jmedchem.9b00847</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra for compound <b>7</b> and its phenol precursor <b>20</b>, with peak assignments; selectivity profile of compound <b>7</b> in CEREP and serine hydrolase selectivity panels; the serine hydrolase selectivity profile of the parent compound of prodrug compound A used as the blocking compound in the NHP PET imaging experiment; inhibition data of standard MAGL inhibitors JZL184, KML29 and FAAH inhibitor URB597; in-house CB1 functional agonism assay protocol and dose–response curve of compound <b>7</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_001.pdf">jm9b00847_si_001.pdf (587.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00847/suppl_file/jm9b00847_si_002.csv">jm9b00847_si_002.csv (0.57 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00847&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00847%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00847" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997cd23aef24cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
